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Maternal death affects 303,000 women every year, with 99% of these occurring in low 
and middle-income countries (LMIC).  Three in four direct maternal deaths are due to 
, haemorrhage, followed by hypertension in pregnancy. The major causes of indirect 
deaths are pre-existing tuberculosis and anaemia.  My thesis is focussed on quantifying 
the burden of maternal death and perinatal outcomes from these conditions, identifying 
risk factors, and assessing role of tests to detect high-risk condition.  
 
Methods 
Systematic reviews of observational, comparative and diagnostic accuracy studies  
 
Findings 
Anaesthesia was the primary cause of death in 1.2 per 1000 undergoing surgery in 
pregnancy.  General anaesthesia administration and non-physician anaesthetist 
practitioners were associated with poorer outcomes.   In women with pre-eclampsia, 
there was a seven fold increase in maternal death in pre-eclamptic women undergoing 
caesarean section with general compared to regional anaesthesia.  The rate of maternal 
mortality in women undergoing Caesarean section was 4.8 per 1000 procedures, mainly 
from postpartum haemorrhage. Emergency and second stage caesarean sections 
increased mortality and morbidity. The cadre or seniority of staff performing the 
caesarean section did not increase the risk of mortality.  
 
Of the point of care tests identified to detect anaemia at a haemoglobin concentration 
of <110 g/l, Copper, Sahli’s and HemoCue had high sensitivity and specificity.  In 
 6 
women with tuberculosis compared to those without, there was a significantly increased 
risk of poor fetal outcomes; perinatal death, preterm birth, low birth rate and birth 
asphyxia.  Maternal outcomes were significantly worse.  
 
Conclusion  
Anaesthesia and caesarean sections contribute disproportionately to maternal deaths in 
LMIC. Copper, Sahli’s and HemoCue were found to be accurate point of care tests for 
anaemia and should be more widely available to increase diagnosis.  Tuberculosis leads 
to worse maternal and fetal outcomes.  
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Chapter 1: Introduction 
 
1.1 Maternal mortality and morbidity in low and middle-income countries (LMIC) 
 
Burden of maternal death:  
Maternal death, defined as the death of a woman while pregnant or within 42 days of 
termination of pregnancy, is a major global health issue.(1) About 99% of maternal 
deaths occur in low and middle-income countries (LMIC), with large disparities 
between, and within regions and countries. About half of these deaths occur in Sub-
Saharan Africa, and a third in South Asia; these two regions together account for 85% 
of maternal mortality in the world (Fig1). 
 
Figure1: Maternal death by burden.  http:// worldmapper.org 
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Three in four maternal deaths are due to direct obstetric causes mainly haemorrhage, 
infection, pre-eclampsia, complication from delivery and unsafe abortion;(2) a quarter 
are from indirect causes and pre-existing medical conditions, such as human 
immunodeficiency virus (HIV), Malaria and tuberculosis (TB) .(2)  
 
Global efforts to tackle maternal mortality: 
Improvement of maternal health, with reduction in maternal mortality has long been a 
global health priority. This was emphasised in the UN Millennium Development Goals 
(MDG) framework, especially MDG4 the reduction by two-thirds the under-five 
mortality rate, and MDG5 the reduction of the maternal mortality ratio by three-quarters 
by 2015 (Fig 2).(3) The MDGs have now come to a close.  
 
Fig2: Millennium Development 
Goals, UN 2015 
 
Looking back, much progress has been made, but many countries did not reach this 
target.(4) Between 1990 and 2015, 10·7 million women worldwide died from maternal 
causes.(5) The global maternal mortality ratio (MMR), decreased by 43·9% (with the 
target being reduction by three quarters). The progress made and present levels of 
maternal mortality differ greatly between regions with the highest regional rate of 
decline for 1990–2015 occurring in eastern Asia (annual continuous rate of reduction 
5·0%) and the lowest in the Caribbean (1·8%).   Regional MMRs for 2015 ranged from 
12 deaths per 100 000 live births for developed regions and 239 per 100 000 live births 
in developing countries with 546 per 100 000 for sub-Saharan Africa. (5) 
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The yearly number of global maternal deaths decreased from 532,000 in 1990, to 
303,000 in 2015. The largest proportion of deaths in 2015 occurred in sub-Saharan 
Africa (201,000 deaths) with the following countries having the top 5 highest MMR; 
South Sudan, Chad, Somalia, Central African Republic and Sierra Leone, mainly 
fragile and humanitarian settings.(5) The sustainable development agenda (SDG) has 
now taken over the MDGs with a target to reduce the global maternal mortality ratio to 
less than 70 per 100 000 live births by 2030; and no country to have a maternal mortality 
rate of more than twice the global average.(6) 
 
Contributors of maternal death in LMIC: 
The majority of maternal deaths are preventable. To truly address this problem the 
underlying causes need to be understood and targeted.  The three delays model is often 
used to explain the problem in LMIC (Fig3).(7)  
Figure 3: Three delays model –Ref: UNFPA 2014 
 
The three delays model describes the three different types of delay in care access; Delay 
1: A delay in making the decision to seek care; this may due to a lack of awareness of 
the need to seek care, 
often due to lack of 
education or low social 
status of women. 
Delay 2: A delay in 
reaching appropriate 
care; this may be due to poverty, not being able to afford the transport required to reach 
the facility, poor roads and infrastructure. Delay 3: A delay in receiving care. These are 
a result of failures in the health services delivery system management.(8)  
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I will use an example of a woman with obstructed labour requiring a caesarean section 
to illustrate these delays.  Delay one: a laboring woman stays at home in a village for 
several days, not realizing that this is abnormal or can be harmful to her and her baby, 
she seeks the advice of the village birth assistant and she is given herbs to increase 
contractions and when this doesn’t work she is advised to go to the health facility.  
Delay Two:  The nearest health facility is five hours away; she is too poor to afford 
transportation and walks.  When she arrives at the nearest health center they diagnose 
obstructed labour and find that her fetus is dead, she needs a caesarean section but they 
do not perform this procedure. An ambulance is called and it takes another 4 hours to 
reach a district hospital where the procedure can be performed due to poor roads and 
delay in transport. Delay 3: On arrival to the district hospital it is busy; there is only 
one doctor and one non-physician anaesthetist and several women requiring caesarean 
sections, they are very understaffed and under resourced, they do not have the 
equipment to do blood tests.  She is weak, very dehydrated and septic.  When she 
eventually has her caesarean section, she is given a general anaesthetic, it is a difficult 
procedure and she suffers from severe hemorrhage from atony and trauma, she is not 
adequately resuscitated by the anaesthetist who lacked the training to deal with this 
emergency and the monitoring equipment to realise the severity of her condition.  She 
dies on the operating table.   
 
If there is any hope of achieving the SDG target, there needs to be a shift to a broader 
focus.  Relying solely on maternal mortality to assess a country’s status in the area of 
maternal health overlooks the importance of maternal morbidity, which at its most 
severe is a precursor to maternal mortality.(9) Maternal morbidity is defined as “any 
health condition attributed to and/or aggravated by pregnancy and childbirth that has a 
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negative impact on the woman’s wellbeing.” (10) Maternal death is only the tip of the 
iceberg, for every woman that dies there are 20-30 more that suffer an acute or chronic 
morbidity often leaving them with long term disability.(11) The true burden of maternal 
morbidity is unknown; the causes of maternal morbidity are many and complex, 
varying in severity and cover a broad range of conditions requiring a variety of 
interventions. 12 
 
Major causes of maternal death in LMIC addressed by the thesis: 
Haemorrhage, which is related to delivery and surgical procedures such as caesarean 
section, is the leading cause of maternal death in LMIC. This is followed by 
hypertension in pregnancy, and other indirect causes of maternal deaths from pre-
existing conditions such as tuberculosis, HIV and malaria.  
 
Figure 4: Causes of maternal 
mortality. WHO 2010 countdown 




My thesis will focus on three areas: anaesthetic and surgical related maternal mortality 
and morbidity, both are an essential components of comprehensive emergency obstetric 
care and have an impact on all other maternal deaths; indirect maternal deaths including 
infectious diseases in pregnancy as they are now contributing for up to a quarter of 
maternal deaths; and anaemia a major contributor of both direct and indirect maternal 







1.2 Obstetric anaesthesia and caesarean sections in LMIC  
 Anaesthesia and surgical interventions during pregnancy are an essential part of 
comprehensive emergency obstetric care (CEmOC).  These interventions are often 
needed in an emergency to treat complications of pregnancy and delivery such as major 
hemorrhage, complications of abortion, obstruction and pre-eclampsia, without timely 
intervention the mother is sure to die and the newborn would suffer long term disability 
or death.(12) Unfortunately these procedures for safety, also contribute to the woman’s 
death, at a disproportionate rate in LMIC.  
 
Caesarean section is the commonest surgical procedure in Africa, with WHO 
recommending an optimal caesarean section rate of 10-15%.(13) Many countries in sub-
Saharan Africa have an overall rate much lower than this and are below 1% for the 
poorest populations in 20 countries, most of them in sub- Saharan Africa.(14) About 18% 
of facilities did not perform the procedure due to lack of skills (53%), nonfunctioning 
equipment (43%), and lack of supplies/drugs (33%) including oxygen and blood.(15)   
 
Surgery is only possible with the availability of anaesthesia; requiring skilled personnel, 
equipment and infrastructure. Most LMIC have a ratio of less than 1 physician or non-
physician anaesthesia provider per 100,000 population.(16)  Anaesthesia providers in 
LMICs include physicians, nurses, and technicians; the safety of non-physician 
anesthetics in not known. A large survey in 191 countries showed that 107 had nurse 
anaesthetists administering anaesthesia as part of the workforce. (17) These anaesthetic 
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personnel have varying degrees of education and training, and may or may not have 
credentials or be licensed.(18) In Uganda only 6% of centers giving an anaesthetic to 
pregnant women fulfilled the appropriate conditions to deliver safe anaesthesia.(19) A 
Lancet commission into global surgery found that if the number of physician 
anaesthetists was increased to 20 per 100,000, maternal mortality could be reduced by 
13%.(20) The magnitude of maternal deaths and risk factors for these are not known.  
 
1.3 Maternal complications from obstetric anaesthesia in women with pre-eclampsia 
Hypertensive disorders are the second most common cause of maternal mortality, 
mainly from pre-eclampsia. In addition to the risks inherent to the condition, these 
mothers face additional risks from delivery, which is the treatment for the condition. In 
mothers with severe pre-eclampsia and eclampsia, and not in labour, caesarean section, 
necessitating anaesthesia is often the only option to minimise complications to mother 
and baby.  
 
High-risk women cause a particular difficulty to healthcare workers and require extra 
skill and expertise when administrating an anaesthetic or carrying out surgery.  
Choosing the right type of anaesthesia, e.g. sedation, local, regional or general, the 
amount and type of drugs and fluids are crucial parts of care.(21) Skilled anaesthetists 
are particularly vital for these women, and can have a big impact on the clinical 
outcomes through resuscitative measure, understanding patient’s pathophysiology and 
by recognising and addressing emergencies swiftly.   The risk of maternal deaths from 
anaesthesia attributed causes, and risk factors are not known in women with pre-





1.43 Anaemia in pregnancy 
The WHO Multicountry Survey on Maternal and Newborn Health has identified 
anaemia as the most common indirect cause of adverse maternal outcomes including 
maternal death.(22) Severe anaemia in mothers also increases the risk of perinatal 
mortality.(23) Anaemia has been linked to poor maternal and perinatal outcomes with a 
high incidence of low birth weight, small for gestational age and prematurity.(24) 
Pregnant women with anaemia have also been shown to have an increased risk of 
caesarean section,(25) anaemia also increases the morbidity associated with the 
procedure.(26) 
 
The commonest cause of anaemia in pregnancy is iron deficiency and this is easily 
treated if identified. In LMIC most women are given prophylactic treatment for 
anaemia in the form of FeFol a combined ferrous sulphate and folic acid tablet. The 
gold standard method of diagnosis is a lab based test but this is often expensive, requires 
specialist skills and unavailable especially in more rural settings.  Diagnosis is therefore 
mainly reliant on symptoms and physical signs such as pallor and bedside tests such as 
hemoCue and WHO colour scale, however the accuracy of these tests especially as a 
diagnostic tool is unknown, and without accurate early detection of disease, treatment 









1.5 Infectious diseases in pregnancy: Tuberculosis (TB) 
Indirect maternal deaths are increasing in number and now account for a quarter of 
maternal deaths; these include infectious diseases such as TB, HIV, and malaria, as well 
as pre-existing or new onset medical disorders.  
 
According to the World Health Organization, Tuberculosis (TB) is second only to 
HIV/AIDS as the greatest killer worldwide due to a single infectious agent. (27)  
The majority of TB related deaths occur in LMIC; TB is among the top five causes of 
death in women of reproductive age, and is a significant contributor to maternal 
mortality.(28) Ending the TB epidemic by 2030 is among the health targets of the newly 
adopted Sustainable Development Goals.(29)   
 
The effects of TB on pregnancy may be influenced by many factors, including the 
severity of the disease, timing of diagnosis, the location of disease, HIV co-infection 
and the treatment instituted.(30) Although there is discrepancy in the literature, obstetric 
complications that have been reported in these women include a higher rate of 
spontaneous abortion, small for date uterus, preterm labour, low birth weight and 
increased neonatal mortality.(31) There is also the risk of congenital tuberculosis, a rare 
complication of in utero tuberculosis infection, which is associated with a high neonatal 
mortality.(32) While other infectious diseases are either prophylactically treated in 
pregnancy (malaria) or routinely screened for (HIV, Syphilis) TB is not, despite it being 






1.6. Aims and objectives 
 
My overall aim is to quantify the burden of maternal and perinatal mortality and 
morbidity in LMIC, and risk factors for complications from exposure to surgical and 
anaesthetic procedures, pre-existing conditions such as pre-eclampsia and tuberculosis, 
which are major contributors of maternal deaths.  My additional aim is to assess the 
accuracy of simple tests to diagnose conditions such as anaemia, which could easily be 
treated to improve pregnancy outcomes. 
 
Research overview 
The specific research questions that I have attempted to answer in this thesis are given 
below, and summarised in a structured format in Table 1.1 
 
Obstetric anaesthesia related maternal mortality and morbidity in all women 
 What are the rates of anaesthesia-attributable maternal deaths as a proportion of 
all maternal deaths, and of all deliveries, in low and middle-income countries? 
  What are the rates of anaesthesia-attributable maternal deaths in pregnant 
women undergoing surgical procedures in low and middle-income countries? 
 What are the risk factors for anaesthesia-related maternal deaths, specifically 
setting, type of anaesthesia and anaesthetic practitioner?   
 
Anaesthesia related maternal mortality and morbidity in women with pre-eclampsia 
 In women with pre-eclampsia, what are risks of complications with general and 
regional anaesthesia?  
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Caesarean section related maternal mortality and morbidity in all women 
 What are the rates of caesarean section related maternal death and caesarean 
section case fatality rates in low and middle-income countries? 
 What are the main causes of caesarean section deaths? 




 What methods are used to diagnose anaemia in pregnancy and which is the most 
accurate?  
 
Infectious diseases: TB  
 Are the risks of maternal and fetal complications increased in women with TB 
in pregnancy, compared to those without the disease? 
 
 




Population Intervention or 
test 
















-Rate of anaesthesia 
attributable maternal 
deaths. 
-Rates of anaesthesia 
attributable deaths in 

























(Physician / non 
physician)  
Type of anaesthesia    
(general/ regional) 
 
Odds of Maternal death, 
admission to ITU and 
PPH. 
Fetal: Perinatal death, low 




















Type of anaesthesia    
(general/ regional) 
 
Odds of Maternal: Death, 
admission to ITU and 
PPH. 













Rates of maternal and 
perinatal mortality and 
morbidity in women 
















Type of caesarean 
section (emergency 
/ elective & second 
/ first stage)  
 




Odds of Maternal death, 
admission to ITU, PPH, 
post partum infections, 
and surgical 
complications. 
Fetal: Perinatal death, low 

















Tests used to 
diagnose anaemia: 
-WHO colour scale 
- HemoCue 
-Copper sulphate, 





Sensitivity and specificity 
of tests to diagnose 














Maternal death, maternal 
morbidity, anaemia, and 
caesarean delivery.   
Perinatal mortality, low 
Apgar score, low birth 
weight and preterm birth.   
 
 









Chapter 2: Methods 
 
What methods are needed to answer these questions? 
When considering the hierarchy of evidence in medicine and public health, systematic 
reviews and meta-analyses are at the top of the pyramid (Fig5), for this reason, these 
are the main methods employed in my research.   
 
        
Fig 5: hierarchy of evidence in medical research 
 
Systematic reviews and meta-analyses 
A systematic review involves five key steps in the identification, appraisal and 
application of the evidence, which consist of the following: 
 Step 1: Framing questions for a review 
The problems to be addressed by the review is are specified in a clear, 
unambiguous and structured questions at the beginning of the work.  The 
question is formed and defined using the PICO format: population, intervention, 
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control/ comparison and outcome with clear inclusion and exclusion criteria for 
every aspect.  It is also best practise to register the review at this stage.  
  
 Step 2: Identifying relevant work 
An extensive search is done using multiple resources and databases (both 
computerized and printed) without language restrictions. Reference lists and the 
grey literature is searched to ensure all relevant studies are included.  The study 
selection criteria will flow directly from the review questions and be specified 
a priori. Reasons for inclusion and exclusion are recorded.   Identifying relevant 
studies is done by two people independently to reduce selection bias.   
 
 Step 3: Assessing the quality of studies 
This step appraises the aspects of the study design, conduct and analysis, and is 
relevant to every step of the review. The quality of a study can be defined as the 
degree to which it aims to minimise bias and error.  There are standardised quality 
tools that are used depending on study design e.g. Newcastle Ottawa scale for 
cohort or case control studies, Cochrane for randomised controlled trials, QUADAS 
for studies of test accuracy.  Quality assessment is carried out by two people 
independently to reduce bias.  In this thesis the main methods used to assess quality 
have been a modified prevalence scale, Newcastle Ottawa scale and QUADAS, 





 Step 4: Summarising the evidence 
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Data extraction and data analysis consists of tabulation of study characteristics, 
quality and effects as well as use of statistical methods for exploring differences 
and significance of results and combining their effects if suitable (meta-analysis). 
Exploration of heterogeneity should be planned as well as identifying potential 
sources.  If an overall meta-analysis cannot be done, subgroup meta-analysis may 
be possible.  Data extraction is again carried out by two people independently to 
ensure data accuracy, detailed information regarding data extraction and analysis is 
included in every chapter.   
 
 Step 5: Interpreting the findings 
Taking into account issues discussed in the previous steps such as study quality and 
heterogeneity as well as exploring the risk of publication bias and related biases 
will help to determine whether the overall summary can be trusted or not.  Any 
recommendations should be graded by reference to the strengths and weaknesses of 
the evidence. (33) 
 
By collating all the available evidence, reviews often highlight gaps in research and the 
paucity in quality and number of existing studies and provide justification for new well-
defined studies, as well as providing recommendations for guidelines and policy.  
Details of such recommendations have been detailed in the upcoming chapters.   
 
Role of the funding source 
Ammalife and Elly Appeal (Bart’s Charity), Charities with a focus on maternal health 
research in developing countries funded my work.  The Charities had no influence on 
the development, conduct or reporting of this work. 




3.1 Abstract:  
Background 
The safety of anaesthesia administered to pregnant women in low- and middle-income 
countries (LMIC), where there is a paucity of physician anaesthetists and resources, 
needs quantification. We undertook a systematic review to estimate the rate of 
anaesthesia-related deaths in pregnant women having obstetric surgical procedures in 
LMIC, and the proportion of all maternal deaths attributed to anaesthesia.  
 
Methods  
We searched major electronic databases until 1st October 2015, without language 
restrictions, for studies including pregnant women in LMIC, which reported maternal 
deaths and complications in women exposed to anaesthesia. Two independent 
reviewers undertook quality assessment and data extraction.  A random effects model 
was used to synthesise the rate data. Odds ratio was the measure of association between 
outcomes and anaesthesia-related risk factors.  
 
Findings 
We included 140 studies. Anaesthesia was the primary cause of death in 1.2 per 1000 
(95% CI 0.8 to 1.7, I2 =83%) pregnancies undergoing an obstetric surgical procedure 
(44 studies; 632,556 pregnancies).  Anaesthesia accounted for 2.8% (95% CI 2.4 to 3.4, 
I2=75%) of all maternal deaths (95 studies; 32,149,636 pregnancies, 36,144 maternal 
deaths), 3.5% (95% CI 2.9 to 4.3, I2=79%) of direct maternal deaths, and 13.8% (95% 
CI 9.0 to 20.7, I2=84%) of deaths during or after caesarean section.  
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Exposure to general anaesthesia increased the odds of maternal (OR 3.3, 95% CI 1.2 to 
9.0, I2=58%), and perinatal deaths (OR 2.3, 95% CI 1.2 to 4.1, I2=73%) compared with 
regional anaesthesia (25 studies; 414,069 pregnancies). The rates of any maternal death 
were higher when anaesthesia was administered by non-physician (9.8/1000, 95% CI 
5.2 to 15.7, I2 =92%) than physician anaesthetists (5.2/1000, 95% CI 0.9 to 12.6, 
I2=95%).  
 
Conclusion:   
Anaesthesia contributes to a disproportionately large number of maternal deaths in 
women undergoing surgery in low- and middle-income countries.  The current 
international priority on strengthening health systems should address the factors 
identified in our review for improving anaesthetic care.  
Key words: anaesthesia, maternal, mortality, low- and middle-income countries 
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A quarter of million mothers die every year during or after pregnancy and childbirth, 
and 99% of these are from low- and middle-income countries (LMIC).(34) Anaesthetic 
interventions are an integral part of emergency obstetric care.(35)  However, there is a 
paucity of physician anaesthetists in many of the poorest countries, with an estimated 
ratio of one physician anaesthetist per million women.(20) There is also a lack of 
infrastructure, drugs and equipment.  
 
The need for safe and affordable surgery and anaesthesia in LMIC is recognised, with 
peri-operative death as a global safety indicator.(36) Anaesthetic complications as a 
cause or contributor to maternal mortality in LMIC have been neglected and there are 
no robust estimates of maternal deaths from obstetric anaesthesia, or of overall maternal 
mortality attributable to anaesthesia. Complications of anaesthesia remain one of the 
most clearly avoidable deaths.  Factors that contribute to maternal and perinatal 
mortality in mothers exposed to anaesthesia in these regions also need identification.  
 
Individual studies have provided varied and imprecise results, with up to a fifth of all 
direct maternal deaths attributed to anaesthesia-related procedures.(37) Systematic 
reviews report estimates of complications in all individuals exposed to anaesthesia, not 
specifically in pregnant women.(38) We undertook a systematic review to obtain precise 
estimates of anaesthesia-attributed deaths in pregnant women undergoing obstetric 
surgical procedures in LMIC, and the rates of overall anaesthesia-attributed maternal 
mortality. We also identified the factors linked to adverse outcomes in pregnant women 




We undertook the systematic review using a prospective protocol (PROSPERO No. 
CRD42015015805) (39) in line with current recommendations, and reported as per the 
PRISMA guidelines.(40)  
 
Literature search 
I searched Medline, Embase, Scopus, CINAHL, Web of Science and WHO Library and 
Medicus until 1st October 2015 and used MeSH headings, text words and word variants 
for "pregnancy" and combined them with terms for low resource countries like "low- 
income " or "middle-income" or "developing country". These were combined with 
terms related to anaesthesia and surgery such as “an(a)esthesia” or “an(a)esthetist” or 
“nurse an(a)esthetist” or “c(a)esarean section” (Appendix 1).  There were no language 
restrictions. Additionally, I searched the reference lists of the included studies and 
relevant reviews for eligible studies. 
 
Study selection 
Studies were selected in two stages. In the first stage, we screened the titles and 
abstracts of all citations for potentially relevant papers. In the second, we examined the 
full texts of the retrieved papers. Two independent reviewers (SS, KD) selected the 
papers against pre-specified inclusion criteria. Discrepancies were resolved after 
discussion with a third reviewer (ST). Studies were included if they assessed maternal 
and perinatal outcomes in pregnant women exposed to anaesthesia in countries 
categorised as LMIC by the World Bank.(41) Exclusions included studies in high-income 
countries, those involving non-pregnant women, case reports, and studies published 
before 1990 to ensure that the estimates reflect the current burden of the condition. 
Anaesthesia-attributed complications were defined as those that occurred directly as a 
result of anaesthesia (as determined by the primary study authors), e.g. failed 
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intubations or a high spinal; anaesthesia-related outcomes as those that were directly or 
indirectly associated with anaesthesia. Maternal mortality included death of a mother 
during pregnancy, and at any time until 42 days after delivery, irrespective of the 
duration and site of the pregnancy as defined by the WHO. This included deaths from 
any cause related to or aggravated by pregnancy and its management, but not from 
accidental or incidental causes.(1) Direct maternal deaths were those that resulted from 
obstetric complications; indirect maternal deaths from conditions aggravated by 
physiological effects of pregnancy, by pre-existing disease, or by diseases that 
developed during pregnancy.(1) We grouped direct and indirect maternal deaths together 
as overall maternal death.  
 
Perinatal death included any fetal death that occurred after 28 completed weeks of 
gestation, stillbirth and early neonatal death until one week after birth.(42) Apgar score 
is a measure of physical condition of a newborn, taking into account and assigning 
points (0,1or 2 for each domain for a total of 10) for heart rate, respiratory effort, 
reflexes, muscle tone and skin coloration, and is assessed at 1, 5 and 10 minutes.(43)  
Apgar scores were classed as low if they were less than or equal to 7 at one and five 
minutes. We accepted the primary study authors’ definitions for maternal and fetal 
complications such as postpartum hemorrhage, cardiac arrest and admission to the 
intensive care unit.  
 
Study quality assessment and data extraction 
Two independent reviewers (SS and KD) undertook study quality assessment and data 
extraction, and discrepancies were resolved with input from the third reviewer (ST). 
For studies on rates of anaesthesia-attributed maternal death, we assessed the following 
criteria: representativeness of the population, sample selection, outcome assessment, 
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adequacy of sample size and ascertainment of the cause of maternal death to 
anaesthesia.(44, 45) A study was considered to be adequate for representativeness if it 
included institutions from multiple settings such as rural and urban hospitals in a region 
or country, and to be inadequate if it included only a single hospital or unit. Sample 
selection was classed as adequate if all deliveries or maternal deaths were included, and 
as inadequate if a particular group of women were excluded. We considered outcome 
assessment to be adequate when a confidential enquiry, verbal autopsy or professional 
panel determined the cause of death; a lack of special effort or use of registry data from 
only one source was considered to be inadequate. An adequate sample size included 
data on at least 10,000 births.  Studies that accounted for the cause of death in at least 
95% of maternal deaths were deemed to be adequate for ascertainment of cause of 
death. A study was classed as high quality if three of the above five criteria were met.(44) 
 
For comparative studies, we used the Newcastle-Ottawa scale to evaluate the risk of 
bias in selection, comparability of cohorts and outcome assessment.(46) Studies that 
scored four stars for selection, two stars for comparability and three stars for 
ascertainment of the outcome were regarded to have a low risk of bias. Studies with 
two or three stars for selection, one for comparability and two for outcome 
ascertainment were considered to have a medium risk of bias. Any study with a score 
of one for selection or outcome ascertainment, or zero for any of the three domains was 
deemed to have a high risk of bias.(46) 
 
Data were extracted on the number of events (anaesthesia-attributed maternal deaths), 
number of women exposed to anaesthesia, total and direct maternal deaths, and deaths 
during or after caesarean section, to compute corresponding proportions for individual 
studies. We extracted data on the number of events (anaesthesia-related maternal death 
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and pregnancy complications) in women exposed and un-exposed to risk factors such 
as type of anaesthesia (regional, general), setting (urban, rural) and practitioner 
(physician, non-physician). 
Data analysis 
Summary rates of deaths from anaesthesia were estimated in all pregnant women 
undergoing surgical procedures, and the proportion of all maternal deaths (direct and 
indirect) attributed to anaesthesia. Sub-group analysis and meta-regression were 
performed for the following factors that were specified a priori: geographical location 
(World Bank classification), country income (low-, low-middle, upper-middle) and 
year of publication (before and after 2000). We assessed the effects of study quality 
(low, high) and design (prospective, retrospective) on the maternal mortality rates. We 
used multilevel random effects logistic models, and included the above factors. The 
meta-regressions were run as separate univariate analyses. Sensitivity analysis was 
performed by limiting our findings to only direct maternal deaths. We also assessed the 
proportion of all maternal deaths during or after caesarean section attributed to 
anaesthesia. 
 
We computed odds ratios for various risk factors and anaesthesia-related complications 
in individual studies, and pooled them using a random effects model. Peto Odds Ratio 
was used when the numbers of events were too scarce.(47) Heterogeneity was evaluated 
using I2 statistic. When comparative data were not available, we reported the proportion 
of complications for each risk factor separately, and provided summary estimates. 
 We assessed publication bias and small study effect using funnel plots and begg’s and 
egger’s tests.  All analyses were performed using Stata 13.(48) 
3.4 Results 
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From 11,782 citations, we included 140 studies. 44 studies (632,556 pregnancies) 
reported deaths from anaesthesia in women exposed to surgical procedures; 95 studies 
(32,149,636 pregnancies, 36,144 deaths) computed anaesthesia-attributed maternal 
mortality; and 25 studies (414,069 pregnancies) assessed the association of various risk 
factors and complications in pregnant women undergoing anaesthesia (Fig 6).  
  
Figure 6. Study selection process in the systematic review of anaesthesia-related 
maternal mortality in low- and middle-income countries (LMIC)  
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44 studies (632,556 pregnancies) reported deaths from anaesthesia in women exposed 
to surgical procedures.  These studies were from 15 countries, which were grouped into 
the following World Bank regions: Sub-Saharan Africa (n=38 studies), South Asia 
(n=4), East Asia and the Pacific (n=2). The majority of studies were facility based 
(42/44, 95%) and in nearly three-quarter (31/44, 71%) of studies, the women were 
managed in an urban setting. Both high and low risk women were evaluated, and 
caesarean section was the most commonly performed surgical procedure. Studies 
ascertained the cause of maternal deaths and exposure to anaesthesia from theatre 
records, patient notes, facility and countrywide maternal death reviews, and verbal 
autopsies.  
 
Of the 95 studies (31 countries) that reported on anaesthesia-attributed maternal deaths 
as a proportion of all maternal deaths, 55% (52/95) provided facility-based data, and 
30% (29/95) provided countrywide data. In half (45/95, 47%) of the studies, women 
were managed in an urban setting.  
 
Studies compared the odds of adverse maternal and fetal outcomes for risk factors such 
as the type of anaesthesia (25 studies, 414,069 pregnancies), setting (1 study, 8070 
pregnancies) and anaesthesia provider (1 study, 8070 pregnancies). Rates of any 
maternal death in anaesthesia administered by a non-physician were assessed in 8 
studies (27,714 pregnancies), and by a physician anaesthetist in 6 studies (20,313 
pregnancies).  
The characteristics of the individual studies included in the systematic review are 
provided in Appendix 3. 
 
Quality of the studies 
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Around two-thirds (65/95, 68%) of the included studies on anaesthesia-attributed 
maternal mortality had low risk of bias. About half had high risk of bias (46/95, 48%) 
for representativeness of the population and setting, 90% had adequate sample selection 
(85/95), a quarter had high risk of bias for outcomes reporting (23/95, 24%). Three 
quarters of all studies had adequate sample size (74/95, 77%) and about two-thirds 
adequately accounted for maternal deaths (59/95, 62%) (Appendix 4a). Four fifth 
(21/25, 84%) of studies on risk factors for complications in women exposed to obstetric 
anaesthesia had high risk of bias (Appendix 4b). 
 
3.41: Mortality rates from anaesthesia in women undergoing obstetric surgical 
procedures  
 
The risk of deaths from anaesthesia in women undergoing surgical procedures in 
pregnancy was 1.2 per 1000 women (95% CI 0.82 to1.7, I2 = 83%), with the highest 
rates in sub-Saharan Africa (1.5 per 1000 women, 95% CI 1.1 to 2.2, I2=85%) (Table 
2). Appendix 5a provides estimates for individual countries. 
 
Subgroup analysis and meta-regression showed a statistically significant difference 
between regions (p=0.004). The risks of death from anaesthesia were higher in rural 
than urban setting (p=0.02), and in low- and low-middle income than upper middle-




Table 2: Mortality rates from anaesthesia in women undergoing obstetric surgical 
procedures in low- and middle-income countries  
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World Bank Regions        
    South Asia  4 16 37,132 0.34 (0.13-0.90) 71% 0.004 
    Sub-Saharan Africa  38 237 567,431 1.5 (1.1-2.2) 85% 
East Asia and   Pacific  2 11 27,993 0.40 (0.22-0.71) - 
Year        
    <2000  17 55 49,232 1.2 (0.76-1.7) 50% 0.74 
    ≥2000  27 209 583,324 1.2 (0.74-2.1) 86% 
Setting       
    Urban  31 85 72,203 1.5 (1.0-2.3) 67% 0.02 
    Rural  1 1 69 14.5 (0.00-42.7) - 
    Both  12 178 560,284 0.67 (0.37-1.2) 89% 
Country income       
    Low  13 53 33,431 1.5 (0.84-2.8) 63% 
    Lower Middle   27 90 80,295 1.4 (0.92-2.2) 72% 0.003 
    Upper Middle  
 
4 121 518,830 0.23 (0.20-0.28) 24% 
OVERALL  44 264 632,556 1.2 (0.82-1.7) 83% 
        
 
3.42 Anaesthesia-attributed maternal mortality rates 
Anaesthesia was the cause of 2.8% (95% CI 2.4 to 3.4, I2=75%) of all maternal deaths 
(direct and indirect), with the highest rates in Middle East and North Africa (6.2%, 95% 
CI 3.9 to 9.7, I2 =86%), and the lowest in East Asia and Pacific (1.5%, 95% CI 0.9 to 
2.3, I2=63%).  
Meta regression demonstrated a significant difference in the overall anaesthesia-
attributed mortality rates by geographical region (p = 0.004) and year of publication 
(p=0.002). There were no significant differences by setting (p=0.29), study design 
(p=0.68), income level (p=0.57) or study quality (p=0.12). (Table 3) 
 
The global burden of anaesthesia-attributed overall maternal mortality is depicted in 
Table 3, and estimates from individual countries are provided in Appendix 5b and 
shown as a world map in figure 7. 
Table 3. Anaesthesia-attributed maternal mortality in low- and middle-income 
countries 
Factors No. of 
studies 
No. of deaths 
from anaesthesia 
(n) 











World Bank Regions*        
    Sub-Saharan Africa  50 675 24,873 2.9 (2.3-3.6) 61% 0.004 






















                
0.12 
    South Asia  18 89 4,317 2.4 (1.5-3.8) 79% 
    Middle East and North Africa  10 136 2,555 6.2 (3.9-9.7) 86% 
    East Asia and Pacific  9 49 3,276 1.5 (0.9-2.3) 63% 
    Europe and Central Asia  4 14 455 3.0 (1.3-6.7) 64% 
Latin America and The  
Caribbean  
4 24 668 3.6 (2.4-5.3) 0% 
Year       
    <2000  28 250 6,589 4.1 (3.0-5.5) 77% 
    >2000  67 737 29,555 2.4 (1.9-2.9) 72% 
Setting       
    Rural  8 14 894 1.9 (0.9-3.8) 38% 
    Urban  45 245 7,987 3.3 (2.5-4.2) 72% 
    Both  42 728 27,263 2.5 (1.9-3.4) 80% 
Study design       
    Prospective  9 35 1,819 2.5 (1.1-5.6) 77% 
    Retrospective  86 952 34,325 2.9 (2.4-3.4) 75% 
Country income       
    Low  17 89 3,171 2.6 (1.9-3.6) 35% 
    Lower Middle  38 199 8,130 2.6 (1.9-3.6) 78% 
    Upper Middle  40 699 24,843 3.1 (2.4-4.1) 78% 
Study quality       
    High 65 859 32,099 2.6 (2.1-3.2) 79% 
    Low 30 128 4,045 3.6 (2.6-4.8) 59% 
 
OVERALL  95 987 36,144 2.8 (2.4-3.4) 75% 
       
 
Figure 7: World map depicting the burden of anaesthesia-attributed maternal mortality 




Anaesthesia was responsible for 3.5 % (95% CI 2.9 to 4.3, I2=79%) of the 20,780 direct 
maternal deaths (76 studies, 26,750,727 pregnancies) (Table 4), and for 13.8% (95% 
CI 9.0 to 20.7, I2 =84%) of all maternal deaths that occurred during or after caesarean 
section (31 studies, 1028 deaths) (Table 5). 
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Table 4: Anaesthesia-attributed deaths as a proportion of all direct maternal deaths in 
low- and middle-income countries  











Rate(%) 95% CI I2 
World Bank Regions       
    Latin America and The     Caribbean  4 24 487 4.9 (3.3-7.3) 0% 
    East Asia and Pacific  8 47 2,756 1.7 (1.0-2.8) 72% 
    Europe and Central Asia  4 14 356 3.8 (1.6-8.6) 66% 
    Middle East and North Africa  6 84 1,431 6.0 (4.5-7.9) 45% 
    South Asia  12 56 2,066 3.3 (1.7-6.1) 85% 
    Sub-Saharan Africa  42 641 13,684 3.9 (3.1-4.9) 72% 
Year       
    <2000  23 194 5,473 3.7 (2.6-5.1) 81% 
    >2000  53 672 15,307 3.5 (2.8-4.4) 79% 
Setting       
    Rural  6 9 353 3.1 (1.3-7.3) 58% 
    Urban  35 218 5,567 3.9 (2.9-5.2) 75% 
    Both  35 639 14,860 3.3 (2.5-4.3) 85% 
Design       
    Prospective  9 17 1,134 1.9 (0.9-3.9) 44% 
    Retrospective  67 849 19,646 3.7 (3.1-4.6) 80% 
Income       
    Low-Income  15 94 2,351 3.6 (2.3-5.6) 73% 
    Lower-Middle Income  27 105 4,167 3.1 (2.1-4.5) 75% 
    Upper-Middle Income 34 667 14,262 3.9 (3.0-5.0) 79% 
Quality       
    High 56 768 18,340 3.3 (2.6-4.2) 83% 
    Low 20 98 2,440 4.5 (3.2-6.3) 61.% 
OVERALL  76 866 20,780 3.5 (2.9-4.3) 79% 
 
Table 5: Anaesthesia-attributed maternal deaths as a proportion of caesarean section 
deaths in low- and middle-income countries 
Factor No. of 
Studies 
No. of anaesthesia 
attributed deaths 
(n) 
No. of caesarean 
section deaths 
(N) 
Rate (%) 95% CI I2 Meta-
regression 
P-Value 
World Bank Regions        
    South Asia  3 13 122 8.5 (3.0-22.0) 70% 
0.34     Sub-Saharan Africa  25 110 606 16.1 (9.8-25.4) 84% 
    East Asia and Pacific  3 22 300 8.0 (4.2-14.7) 66% 
Year        
    <2000  14 83 601 14.5 (6.9-28.0) 91% 
0.80 
    >2000  17 62 427 13.5 (8.3-21.3) 64% 
Setting        
    Rural  1 1 5 20.0 (0.00-55.1) - 
0.90     Urban  18 63 396 14.5 (6.7-28.0) 88% 
    Both  12 81 627 13.1 (8.9-18.8) 70% 
Income        
    Low Income  8 44 192 21.3 (14.0-31.0) 33% 
0.51     Lower Middle Income  19 76 509 13.5 (6.8-24.9) 87% 
    Upper Middle  4 25 327 7.3 (3.5-11.2) 55% 
OVERALL  31 145 1028 13.8 (9.0-20.7) 84%  
3.43: Factors linked to adverse outcomes in pregnant women exposed to anaesthesia 
 
Administration of general anaesthesia tripled the odds of maternal (OR 3.3, 95% CI 1.2 
to 9.0, I2=58%), and doubled the perinatal death odds (OR 2.3, 95% CI 1.2 to 4.1, 
I2=73%) when compared to regional anaesthesia. There was an increase in other 
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complications such as postpartum haemorrhage (OR 9.4, 95% CI 5.1 to 17.2, I2=65%), 
low Apgar score at 1 minute (OR 6.3, 95% CI 2.9 to 13.6, I2=64%) and at 5 minutes 
(OR 3.2, 95% CI 2.3 to 4.4, I2=0%) with general compared to regional anaesthesia (Fig 
8).  There were no differences in cardiac arrest (OR 3.6, 95% CI 0.6 to 20.6, I2=71%) 
between the two groups.  
 
Figure 8. Maternal and fetal complications in women exposed to general vs. regional 
anaesthesia in low- and middle-income countries (LMIC) 
   
Management in a rural setting was associated with an increase in the odds of maternal 
death (OR 2.1, 95% CI 1.2 to 3.7) compared with an urban setting.(49)  
 
No comparative data were available for physician versus non-physician providers. One 
study reported an increase in the odds of maternal deaths (OR 2.7, 95% CI 1.6 to 4.6) 
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compared to those with training.(49) The overall risk of any maternal death (6 studies, 
27,515 women) when care was provided by non-physicians was 9.8/1000 (95% CI 5.2 
to 15.7, I2 =92%); rate of anaesthesia-attributed maternal deaths (5 studies, 24,613 
women) was 1.8/1000 (95% CI 0.25 to 4.3, I2 =85%). The corresponding estimates for 
physician anesthetists were 5.2/1000 (95% CI 0.9 to12.6, I2= 95%) for any maternal 
death (8 studies, 20,253 women), and 1.3/1000 (95% CI 0.16 to 3.1, I2 =79%) for 
anaesthesia-attributed maternal deaths (7 studies, 20,464 women) respectively (Table 
6)   
Table 6: Type of anaesthetic provider and rates of maternal deaths in low- and middle- 
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Non-physician  5 42 24,613 1.8 0.3-4.3 85% 













3.44: Causes of anaesthesia attributed maternal mortality 
The underlying causes were reported for 124 maternal deaths (24 studies). Half (56/124, 
45%) of all deaths resulted from airway complications such as difficult or failed 
intubation, esophageal intubation, bronchospasm, ventilation difficulties and hypoxia; 
a third (38/124, 31%) from pulmonary aspiration; a quarter (34/124, 27%) from issues 
related to staff competency, poor pre-assessment, intraoperative monitoring and 
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equipment failure. Other causes included cardiac arrest at induction or during the 
procedure (7/124, 6%), ‘high’ spinal anaesthesia (8/124, 6%), and drug overdose or 
adverse reactions (7/124, 6%).  
 
3.5: Discussion 
Anaesthesia contributes disproportionately to maternal mortality in LMIC. Exposure 
to general anaesthesia, and administration of anaesthesia by non-physicians, 
particularly those with no formal training, were major risk factors for maternal deaths 
from anaesthesia. We have mapped the safety of obstetric anaesthesia across various 
economic regions and individual countries. Most studies were from Sub-Saharan 
African region, which also had the highest risk of deaths from anaesthesia in women 
undergoing surgery. One in seven deaths during or after caesarean section was due to 
anaesthesia, an exceedingly high mortality rate compared to developed countries.(50)  
 
 
Ours is the first review, to our knowledge, to comprehensively evaluate the risk of 
maternal deaths from anaesthesia in LMIC. We assessed the extent of the problem in 
detail by assessing rates of death in women exposed to surgery, and as a proportion of 
any, direct, and caesarean section related maternal deaths. The effects of study quality 
on mortality estimates were reported. We looked for variations in anaesthesia-attributed 
maternal mortality rates according to economic regions, individual countries, setting, 
year and anaesthesia provider, and identified the anaesthesia related risk factors for 
various maternal and fetal complications in women undergoing surgery.  
 
Our findings were limited by the differences in quality and reporting of outcomes in 
the studies. Fewer studies were published in low-income countries that were outside 
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Sub Saharan Africa. It is likely that the actual rates of anaesthesia-attributed deaths are 
higher than current estimates due to paucity of data from the lowest income countries 
with high rates of maternal mortality and poor healthcare resources.  We found 
significant heterogeneity in our findings despite adjusting for various factors. The 
antenatal risk status of the mother was not known. Few studies provided detailed reports 
on the underlying cause of death from anaesthesia. Studies mainly focused on 
evaluating the risks associated with type of anaesthesia, and less on other factors. This 
limited our synthesis, and we could only provide rates for these risk factors separately. 
 
Administration of anaesthesia in pregnancy requires specific training, which takes into 
account maternal physiological changes, particularly in the third trimester. The rates of 
complications such as failed intubation are ten-fold higher in pregnant women than in 
general population.(51) In Cochrane review including high- and high-middle income 
countries, general anaesthesia in pregnant women was also associated with increased 
blood loss compared with regional anaesthesia, but studies do not have sufficient 
sample size to assess maternal deaths.(52) The increased mortality and morbidity that we 
identified in our review with general anaesthesia could be due to the following reasons: 
inadequate training and resources, poor general condition of the mother at baseline 
necessitating general anaesthesia, or concomitant complications such as postpartum 
haemorrhage worsening the outcome. The low Apgar scores at one and five minutes 
associated with general anaesthesia exposure are also indicators of absence of good 
maternal and neonatal care, and the lack of newer volatile agents which limit the risk if 
fetal respiratory depression.  
 
 In high-income countries such as the US, there are no differences in anaesthetic 
complications between physician and non-physician anaesthetists. (53-55) Although 
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comparative rates were not available for LMIC setting, the reported estimates of 
maternal mortality were higher for anaesthesia administered by non-physician 
anaesthetists than their physician counterparts; the risks were also high for non-
physicians without adequate training.(49) However, compared to the rigorous additional 
training provided to non-physician anaesthetists in the US, their counterparts in LMIC 
have very little training, and the training received is very variable amongst countries. 
Many of the reported causes of anaesthesia-attributed deaths such as airway 
complications and pulmonary aspiration with general anaesthesia, and hypotension and 
high spinal with regional anaesthesia are preventable with appropriate training and 
resources.(56) 
 
The global definition and classification of anaesthesia-attributed deaths require 
standardisation to identify the real burden of exposure to anaesthesia. Anaesthetists 
should be part of the panel analysing the causes of maternal deaths, and the level of 
contribution of anaesthesia to the death should be reported clearly.(57) 
 
Strategies to reduce maternal mortality should include increasing the number of 
anaesthetists, resources, and the level of training in LMIC. Implementation of simple 
measures, such as the WHO ‘Safer Surgery’ checklist before and during surgery would 
minimise the adverse outcomes.(58) The adoption of these measures among anaesthesia 
providers in the developed world has reduced maternal death from anaesthetic 
complications to very low levels. Governmental and non-governmental organisations 
should prioritise investment in obstetric anaesthesia, to implement the World Health 
Assembly’s resolution to include emergency and essential surgical care and anaesthesia 
as a component of universal health coverage.(59) 
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3.6: Conclusion  
Anaesthesia is a major contributor to maternal deaths in pregnant women undergoing 
surgery in low- and middle-income countries. Targeted efforts are needed to provide 




Chapter 4. Association of type of obstetric anaesthesia and maternal mortality and 
morbidity in women with pre-eclampsia in LMIC: a systematic review  
 
4.1 Abstract:  
Background: 
Pre-eclampsia contributes significantly to the global burden of maternal and fetal 
mortality and morbidity, and delivery is often expedited with caesarean section to 
prevent or treat complications.  The safety of various types of anaesthesia administered 
to mothers with pre-eclampsia has been long debated.  
 
Methods:  
We searched major electronic databases until June 2016, without language restrictions, 
and included studies comparing general with regional anaesthesia in women with pre-
eclampsia. Two independent reviewers undertook quality assessment and data 
extraction. We reported the measure of association between outcomes and type of 
anaesthesia as odds ratio (OR) and with 95% confidence intervals (CI), using a random 
effects model.  We assessed risk of bias of included studies using the Newcastle Ottawa 
scale.   
 
Findings:  
From 11,782 citations, 14 studies (10,411) were included; 37% (3899/10,411) had mild 
pre-eclampsia, 61% (6304/10,411) had severe pre-eclampsia and 2% (208/10,411) had 
eclampsia; 16% (1701/10,411) of caesarean sections were performed under general 
anaesthesia and 84% (8710/10,411) under regional anaesthesia. There was a seven-fold 
increase (OR 7.70, 95% CI 1.9 to 31.0 I2=58%) in maternal death in pre-eclamptic 
women undergoing caesarean section with general anaesthesia compared to regional 
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anaesthesia, and an increase in pulmonary oedema (OR 5.16, 95% CI 2.5 to 10.4, 
I2=0%) and maternal intensive care unit admissions (OR 16.25, 95% CI 9.0 to29.5, 
I2=65%).  Exposure to general anaesthesia increased the odds of perinatal death (OR 
3.01, 95% CI 1.4 to 6.5, I2=56%), low Apgar score at 1 minute (OR 2.5, 95% CI 1.3-
4.6, I2=49.9%) and at 5 minutes (OR4.73, 95% CI 2.4-9.5, I2=40%), when compared to 
regional anaesthesia. 
 
Conclusion:   
Regional anaesthesia is safer in women with pre-eclampsia, and should be considered 
where there are no contraindications.   
Key words: pre-eclampsia, anaesthesia, maternal mortality 
 
Publications arising from this chapter:  
Poster presentation at British Maternal and fetal medicine society conference 2016 and 
associated publication in BJOG 
 
Sobhy S, Dharmarajah K, Zamora J, Thangaratinam S, (2016), Risks associated with 
anaesthesia in women with pre-eclampsia in low- and middle-income countries. 
Systematic review and meta-analysis. BJOG-an international journal of obstetrics and 






Pre-eclampsia is defined as de-novo hypertension present after 20 weeks of gestation 
combined with proteinuria (>300 mg/day), other maternal organ dysfunction, such as 
renal insufficiency, liver involvement, neurological or haematological complications, 
uteroplacental dysfunction, or fetal growth restriction. (60, 61) Pre-eclampsia contributes 
significantly to the global burden of maternal mortality and maternal morbidity; with it 
being one of the biggest causes of intensive care unit admissions, as well as leading to 
poor perinatal outcomes. (34, 62, 63)   
 
There is a higher risk of needing an operative delivery in women with pre-eclampsia,(64) 
and anaesthetic management of these patients remains a challenge.  There has been long 
standing concern regarding the safest type of anaesthesia for use in patients with pre-
eclampsia, especially in those with severe disease or eclampsia.(65) It is now generally 
accepted that regional anaesthesia is considered safer where no contraindications exist 
in pregnant women.(66) However healthcare professionals in many LMIC vary in their 
preference for the type of anaesthesia, some favouring general anaesthesia over regional 
anaesthesia. Studies in LMIC on type of obstetric anaesthesia provide imprecise and 
varied estimates of risks.  
 
I undertook a systematic review of studies that compared the rates of adverse maternal 
and perinatal complication in pregnant women who were administered general vs. 







The systematic review was done using a prospective protocol in line with current 
recommendations, and reported as per the PRISMA guidelines.(40) 
 
Literature search 
We searched Medline, Embase, Scopus, CINAHL, Web of Science and WHO Library 
and Index Medicus from inception until April 2016.  We used MeSH headings, text 
words and word variants for "pregnancy" and combined them with terms for low 
resource countries like "low- income " or "middle income" or " developing country". 
These were then combined with an(a)esthesia and surgery related terms such as “ 
an(a)esthesia” or “ an(a)esthetist” or “ nurse an(a)esthetist” or  ‘c(a)esarean section” 
(Appendix 2).  There were no language restrictions. Additionally, we searched the 
reference lists of the included studies, and relevant reviews and articles for eligible 
papers. A subset of the all studies that included women with pre-eclampsia were 
included in this review, 
 
Study selection 
Studies were selected in a two-stage process.  In the first stage, we screened the titles 
and abstracts of all citations for potentially relevant papers.  In the second stage, we did 
a detailed examination of the full texts of the retrieved papers. Two independent 
reviewers (SS, KD) selected the papers against pre-specified inclusion criteria. Any 
discrepancies were resolved after discussion with a third reviewer (ST).  Studies were 
included if they were comparative cohort studies, and assessed maternal and perinatal 
outcomes in pre-eclamptic women exposed to general or regional anaesthesia in LMIC 
as defined by the World Bank.(41) We excluded studies in high-income countries, those 
involving women without pre-eclampsia and studies published before 1990. 
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Maternal death was defined as the death of a woman while pregnant or within 42 days 
(or 1 year for late maternal deaths) of birth or termination of pregnancy, irrespective of 
the duration and site of the pregnancy, from any cause related to or aggravated by the 
pregnancy or its management, but not from accidental or incidental causes.(1) 
Perinatal death included any fetal death that occurred after 28 completed weeks of 
gestation, stillbirth and early neonatal death until one week after birth.(42) Apgar scores 
were classed as low if they were less than or equal to 7 at one and five minutes.   We 
accepted the authors’ definitions for other maternal and fetal complications such as 
postpartum hemorrhage, cardiac arrest and admission to the intensive care unit. 
The definitions for mild, moderate, severe pre-eclampsia and eclampsia were taken as 
defined by the study authors and included in Appendix 6. 
 
Quality assessment of the included studies 
We used the Newcastle-Ottawa scale to evaluate the risk of bias in the selection, and 
comparability of subjects and cohorts and of the outcome.(46) Studies that scored four 
stars for selection; two stars for comparability and three stars for ascertainment of the 
outcome were regarded to have a low risk of bias. Studies with two or three stars for 
selection, one for comparability and two for outcome ascertainment were considered to 
have a medium risk of bias. Any study with a score of one for selection or outcome 




Data extraction and analysis 
Data were extracted by two independent reviewers (SS and KD). We obtained 
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information on study design, setting, population characteristics, type of anaesthesia, 
year of publication and maternal and fetal outcomes.  We extracted data on the number 
of events observed amongst women exposed to the different types of anaesthesia, 
mainly general and regional anaesthesia.   We computed individual study odds ratios 
and pooled them using a random effects model.  Heterogeneity was evaluated using I2 
statistic.  All analyses were performed using Stata 12.(48) 
 
4.4: Results 
From 11,200 citations, we included 14 studies that evaluated the association between 
type of anaesthesia and pregnancy complications in women diagnosed with pre-
eclampsia. (Figure 9) 
 
Figure 9: Study selection process in the systematic review of maternal and fetal 
outcomes related to type of anaesthesia in women with pre-eclampsia in low- and 
middle-income countries  
                 


















Citations identified from electronic databases (n=11,170) 
Citations identified through references and other sources 
(n=30) 
 
Articles excluded (n=11095) 
1450 duplicates  
9645 with exclusion criteria 
 
105 citations included for full text review 
Total no. of studies included (n=14) 
 
 91 studies excluded: 
25 narrative reviews, commentary 
10 inappropriate populations 
28 inappropriate study design 
15 inappropriate exposures 





Fourteen studies included 10,411 pregnant women undergoing caesarean section with 
varying severity of pre-eclampsia. Of these, 37% (3899/10,411) had mild pre-
eclampsia, 61% (6304/10,411) had severe pre-eclampsia and 2% (208/10,411) had 
eclampsia; 16% (1701/10,411) of caesarean sections were performed under general 
anaesthesia and 84% (8710/10,411) under regional anaesthesia.   The studies included 
women from Nigeria (n=5), South Africa (n=3), India (n=2) and 1 study from each of 
the following countries: Iran, Pakistan, Thailand and Taiwan. All women were 
delivered in tertiary centers. Ten were retrospective observational studies, one was a 
prospective study and three were randomised studies.   
 
The studies reported the following outcomes: maternal death (n=8), perinatal death 
(n=7), low Apgar score at 1 minute (n=6), low Apgar score at 5 minutes (n=5), 
postpartum hemorrhage (n=3), intensive care unit admission (n=6), seizures (n=6), 
pulmonary oedema (n=4), postpartum haemorrhage (n=4), and one reported on the 
following outcomes, admission to neonatal intensive care unit (NICU), post operative 
ventilation, blood transfusion and cerebral vascular accidents (CVA). Appendix 6 
shows characteristics of included studies. 
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Quality of the studies 
Quality assessment by the Newcastle Ottawa Scale for comparative studies on type of anaesthesia in 
women with pre-eclampsia showed that a fifth (3/14, 21%) had high risk of overall bias. None of the 
studies had a high risk of bias for selection or outcome assessment domains, and three quarters (11/14) 
had high risk of bias for comparability. The risks of bias for individual domains are provided in Fig 
10. 
 
Figure10: Newcastle Ottawa quality scale for studies evaluating type of anaesthesia in women with 
pre-eclampsia 


























4.41: Effects of types of anaesthesia on maternal outcomes  
Administration of general anaesthesia increased the odds of maternal death  (OR 7.70, 95% CI 1.9- 
31.0, I2=58%) by seven fold in women with pre-eclampsia compared with regional anaesthesia. There 
was a significant increase in the odds of maternal admission to intensive care unit (OR 16.25, 95% 
CI 9.0 to 29.5, I2=65%), need for post operative ventilation (OR 45.0, 95% CI 8.16 to 248.12), 
pulmonary oedema (OR 5.16, 95% CI 2.5 to 10.4, I2=0%) and post partum haemorrhage (OR 6.53, 
95% CI 2.3 to 18.9, I2=78%).   There was no significant difference in the risk of seizures. (Fig 11).   
 
Figure 11: Maternal outcomes in women with pre-eclampsia exposed to general vs. regional 





4.42: Effects of types of anaesthesia on perinatal outcomes 
 
The odds of perinatal death was were increased by three fold (OR 3.01, 95% CI 1.4 to 6.5, I2=56%) 
when general anaesthesia was administered to women with pre-eclampsia rather than regional 
anaesthesia. There was a significant association between general anaesthesia administration and low 
Apgar score at 1 minute (OR 2.50, 95% CI 1.3 to 4.6, I2=50%), at 5 minutes (OR 4.73, 95% CI 2.4 
to 9.5, I2=40%), and admission to NICU (OR2.75, 95% CI 1.5 to 5.0) than regional anaesthesia (Fig 
12).  
 
Figure 12: perinatal outcomes in women with pre-eclampsia exposed to general vs. regional 




4.43:Effects of types of anaesthesia on maternal heamodynamic state 
General anaesthesia was significantly associated with intraoperative hypertension (OR 17.49, 95% 
CI 5.43-56.36, I2=41%), postoperative hypertension (OR 13.4, 95% CI 2.46-73.46, I2=0%), and 
maternal tachycardia (defined as rise of 25% from baseline) in this group (OR 5.50, 95% CI 2.51-
12.05, I2=0%).   (Figure 13) 
 
We observed a protective effect of general anaesthesia on intraoperative hypotension (OR 0.43, 95% 
CI 0.21-0.85, I2=0%), vasopressor use (OR 0.45, 95% CI 0.22-0.94, I2=0%), and maternal 
bradycardia (defined as fall of 25% from baseline) (OR 0.40, 95% CI 0.17-0.95, I2=0%) than regional 
anaesthesia. There were no differences in postoperative hypotension (OR 0.46, 95% CI 0.13-1.63, 
I2=0%) (Figure 13). 
 
Figure 13: Heamodynamic status of women with pre-eclampsia exposed to general vs. regional anaesthesia in 
LMIC 
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4.5: Discussion 
General anaesthesia is associated with increase in maternal and perinatal death, and other 
complications such as maternal intensive care admission, pulmonary oedema and low Apgar scores 
at one and five minutes.  There was also a higher association of intraoperative and postoperative 
hypertension following general anaesthesia.   
 
The review was carried out using a prospective protocol, and rigorous methodology.  The studies 
included women across the spectrum of disease, and the findings are generalisable.  We were able to 
perform analysis of comparative data for general and regional anaesthesia, for key clinical outcomes. 
We were limited by the heterogeneity in definitions of population, intervention and outcome. 
Individual studies did not provide data on outcomes according to the severity of the disease, and we 
were unable to look for a differential effect according to disease severity. The methods and drugs 
used to carry out the regional and general anaesthesia were not the same across the studies, or were 
not documented.(67, 68)  The majority of the studies were limited to only tertiary centers, with the 
possibility of worse outcomes in district and rural settings.  We were unable to undertake meta-
regression to assess the effects of setting, practitioners, study quality and year of publication on 
outcomes due to paucity of data, and the small numbers of studies.  
 
Existing systematic reviews in pregnant women in LMIC has shown tripling of odds of maternal 
death with caesarean section(69); this was however doubled with seven fold increase of maternal death 
in women with pre-eclampsia. Women with pre-eclampsia are at higher risk from general anaesthesia, 
and the associated airway oedema makes intubations difficult, furthermore more than half of the 
women in the review had severe pre-eclampsia.  The adverse effect on perinatal deaths with general 




We found an increase in intraoperative and post-operative hypertension (rise in 20-25% from 
baseline) in the general anaesthesia group.  This is similar to the findings observed in other studies(70), 
and is hypothesised to be due to sympathetic response during intubation.   Such a phenomenon could 
be very serious in women who have severe pre-eclampsia and are already severely hypertensive.  UK 
confidential enquiries have found that in deaths the largest number of deaths following pre-eclampsia 
are secondary to intracranial haemorrhage, a known complication of severe hypertension.(50)   
 
The fear of spinal anaesthesia in patients with severe pre-eclampsia is the perceived risk of severe 
hypotension and low cardiac output resulting in placental hypo perfusion and poor perinatal 
outcomes, as well as the risk of iatrogenic pulmonary oedema while correcting the hypotension.(65, 71) 
However studies have shown that patients with severe preeclampsia have less frequent and less severe 
hypotension in response to spinal anaesthesia than normotensive parturients. (72)  Our findings have 
shown intraoperative hypotension (fall in 20-25% from baseline) in the spinal group, but this was 
reported to be easily treated and to have responded well to vasopressors.  
 
In high-income countries it is now generally accepted that regional anaesthesia is considered safer 
where no contraindications exist in pregnant women, and in women with pre-eclampsia epidural 
anaesthesia is generally recommended. However in LMIC, these recommendations do not always 
filter through and are sometimes unclear or not always easy to follow. Anaesthetic care providers in 
LMIC are restricted in their ability to perform regional anaesthesia due to the high cost and 
unavailability of epidural and spinal sets, lack of personnel with the skills to administer regional 
anaesthesia, and moribund condition of the presenting patients, and little time and resources to 
optimise the condition prior to anaesthesia.  Our systematic review has highlighted the potential harm 
with routinely using general anaesthesia in this group of very high-risk women. The haemodynamic 
effects and feto-maternal consequences of spinal anaesthesia need to be also compared with epidural 
anaesthesia, which is considered the current benchmark technique.  
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There is a need for well conducted large studies evaluating the risks of general and regional 
anaesthesia in LMIC, and compare the effects of administering anaesthesia between physician 
anaesthetists, and non-physician cadre of trained anaesthetic providers. Health policy makers need to 
prioritise improvements in the ability of maternity units in LMIC to provide safe anaesthesia and 
promote good practice guidelines in the management of high-risk patients. On going efforts such as 
those of LifeBox, which promote safe anaesthesia during surgery(58), needs to be extended to include 
high risk women undergoing caesarean section. 
 
4.6: Conclusion:  
Regional anaesthesia should be considered as the first choice of anaesthesia in women with pre-
eclampsia in LMIC necessitating caesarean section if there are no specific contraindications.   Further 
training is required in the management of these high-risk women especially when dealing with airway 
complications.   
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Chapter 5: Maternal and fetal complications related to caesarean section in LMIC 
 
5.1: Abstract:  
Background 
Caesarean section is a life saving procedure for both mother and fetus. It is also poses a small but 
significant risk to mother and child, which are disproportionately high in LMIC.  
 
Methods:  
We searched major electronic databases until June 2016, for studies reporting risks of maternal death 
from caesarean section in LMIC. Two independent reviewers undertook quality assessment and data 
extraction.  We also included unpublished studies without any language restrictions. We computed 
proportions of caesarean section deaths and complications and odds ratios for risk factors, and pooled 
the data using a random effects model. 
 
Findings:  
From 11822 citations, we included 192 studies. 69 studies (30868 maternal deaths, > 12 million 
deliveries, 50 countries) reported on caesarean section deaths as a proportion of all maternal deaths.  
138 studies/ 205 cohorts (2601330 caesarean sections, > 11 million deliveries, 63 countries) reported 
on caesarean section deaths as a proportion of all caesarean sections. 47 studies (285655 caesarean 
sections) assessed the association of various risk factors and complications in pregnant women 
undergoing caesarean section 
 
Of all maternal deaths 24% (95% CI 21.7 to 27, I2=93.7%) had undergone a caesarean section with 
the highest rates in Latin America and the Caribbean (58%, 95% CI 42.7 to 73.5, I2 =38%), and the 
lowest in East Asia and Pacific (17%, 95% CI 13.7 to 20.7, I2=64.9%).  The overall rate of death in 
women undergoing a caesarean section was 4.8 per 1000 (95% CI 4.23 to 5.6, I2 = 97%) procedures, 
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with the highest rates in sub-Saharan Africa (10.0 per 1000 caesarean -sections, 95% CI 8.7 to 11.5, 
I2=98%). 
 
The overall rate of stillbirth in women undergoing a caesarean section was 44 per 1000 procedures  
(95% CI 35.0 to 54.9, I2 = 99%), with the highest rates in sub-Saharan Africa (79 per 1000 caesarean 
sections, 95% CI 64.5t o 95.3, I2=98%).  The overall risk of perinatal death in women undergoing a 
caesarean section was 74 per 1000 caesarean sections  (95% CI 60 to 88, I2 = 99%), with the highest 
rates in Middle East and North Africa (116 per 1000 caesarean sections, 95% CI 0 to 478, I2=99%). 
 
The odds of maternal death was doubled (OR 2.14, 95% CI 1.20 to 3.82, I2=62%), and perinatal death 
was quadrupled (OR 4.24, 95% CI 2.56 to 7.10, I2=83%) with emergency than elective caesarean 
section. Caesarean section that was performed in the second stage of labour increased the odds of 
maternal death by 12 fold (OR 12.27, 95% CI 2.87 to 52.49, I2=0%), and increased perinatal death 
(OR 9.23, 95% CI 4.24 to 20.10) compared to those performed before full dilatation. There was no 
significant difference in mortality with different cadres or seniority of staff performing the procedure. 
 
 Conclusion: Caesarean sections carry a high maternal mortality rate in low- and middle-income 
countries.  Interventions should be used to reduce the rate of unnecessary caesarean sections and 
improve the safety of this procedure.   
 
Publications arising from this chapter: 
Accepted for poster presentation for Royal College of Obstetricians and Gynaecologist Congress 
2017 
 
5.2: Introduction:  
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Caesarean sections are a part of comprehensive emergency care (CEmOC) and is essential in the 
management of several obstetric emergencies. When used appropriately caesarean section is a life 
saving procedure for both mother and fetus.   There is a lack of equity in the accessibility to caesarean 
sections with the lowest income countries having a caesarean section rate of 2%,(73) this leads to care 
being administered ‘too little and too late’ resulting in maternal and fetal complications. (74) 
 
Although caesarean sections save lives, the surgery is potentially dangerous. This can be a result of 
from surgerical y and anaesthesia related mortality and morbidity in the current pregnancy, and from 
uterine rupture during subsequent pregnancies.  This risk is further heightened by lack of surgical 
skill, lack of equipment and lack of blood.(15) There are no robust estimates of maternal deaths from 
caesarean sections. The causes and factors that contribute to maternal mortality in mothers 
undergoing caesarean section are varied and multifactorial but need further clarification.  
 
We undertook a systematic review to identify the factors linked to adverse outcomes in pregnant 
women undergoing a caesarean section in LMIC, and to obtain precise estimates of poor outcomes 
including death and associated factors.  
 
5.3: Methods: 
We undertook the systematic review using a prospective protocol (PROSPERO No. 







We searched Medline, Embase, Scopus, CINAHL, Web of Science and WHO Library and Index 
Medicus until 1st June 2016. We used MeSH headings, text words and word variants for "pregnancy" 
and combined them with terms for low resource countries like "low- income " or "middle-income" or 
"developing country". These were combined with terms related to caesarean sections and surgery 
such as “c(a)esarean section”  or “an(a)esthesia” (Appendix 2).  There were no language restrictions. 
Additionally, we searched the reference lists of the included studies and relevant reviews for eligible 
studies.  We also obtained primary data from WHO Multi-country and Global surveys and re-
analysed for factors of interest.   
 
Study selection 
Studies were selected in two stages. In the first stage, we screened the titles and abstracts of all 
citations for potentially relevant papers. In the second, we examined the full texts of the retrieved 
papers. Two independent reviewers (SS, NM) selected the papers against pre-specified inclusion 
criteria. Any discrepancies were resolved after discussion with a third reviewer (ST). Studies were 
included if they assessed maternal and perinatal outcomes in pregnant women undergoing a caesarean 
section in countries categorized as LMIC by the World Bank.(41)  We excluded studies in high-income 
countries, those involving non-pregnant women, case reports, and studies published before 1990 to 
ensure that the estimates reflect the current burden of the condition.  
 
Caesarean section was defined as the delivery of the fetus through an abdominal and uterine incision.  
Elective caesarean section are planned in advance and happen before labour often for conditions that 
make normal delivery dangerous for either mother or fetus. Emergency caesarean sections are often 
carried out because of concerns to the mother or fetus that develops before or after labour has started.  
First stage caesarean sections are defined as a caesarean section done before the cervix is fully dilated; 
second stage caesarean sections are defined as a caesarean section done after the cervix is fully 
dilated.  We accepted the primary study authors’ definitions for elective and emergency caesarean 
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sections. Maternal mortality was defined as death of mother during pregnancy, and at any time until 
42 days after delivery, irrespective of the duration and site of the pregnancy as defined by the World 
Health Organization (WHO). This included deaths from any cause related to or aggravated by 
pregnancy and its management, but not from accidental or incidental causes.(1) Perinatal death 
included any fetal death that occurred after 28 completed weeks of gestation, stillbirth and early 
neonatal death until one week after birth.(42) Apgar scores were classed as low if they were less than 
or equal to 7 at one and five minutes. We accepted the primary study authors’ definitions for maternal 
and fetal complications such as postpartum haemorrhage, cardiac arrest and admission to the intensive 
care unit.  
 
Study quality assessment and data extraction 
Two independent reviewers (SS and NM) undertook study quality assessment and data extraction, 
and any discrepancies were resolved with input from the third reviewer (ST).  
For studies assessing caesarean section case fatality rates, a study was considered to be adequate for 
representativeness unless the hospitals involved were private hospitals or funded by an NGO or were 
part of large multicounty trial where interventions were initiated.  Sample selection was classed as 
adequate if all caesarean sections were included, and as inadequate if a particular group of women 
were excluded, e.g. only those undergoing an elective procedure. We considered outcome assessment 
to be adequate if registry data e.g. from theatre books or patient notes were used and inadequate if 
verbal reports were the source of information. Studies that accounted for the cause of caesarean deaths 
to mother of fetus in at least 95% of cases were deemed to be adequate for ascertainment of cause of 
death. A study was classed as high quality if three of the above four criteria were met.(44) 
 
Data were extracted on the number of events (caesarean section maternal death and complications) 
in women exposed and un-exposed to risk factors such as type of caesarean (elective/ emergency, 
first stage/ second stage) and type of practitioner (physician, non-physician) as well as grade. We 
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obtained information on the number of women undergoing caesarean section, total number of 
maternal deaths, and deaths during or after caesarean section, to compute corresponding proportions 
for individual studies.  
 
Data analysis 
Summary rates of deaths following caesarean sections were estimated as a proportion of total 
maternal deaths and a proportion of total caesarean sections.  Sub-group analysis and meta-regression 
were performed for the following factors that were specified a priori: geographical location (World 
Bank classification), country income (low-, low-middle, upper-middle), type of hospital, and year of 
publication (before and after 2000). We also assessed the effects of study quality (low, high) and 
study design (prospective, retrospective).  We used multilevel random effects logistic models, and 
included the above factors. The meta-regressions were run as separate univariate analyses. We 
performed sensitivity analysis by excluding studies that included only subsets of the pregnant 
population, e.g. only elective caesarean sections. We did a further sensitivity analysis by carrying out 
caesarean section mortality rate as a proportion of postpartum maternal deaths rather than all maternal 
deaths.   Proportions of causes of caesarean section mortality and morbidity were also calculated.   
 
For comparative data, we computed odds ratios for various risk factors such as type (emergency V 
elective), timing of caesarean section (second V first stage) and type and grade of operating surgeon 
(junior V senior/ non-physician V physician) and pooled them using a random effects model. 




From 11822 citations, we included 192 studies. (Figure 14).    
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Figure 14. Study selection process in the systematic review of caesarean section related mortality in 
low- and middle-income countries (LMIC)  
                                           
 
69 studies / 119 cohorts (30,868 maternal deaths, > 12 million deliveries, 50 countries) reported on 
caesarean section deaths as a proportion of all maternal deaths.  138 studies/ 205 cohorts (260,1330 
caesarean sections, > 11 million deliveries, 63 countries) reported on caesarean section deaths as a 
proportion of all caesarean sections. 47 studies (285655 caesarean sections) assessed the association 
of various risk factors and complications in pregnant women undergoing caesarean section; type of 
caesarean section  (elective V emergency- 30 studies, 257073 caesarean section, second V first stage- 
8 studies, 8988 caesarean sections,) and type of practitioner (11 studies, 59629 caesarean sections) 
were the analysed risk factors.  Data was available from all World Bank regions.  114 studies provided 
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Indications for caesarean sections 
Indications for caesarean section were reported on by 89 studies and 345,688 caesarean sections.   
22% (78,737/345,688) were done for failure to progress, cephalo-pelvic disproportion or obstruction, 
17% (61,868, 345,688) were carried out due to previous cesarean section, 11% (41,181/345,688) 
were done for fetal distress, 7% (25,491/345,688) were done for hypertensive disorders, 3% (10,540, 
345,688) were done for Antepartum haemorraghe, and 28 % (99,139, 345,688) were due to other 
cause such as multiple pregnancies, malpresentation or ruptured uterus 
See appendix 7 for table of study characteristics.   
 
Quality of the studies 
Three quarters (97/138, 70%) of the included studies on mortality rates following caesarean section 
caesarean section were deemed high quality. Nearly all studies were deemed high quality (127/138, 
92%) for representativeness of the population and setting, three quarters of studies (101/138, 73%) 
had adequate sample selection, four fifth were assessed as good quality for outcomes reporting 
(114/138, 82%) and two-fifth adequately accounted for <95% of maternal deaths (55/138, 40%) (Fig 
15).  
 
Figure 15: Quality assessment for studies providing rates of mortality following caesarean section.   
                        



























Of all maternal deaths 24.3% (95% CI 21.7 to 27.9, I2=93%) had undergone a caesarean section with 
the highest rates in Latin America and the Caribbean (58.4%, 95% CI 42.7 to 73.5, I2 =38%), and the 
lowest in East Asia and Pacific (17%, 95% CI 13.7 to 20.7, I2=65%).  There was a statistically 
significant difference between the regions (p<0.001), and between different study designs (p<0.001) 
with higher estimates from prospective studies.  (Table 7). 
 
Of all maternal deaths who had delivered 36.7% (95% CI 31.7 to 41.7, I2=94%) had delivered by 
caesarean section with the highest rates in Latin America and the Caribbean (73.5%, 95% CI 56.3 to 
88.4, I2 =38%). There was a statistically significant difference between the regions (p<0.001).  
Sensitivity analysis in appendix 8 
 
Table 7: Rates of caesarean section deaths as a proportion of total maternal deaths.   
Factors Studies/Cohort
s 
n N Prevalence (%) Heterogeneity I2 Subgroup 
P Value 
   
Region 
East Asia and Pacific 18 624 3,372 17.1 (13.7; 20.7) 64.9%  
<0.001 
Europe and Central Asia 1 50 174 28.7 (22.5; 35.9) -  
Latin America and the 
Caribbean 
16 239 523 58.4 (42.7; 73.5) 37.5%  
Middle-East and North Africa 13 364 2,029 35.0 (20.3; 51.1) 97.2%  
South Asia 20 430 2,610 24.5 (17.6; 31.9) 91.6%  
Sub-Saharan Africa 44 5,703 22,159 22.9 (20.2; 25.6) 93.1%  
Year of 
study 
<2000 28 1,325 6,162 23.5 (18.7; 28.7) 95.0%  
0.203 
>2000 84 6,085 24,705 25.0 (21.9; 28.3) 93.1%  
Study 
design 
Prospective 53 562 1,813 33.8 (28.0; 39.9) 71.5%  
<0.001 
Retrospective 59 6,848 29,054 22.2 (19.5; 25.0) 96.2%  
Income 
setting 
Low 21 757 2,462 27.9 (20.2; 36.3) 93.9%  
0.461 Lower-Middle 49 1,074 6,178 22.0 (17.1; 27.1) 93.6%  
Upper-Middle 41 5,567 22,172 24.0 (20.8; 27.3) 89.8%  
Quality 
Low 9 213 844 20.4 (11.4; 31.0) 91.8%  
0.239 
High 103 7,197 30,023 24.8 (22.0; 27.7) 93.9%  





5.42: Risk of maternal death in women undergoing caesareans section   
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Caesarean section mortality rates were 4.8 (95% CI 4.2 to 5.6, I2 = 97%) per 1000 procedures.  
Subgroup analysis and meta-regression showed a statistically significant difference between regions 
(p<0.001). The highest rates of deaths following caesarean sections was in Sub- Saharan Africa, with 
10 per 1000 procedures, (95% CI 8.7 to 11.5, I2=98%) and the lowest rates were in Europe and Central 
Asia with 0.3 per 1000, (95% CI 8.7 to 11.5, I2=98%), (Table 8). Appendix 9 and figure 16 provides 
estimates for individual countries.    
There was also a significant difference between year of study, with those published after year 2000 
4.2 per 1000, (95% CI 3.5 to 4.9, I2=96%) having almost half the rate of death as those published 
before year 2000, 7.6 per 1000, (95% CI 6.6 to 8.8, I2=97%),  (p<0.001).  There was also a difference 
in income setting with low income countries having the highest rates of mortality of 11.0 per 1000, 
(95% CI 8.3 to 14.2, I2=95%), (p<0.001).  The quality of studies also affected the rates,  (p<0.001).   
A sensitivity analysis excluding studies that included only specific groups of women did not show a 
























Table 8: Rates of deaths in women undergoing caesarean section / 1000 caesarean sections.  
Factor  Studies/
Cohorts 
n N Prevalence 







East Asia and Pacific 16 143 151,361 0.6 (0.2; 1.1) 74.9% 
<0.001 
Europe and Central Asia 2 51 130,596 0.3 (0.2; 0.5) 98.3% 
Latin America and the Caribbean 17 202 215,982 0.6 (0.4; 0.8) 33.4% 
Middle-East and North Africa 7 24 9,217 1.9 (0.0; 5.8) 84.8% 
South Asia 24 289 91,287 1.6 (0.8; 2.7) 82.1% 
Sub-Saharan Africa 99 5,848 1,894,908 10.0 (8.7; 11.5) 97.6% 
Year of 
study 
<2000 30 947 302,637 7.6 (4.8; 10.9) 98.3% 
0.035 
>2000 136 5,650 2,193,655 4.2 (3.5; 4.9) 96.3% 
Study 
design 
Prospective 97 1,647 290,461 3.5 (2.3; 4.9) 95.9% 
<0.001 
Retrospective 69 4,950 2,205,831 7.7 (6.6; 8.8) 97.5% 
Income 
setting 
Low 56 1,809 134,763 11.1 (8.3; 14.2) 95.1% 
<0.001 Lower-Middle 44 559 153,747 1.7 (0.9; 2.7) 88.4% 
Upper-Middle 65 4,189 2,204,841 2.8 (2.3; 3.4) 95.9% 
Quality 
Low 32 1,397 137,403 8.9 (6.1; 12.1) 95.3% 
<0.001 
High 133 5,194 2,356,829 4.0 (3.4; 4.6) 96.0% 
Type of 
Hospital 







Mixed 19 4,724 2,033,216 6.2 (4.6; 7.9) 99.2% 
Private hospital 2 3 1,470 1.5 (0.0; 4.6) 100.0% 
Teaching hospital 48 1,127 243,966 9.1 (5.9; 12.8) 97.9% 
Tertiary hospital 26 304 41,692 8.9 (5.9; 12.6) 89.7% 

















The overall rate of stillbirth in women undergoing a caesarean section was 44 per 1000 procedures  
(95% CI 35 to 55, I2 = 99%), with the highest rates in sub-Saharan Africa (79.2 per 1000 C-sections, 
95% CI 64 to 95.3, I2=97%) (Table 9). Subgroup analysis and meta-regression showed a statistically 
significant difference between regions (p=0.001), between income groups (p=0.001), with the lowest 
income countries having the highest rates of stillbirths (76 per 1000 caesarean sections, 95% CI 54 
to 103, I2=98%), between type of hospitals (p=0.001), between study design (p=0.001) and by year 
(p=0.003) with rates after year 2000 being almost half of that before 2000. (Table 9).    
 









I2   
Region 
East Asia and Pacific 10 586 17,264 13.8 (0.2; 45) 99.3%  
<0.001 
Europe and Central Asia 0 - - - -  
Latin America and the 
Caribbean 
9 2,418 187,084 9.0 (6.4; 12.1) 93.4%  
Middle-East and North Africa 2 65 2,782 22.4 (17.2; 28.3) 99.2%  
South Asia 11 423 21,107 18.7 (9.6; 30.5) 95.3%  
Sub-Saharan Africa 41 5,440 68,780 79.2 (64.5; 95.3) 97.9%  
Year of 
study 
<2000 17 4,152 48,713 75.2 (49.0; 106.4) 99.1%  
0.003 
>2000 56 4,780 248,304 35.9 (28.8; 43.7) 98.3%  
Study 
design 
Prospective 45 2,114 89,196 29.3 (21.2; 38.6) 98.2%  
<0.001 
Retrospective 28 6,818 207,821 74.5 (50.9; 102.2) 99.6%  
Income 
setting 
Low 23 2,131 25,489 76.4 (53.6; 102.8) 98.1%  
0.001 Lower-Middle 22 3,076 63,021 23.3 (10.7; 40.3) 99.2%  
Upper-Middle 28 3,725 208,507 40.2 (29.3; 52.7) 98.8%  
Quality 
Low 13 2,220 29,151 74.4 (52.9; 99.1) 95.1%  
0.003 
High 59 6,687 265,806 39.8 (30.5; 50.4) 99.1%  
Type of 
Hospital 
District hospital 5 560 7,298 77.4 (29.6; 144.8) 98.6%  
<0.001 
Mixed 5 2,214 154,146 49.6 (16.8; 97.8) 97.7%  
Private hospital 2 34 1,937 16.6 (11.3; 22.9) 99.4%  
Teaching hospital 21 4,129 48,934 67.6 (44.5; 94.9) 98.9%  
Tertiary hospital 19 834 16,978 47.9 (31.1; 68.1) 96.4%  





The overall risk of perinatal death in women undergoing a caesarean section was 74 per 1000 
caesarean sections  (95% CI 60 to 88, I2 = 99%), with the highest rates in Middle East and North 
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Africa (116 per 1000 caesarean sections, 95% CI 0 to 478, I2=99%) and lowest in Europe and Central 
Asia (1.8 per 1000 caesarean sections, 95% CI 0.9 to 3.8). Subgroup analysis and meta-regression 
showed a statistically significant difference between regions (p=0.001), between income groups 
(p=0.002), with the lowest income countries having the highest rates of perinatal mortality (107 per 
1000 caesarean sections, 95% CI 83 to 133, I2=99%), between type of hospitals (p=0.001), between 
study design (p=0.011) and by year (p=0.007), with rates after year 2000 being almost half of that 
before 2000.  (Table 10). 
 






n N Prevalence  





East Asia and Pacific 12 1,039 19,719 25.0 (2.7; 67.8) 99.5%  
<0.001 
Europe and Central Asia 1 7 3,817 1.8 (0.9; 3.8) -  
Latin America and the Caribbean 8 607 34,974 17.5 (14.3; 21.0) -  
Middle-East and North Africa 3 1,549 6,013 116.3 (0.0; 477.9) 99.9%  
South Asia 13 883 23,491 43.9 (26.9; 64.7) 97.5%  
Sub-Saharan Africa 72 10,461 111,982 99.3 (83.8; 115.9) 98.7%  
Year of 
study 
<2000 24 6,828 55,906 119.0 (78.4; 166.5) 99.5%  
0.007 
>2000 85 7,718 144,090 62.1 (50.2; 75.2) 98.9%  
Study 
design 
Prospective 64 6,308 121,778 57.7 (45.2; 71.6) 99.0%  
0.011 
Retrospective 45 8,238 78,218 97.9 (70.1; 129.7) 99.5%  
Income 
setting 
Low 39 6,362 63,277 107.0 (83.0; 133.6) 99.0%  
0.002 Lower-Middle 32 5,665 70,798 57.1 (33.2; 86.6) 99.5%  
Upper-Middle 38 2,519 65,921 57.3 (41.8; 75.1) 98.8%  
Quality 
Low 28 4,326 47,397 93.2 (75.2; 113.0) 97.1%  
0.047 
High 80 10,151 150,539 68.0 (51.8; 86.1) 99.4%  
Type of 
Hospital 
District hospital 18 1,103 14,092 78.5 (42.9; 123.3) 98.6%  
<0.001 
Mixed 10 3,230 27,030 129.4 (94.8; 168.4) 98.4%  
Private hospital 2 73 1,937 37.7 (29.6; 46.7) 99.8%  
Teaching hospital 34 6,660 63,568 89.1 (57.3; 127.1) 99.5%  
Tertiary hospital 24 1,498 25,645 71.1 (47.5; 98.8) 98.3%  
Overall 109 14,546 199,996 73.6 (60.0; 88.4) 99.4%    
 
 
5.44: Risk factors for adverse outcomes in pregnant women undergoing caesarean section 
Emergency vs. elective caesarean section 
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The odds of maternal death was were doubled (OR 2.14, 95% CI 1.20 to 3.82, I2=62%), and perinatal 
death was quadrupled (OR 4.26, 95% CI 22.56to 7.10, I2=83%) with emergency rather than elective 
caesarean section. There was a significant increase in other complications such as postpartum 
haemorrhage (OR 2.87, 95% CI 1.08 to 7.68, I2=82%), postpartum infection (OR 10.16, 95% CI 4.36 
to 23.69, I2=0%), wound dehiscence (OR 3.87, 95% CI 1.26 to 11.89, I2=0%) and respiratory 
complications (OR 2.48, 95% CI 1.13 to 5.43, I2=48.5%).   (Figure 17)  Appendix 11 includes table 
of results. 
 




Second vs. first stage of labour caesarean section 
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Caesarean section that was performed in the second stage of labour increased the odds of maternal 
death by 12 fold (OR 12.27, 95% CI 2.87 to 52.49, I2=0%) compared to those performed before full 
dilatation.  There was also an increase in maternal ITU admissions (OR 16.68, 95% CI 4.90 to 56.77, 
I2=0%), hysterectomy (OR 22.08, 95% CI 7.56 to 64.43, I2=0%), postpartum hemorrhage (OR 5.17, 
95% CI 1.78 to 15.03, I2=83.3%) and the need for a blood transfusion (OR 1.99, 95% CI 1.03 to 3.84, 
I2=71.9%).   
 
There was a significant increase in intraoperative complications such as bladder injuries (OR 5.62, 
95% CI 2.99 to 10.58, I2=36.9%), lower segment tears (OR 7.1, 95% CI 4.28 to 14.23, I2=0%) and 
extension of tears of uterine incisions (OR 11.45, 95% CI 4.20 to 31.23, I2=85.3%). There was also 
an increase in infective complications such as postpartum endometritis  (OR 1.71, 95% CI 1.11 to 
2.64, I2=83%), wound infections (OR 2.77, 95% CI 1.18 to 6.49, I2=84%), and febrile illness (OR 
4.07, 95% CI 2.95 to 5.61, I2=0%).   
 
The odds of complications in the offspring were increased when caesarean section was performed at 
full dilatation for perinatal death (OR 9.23, 95% CI 4.24 to 20.10, I2=0%), low Apgar score at one 
(OR 23.75, 95% CI 2.94 to 191.6, I2=0%) and 5 minutes (OR 11.89, 95% CI 1.09 to 130.3, I2=0%), 
and admissions to neonatal intensive care unit (OR 3.57, 95% CI 2.20 to 5.79, I2=69%),  (Figure 18). 











Type of practitioner and caesarean section complications.   
There was no significant difference in outcomes between a senior registrar and consultant, nor 
between a registrar and consultant.  Comparison between a junior and senior registrar found that the 
odds of post partum hemorrhage (OR 4.87, 95% CI 2.25 to 10.55, I2=0%) and wound dehiscence (OR 
22.0, 95% CI 2.81 to 172.1, I2=0%) were increased if a junior doctor was operating compared to a 
senior doctor.  Comparison of non-physician and physician operators found that the odds of perinatal 
death (OR 1.54, 95% C1.1.07 to 2.24, I2=95%) and wound dehiscence (OR 2.00, 95% CI 1.36 to 
2.95, I2=0%) were increased if a non-physician was operating in comparison to a physician.  
Hysterectomy (OR 0.15, 95% C1. 0.11 to 0.20, I2=0%) and blood transfusion (OR 0.31, 95% C1.0.26 




Table 11: Type of practitioner and associated maternal / perinatal outcomes.  













Bladder / Uterine extensions 
Uterine vessel injury 
Perinatal death 
Low apgar score- 5 mins. 
Low apgar score- 1 mins. 
Neonatal intensive care unit admission 
12.27 (2.87, 52.49) 
16.68 (4.90, 56.77) 
22.08 (7.56, 64.43) 
1.99 (1.03, 3.84) 
5.19 (1.83, 14.73) 
17.84 (3.34, 95.33) 
5.62 (2.99, 10.58) 
7.81 (4.28, 14.23) 
4.07 (2.95, 5.61) 
1.71 (1.11, 2.62) 
2.77 (1.18, 6.48) 
11.45 (4.20, 31.23) 
28.06 (1.50, 526.01) 
6.38 (3.23, 12.60) 
9.23 (4.24, 20.10) 
11.89 (1.09, 130.27) 
23.75 (2.94, 191.59) 
3.57 (2.20, 5.79) 
OR (95% CI) 










































































































































First stage Second stage 

























Anaemia 1 104 69 35 23 0.99 0.54 1.82 0.975 - 
Hypovolemic shock 1 19 154 6 52 1.07 0.41 2.82 0.892 - 
Maternal mortality 3 20 568 0 97 1.42 0.26 7.88 0.688 0% 
Postpartum haemorrhage 1 23 126 6 72 2.19 0.85 5.63 0.104 - 
Sepsis 1 35 138 12 46 0.97 0.47 2.03 0.940 - 




Anaemia 1 71 47 35 23 0.99 0.52 1.89 0.982 - 
Hypovolemic shock 1 13 195 6 52 0.58 0.21 1.59 0.289 - 
Maternal mortality 2 4 216 0 62 4.60 0.24 86.86 0.309 - 
Postpartum haemorrhage 1 10 267 6 72 0.45 0.16 1.28 0.134 - 





Anaemia 2 110 212 72 323 2.71 0.26 28.68 0.408 79% 
Hypovolemic shock 1 19 154 13 195 1.85 0.89 3.87 0.101 - 
Maternal mortality 2 18 355 4 216 2.62 0.39 17.48 0.319 43% 
Postpartum endometritis 1 6 214 13 504 1.09 0.41 2.90 0.868 - 
Postpartum haemorrhage 1 23 126 10 267 4.87 2.25 10.55 <0.00
1 
- 
Sepsis 2 36 286 25 370 1.04 0.59 1.84 0.891 0% 
Wound dehiscence 1 11 138 1 276 22.00 2.81 172.14 0.003 - 





Postpartum heamorrhage 1 1 732 4 1,568 0.54 0.06 4.80 0.577 - 
Fever 1 388 1,487 56 200 0.93 0.68 1.28 0.662 - 
Maternal morbidity 1 33 912 6 137 0.83 0.34 2.01 0.674 - 
Maternal mortality 7 323 141,497 258 148,012 1.27 0.79 2.04 0.326 7% 
Wound dehiscence 3 98 3,468 43 2,898 2.00 1.36 2.95 <0.00
1 
0% 
Wound infection 2 157 2,451 47 1,781 1.34 0.90 1.99 0.156 0% 
Blood transfusion 1 1,052 129,679 3,599 137,552 0.31 0.29 0.33 <0.00
1 
- 
Hysterectomy 1 41 130,726 304 140,703 0.15 0.11 0.20 <0.00
1 
- 
Perinatal death 7 5,010 137,803 5,109 143,916 1.54 1.07 2.24 0.022 96% 
Stillbirth 1 2,749 127,994 3,019 138,414 0.99 0.94 1.04 0.563 - 
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5.45 Causes of maternal deaths in women undergoing caesarean section   
The underlying causes of death were reported in 56 studies, with data on 4387 deaths 
following caesarean section.  A Third (1207/4387, 38%) of all deaths resulted from 
postpartum hemorrhage, 15% (658/4387) related to pre-eclampsia, 14%  (591/4387) 
from sepsis, 7.5% (330/4387) due to anaesthesia, and a quarter due to other causes such 
as pulmonary embolus and other respiratory complications, anaemia or pre-existing 
medical conditions.   
 
Morbidity in women undergoing caesarean section   
Morbidity following caesarean section (24 studies) was 27 % (95% CI 22to 31, I2 = 
99%), these included post partum haemorrhage, blood transfusions, hysterectomy, post 
partum sepsis, wound infections, and itu admissions.   
 
5.5: Discussion 
The rates of maternal mortality in women undergoing caesarean sections in LMIC is 
10-fold higher than what is observed in high-income countries,(75) with the risks 
increased further in Sub Saharan Africa. Deaths in women undergoing caesarean 
section contributed to a quarter of all maternal deaths. The outcomes were even worse 
for the fetus following caesarean section with stillbirths diagnosed in 1 in 22, and 
perinatal deaths about 1 in 13 women undergoing caesarean section. Emergency 
caesarean sections and those performed in the second stage of labour significantly 
increased maternal and perinatal mortality and morbidity. The rates of most maternal 
and fetal complications were not affected by the cadre or seniority of staff performing 
the caesarean section, however the oddsff of hysterectomy was higher when a physician 
was operating in comparison to a non-physician, this maybe due to the fact that 
physicians may encounter the sickest, more complicated cases.  
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Ours review comprehensively and systematically evaluated the risk of maternal 
perinatal deaths, and other relevant outcomes in women undergoing caesarean section. 
We restricted our meta-analysis to only primary and published data rather than 
modelled data with many assumptions.(76) In addition to quantification of the rates of 
complications in women undergoing caesarean section, we explored in detail the risk 
factors for these outcomes. We looked for variations in death rates according to 
economic regions, individual countries and type of hospital.  
 
There are limitations in estimating fatality rates from caesarean section, due to lack of 
data on underlying risk factor resulting in caesarean section, and could have influenced 
the mortality and morbidity. Hence, we were only able to quantify the overall 
association of caesarean section with complications. We were limited by the differences 
in reporting of outcomes, and their definitions in individual studies. Few studies were 
published in low-income countries that are outside Sub Saharan Africa and Asia.  A 
large proportion of studies were from teaching and/ or tertiary hospitals, and although 
they will tend to be referred the sickest cases, they will also be the best equipped and 
staffed, so therefore the rates of deaths maybe higher in small rural centers. It is likely 
that the actual burden of complications is higher than our estimates, which were 
predominantly from facility-based data. We found significant heterogeneity in our 
findings which may be related to various factors and reflecting the variation in 
population, risk factors, setting and outcome.    
 
Second stage caesarean section pose particular risk and require more surgical skill. Our 
review found poorer maternal and fetal outcomes following second stage caesarean 
section, and this was supported in previous reviews.(77) If alternative methods of 
delivery are possible these should be considered as first line, e.g. instrumental delivery, 
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symphysiotomy for obstructed labour or destructive deliveries for fetal deaths in 
neglected labours. (78, 79) These measure are much needed in low- income countries to 
reduce mortality and morbidity, more training is required to make sure that these 
procedures are performed safely.(80, 81) 
 
We found haemorrhage to be the highest cause of death following caesarean section; 
similar concerns have been raised in the recent South African confidential enquiries.(82) 
Risk factors for haemorrhage should be identified earlier and modified if possible.  
Places with limitation in management of haemorrhage such as access to uterotonics and 
poor availability of blood should escalate their management of intra-partum and 
postpartum haemorrhage (PPH) earlier. Interventions such as balloon tamponade, B-
lynch suture and early hysterectomy should be considered.  PPH and the need for blood 
transfusion were also contributed to morbidity following the procedure. This is 
followed by wound infection and postoperative pyrexia. Better morbidity definitions 
and data is needed to fully assess the rates of morbidity associated with caesarean 
sections.  
 
The most frequent indication reason for caesarean section was failure to progress and 
cephalo-pelvic disproportion, this is possibly being over diagnosed and safe active 
management of labour should be encouraged, we do not have the figures of how many 
of these labours were augmented.   The second most frequent cause was a previous 
caesarean section, as the caesarean section rises and with hospitals in LMIC reluctant 
to undertake a trial of vaginal birth after caesarean section (VBAC) this will only further 
increase the caesarean section rate and exacerbate the long term problem with 
associated such as ruptured uterus, placenta praevia and accrete in future pregnancies.  
Audits need to be done not just for caesarean outcomes, and but also audits of the 
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appropriateness of cesarean section are essential.   Studies in the literature where this 
has been done found that suboptimal management occurred in large numbers of cases 
and that there was a lack of awareness and use of evidence-based guidelines, leading to 
unnecessary procedures.(83, 84) Robsons criteria for caesarean section may be helpful in 
monitoring caesarean sections in the future and follow trends so interventions can be 
better targeted. (85) 
 
Caesarean section are commonly done either to save the mother or the fetus. However 
the very high rate of observed stillbirths and perinatal deaths in our review indicate the 
possibility of inappropriate indication for the procedure e.g. for a dead fetus or the 
procedure being done far too late, putting the mother at risk without the benefit of 
having a live baby. Current guidelines have moved away from recommending a set 
caesarean section rate, but recommend that every woman who needs a cesarean section 
should receive one in a timely manner.  Ecological studies found that once the caesarean 
section rate reached 10-15% at a population level the mortality curve had no significant 
impact on maternal and infant mortality rates (86, 87), and the recent rise in caesarean 
section rate has been a cause for concern.  With the global increase in caesarean 
sections, there is a need to ensure that only truly medically indicated caesarean sections 
take place and that they are done in a timely manner to reduce poor outcomes.   
 
Caesarean section rates should be monitored and only necessary caesarean sections 
should be done.  Improving access and infrastructure is essential but not without 
improving quality and safety.  Strategies to reduce maternal mortality should include 
increasing the number of anaesthetists and obstetricians- or increase the numbers of 
people able to do caesarean sections by task shifting. Non-physician cadres should be 
adequately trained and supervised to ensure safe care.   Implementation of simple 
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measures, such as the WHO ‘Safer Surgery’ checklist before and during surgery would 
minimise adverse outcomes.(58) Governmental and non-governmental organisations 
should prioritise investment in obstetric surgery, to implement the World Health 
Assembly’s resolution to include emergency and essential surgical care and anaesthesia 
as a component of universal health coverage.(59) 
 
5.6: Conclusion  
Caesarean section death rates are disproportionately high in LMIC.  More needs to be 
done to increase access to caesarean section where they are needed, but also reduce the 
caesarean section rate where they are overused through targeted intervention.   Efforts 









Anaemia is a significant contributor to poor maternal and perinatal outcomes.  Its 
prevalence in pregnancy varies but is estimated to be 42% in low- and middle-income 
countries.  Testing for anaemia is poorly done in these countries especially in rural 
settings, where diagnosis is often based on symptoms and physical examination. Onsite 
tests are available but their accuracy is unclear. We carried out a systematic review to 
determine the accuracy of on-site tests used to detect anaemia in pregnancy.  
 
Methods:  
Medline, Embase, Scopus, CINAHL and Web of Science were searched from inception 
till February 2016. Background information was extracted as well as true positive, true 
negative, false positive and false negative rates. QUADAS-2 tool was used to assess 
study quality.  Sensitivity, specificity, likelihood ratios and post-test probabilities were 
calculated for each test. 
 
Findings:   
Ten studies (4023 pregnant women) were included.  Half of the studies had a low risk 
of bias for study design and all had a low risk of bias for applicability.  Of the tests 
identified to detect anaemia at a haemoglobin concentration of <110 g/l, Copper 
sulphate had a sensitivity 97%  (95% CI 88-100) and a specificity 71% (95% CI 55-
85), Sahli’s method had a sensitivity 86% (95% CI 75-94) and a specificity 83.3% (95% 
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CI 68-93) and HemoCue had sensitivity of 85% (95% CI 79-90) and a specificity 80% 
(95% CI 76-83). 
 
Conclusion:  
There should be wider availability of onsite tests found to be accurate in this review, to 
help improve detection of anaemia in pregnant women.   
 
Publication arising from this Chapter:  
Included in new WHO Antenatal care Guidelines:  
WHO recommendations on antenatal care for a positive pregnancy experience, World 
Health Organization, Nov 2016, P. 41-42 
 
Sobhy s, Rogosinska E, Khan KS, Accuracy of on-site tests to detect anaemia in 















Maternal anaemia, measured as low haemoglobin concentration (Hb) in the blood 
remains a serious global health problem. It affects 42% of women in pregnancy, with 
Africa and Southeast Asia being the most affected.(88, 89) An estimated 56 million 
pregnant women are affected by anaemia, a condition that declined by only 5% since 
1995.(88) Anaemia is considered the most common indirect cause of adverse maternal 
outcomes and maternal death, contributing to up to 50% of both.(22) The risks of 
macerated late fetal death, fresh stillbirth, and early neonatal death were also 
consistently increased in mothers with severe anaemia.(23) Studies have shown a link 
between anaemia and low birth weight, small for gestational age and preterm birth.(89, 
90) Women with anaemia are less likely to withstand the adverse effects of excessive 
blood loss and are more susceptible to infection, fatigue, and depression.(91) Anaemia 
pre-operatively also increases risks of poor outcomes.  
 
Testing for anaemia is poorly done in low and middle-income countries especially in 
rural settings.  In this setting, diagnosis of anaemia is often based on symptoms and 
physical examination rather than on objective testing, and so anaemia goes undetected 
and untreated.(92) Although laboratory tests such as haemiglobincyanide by 
spectrometry is the gold standard, this is expensive and not widely available.(93) As a 
result, simple, safe, accurate and low-cost haemoglobin assessment tools are needed. 
(94) Tests currently available in use are HemoCue, WHO color scale, and copper 
sulphate, however, their accuracy is unclear. 
 
Reviews exist on the accuracy of tests such as the WHO colour scale, HemoCue, and 
non-invasive methods, but these did not include studies conducted in antenatal care 
setting exclusively.(95, 96) Anaemia in pregnancy is diagnosed using a different threshold 
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compared to a non-pregnant population.(97) The use of a mixed population in previous 
reviews is a key deficiency because spectrum variation has an impact on accuracy.(98, 
99) Reviews have also previously used HemoCue as a reference,(96) since this is more 
widely available in low-income countries, however studies have shown that 
Haemoglobin concentration measured by HemoCue has a lower precision than that of 
automated analysers, and its precision is also variable by sample type.(100-104)  
This systematic review bridges highlighted gap assessing the accuracy of the on-site 
test in detecting anaemia in pregnant women. 
 
6.3: Methods  
We undertook the systematic review using a prospective protocol (PROSPERO 
No.CRD42015029172) in line with current recommendations and reported according 
to PRISMA guidelines.(40) 
 
Literature search 
We searched Medline, Embays, Scopus, CINAHL and Web of Science from inception 
until February 2016 and with no language restrictions. We used MeSH headings, text 
words and word variants for "pregnancy" and combined them with terms for 
"An(a)emia " and "H(a)emoglobin", with exclusion (NOT) for words relating to the 
fetus such as cord, neonatal and placenta, (Appendix 12). Additionally, we searched the 
reference lists of the included studies and relevant reviews for eligible studies. 
 
Study selection 
Studies were selected in two stages. In the first stage, we screened the titles and 
abstracts of all citations for potentially relevant papers. In the second, we examined the 
full texts of the retrieved papers. Two independent reviewers (SS, ER) selected the 
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papers against pre-specified inclusion criteria. Any discrepancies were resolved 
through a discussion with a third reviewer (KSK). Studies were included if they met 
the following criteria: recruited pregnant women attending antenatal care; evaluated 
tests assessing Hb compared with a laboratory-based reference test.  
 
Study quality assessment and data extraction 
Two independent reviewers (SS and ER) undertook study quality assessment and data 
extraction, and any discrepancies were resolved with input from the third reviewer 
(KK).  Data were extracted using a standardised, pre-piloted form.  Information on the 
type of test, the setting, the type of sample (venous or capillary) and the type of 
practitioner doing the tests was included. Data were extracted for different thresholds 
of Hb reported in the studies. The definition of anaemia in pregnancy, per the World 
Health Organisation standards, is Hb concentration below 110 g/l(97), at sea level with 
three grades of severity; mild (109-100 g/l), moderate (990-700 g/l) and severe (<700 
g/l). True positive, true negative, false positive and false negative rates were extracted 
for the reference test and index test in a 2x2 table. Where the sensitivity, specificity, 
positive and negative predictive values were presented, the parameters needed to assess 
accuracy were re-calculated.  
 
Study quality was assessed using the QUADAS-2 tool independently by two reviewers 
(SS and ER).(99) Four domains were evaluated: patient selection, use of the index test 
implementation of the reference standard, and flow of patients through the study and 
timing of the index test(s) and reference standard (“flow and timing”). Each domain is 
assessed in terms of the risk of bias and the first three are also assessed in terms of 
concerns regarding applicability of the findings. The risk of bias was assessed as low, 
high or unclear for each domain. We considered a study to be of high quality if the 
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patients were selected in a consecutive or randomised manner, specific inclusion and 
exclusion criteria were applied, the index and reference standard tests were recognised 
and performed with an appropriate delay between them, and all patients received a 
laboratory based reference test.  
 
Data analysis 
Numbers of true positive, false positive, true negative and false negative rates were 
obtained from the publication or, if necessary, calculated from the reported estimates. 
The study data  was plotted in the receiving operating characteristic (ROC) space. 
Where we had a sufficient number of studies, we pooled the diagnostic accuracy 
parameters using a bivariate, hierarchical model (random effect).(105) If less than four 
studies reported accuracy of a given test, we pooled sensitivity and specificity, as well 
as likelihood ratios using univariate model.(106) We calculated 95% confidence intervals 
(CIs) for all estimates. The analyses were done using STATA software version 12.1.(48)   
Assuming a pre-test probability of 42% for Hb < 110g/l (89, 107) we calculated post test 
probabilities for a negative and positive test result using an online calculator.(108) We 
used a pre test probability of 8% for moderate anaemia and 1% for severe anaemia.(107) 




Out of 7776 citations, 10 studies were selected (Figure 19). These studies included 4023 
pregnant women from seven low- and middle-income countries, South Africa (n=2), 
Malawi (n=1), Benin (n=1), Kenya (n=1), India (n=2), Pakistan (n=1) and Indonesia 
(n=2).  Six tests were identified in the review and compared with a laboratory standard. 
Five studies reported data on clinical examination,(111-115) four on Haemoglobin Colour 
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Scale (HCS)(112-114, 116) and three reported on Copper sulphate test.(117-119) HemoCue(112), 
Sahli’s haemoglobinometer(119)and NBM 2000(120)a non-invasive haemoglobin sensor, 
were reported on by one study each. The studies were all published between 1996 and 
2016.  The prevalence of anaemia (haemoglobin < 110 g/l)(97) across the studies varied 
from 23 - 77 % (appendix 13 details study characteristics). 
 













Citations identified from electronic 
databases (n = 7766) 
Citations identified through references and 
other sources (n = 13) 
Total number of citations n=7779 
10 studies included in systematic review: 
(n = 4023 pregnant women) 
Clinical assessment (4 studies)      
Haemoglobin colour scale (4 studies)  
Copper Sulphate (3 studies)                          
Sahli’s Method (1 study)  
HemoCue (1 study) 







30 studies excluded:  
2 conference abstracts 
4 technical performance reviews 
4 inappropriate populations 
3 prevalence studies 
6 inappropriate gold standards 
 




Articles excluded (n =7739) 
1580 duplicates  
6159 with exclusion criteria 
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Half of all of studies (50%) had low risk of bias and low concern regarding applicability 
across all domains. Two studies (20%) had a high risk of bias regarding patient 
selection; and three studies (30%) had an unclear risk of bias as the recruitment process 
was not adequately described. One study had an unclear risk of bias regarding flow and 
timing. All studies had low risk of bias for applicability (Appendix 14). 
 
6.41: Accuracy of the tests by disease severity 
For mild anaemia (Hb <110 g/l) four tests provided diagnostic accuracy data: clinical 
assessment (4 studies, 1853 women), HCS (4 studies, 1051 women), HemoCue (1 
study, 671women), Copper sulphate (1 study, 100 women), Sahli’s method (1 study, 
100 women) and NBM 2000 (1 study, 269 women) (Table 11).  
In order of decreasing sensitivity values these were: Copper sulphate with sensitivity 
97% (95% CI 88-100) and specificity 71% (95% CI 55-85), Sahli’s method with 
sensitivity 86% (95% CI 75-94) and specificity 83% (95% CI 68-93), HemoCue with a 
sensitivity of 85% (95% CI 79-90) and specificity 80% (95% CI 76-83); HCS with a 
sensitivity of 67% (95% CI 56-76) and specificity of 67% (95% CI 48-82); clinical 
assessment with a sensitivity 56% (95% CI 19-92) and specificity 62% (95% CI 30-
93), (appendix 4) and NBM 2000 with a sensitivity 34% (95% CI 27-41) and specificity 





Figure 20: Overview of on-site test accuracy to detect mild anaemia 
(haemoglobin < 110 or < 100 g/l) among pregnant women in Receiver 




For moderate anaemia (Hb <80 g/l) one study provided diagnostic accuracy data for 
three tests: clinical assessment (644 women), HCS (641 women) and HemoCue 
(671women). Another study provided data for Copper sulphate (100 women) and 
Sahli’s method (100 women) for a cut-off of Hb <88 g/l.  
In order of decreasing sensitivity values these were: HemoCue had a sensitivity 97% 
(95% CI 85-99) and specificity 94% (95% CI 92-96%); Sahlis method had a sensitivity 
83% (95% CI 85-98%) and specificity 93% (95% CI 85-98%); HCS, sensitivity 82% 
(95% CI 61-93%), and specificity 76% (95% CI 73- 79%), Copper sulphate with 
sensitivity 75% (95% CI 55-89%) and specificity 94% (95% CI 86-98) and clinical 




For severe anaemia, defined as Hb less than 60 g/l, one study provided diagnostic 
accuracy data for three tests: clinical assessment (644 women), HCS (641 women) and 
HemoCue (671 women) and another study provided data for Copper sulphate (100 
women) and Sahli’s method (100 women) for Hb less than 68 g/l.  
In order of decreasing sensitivity values these were: HemoCue a sensitivity 83% (95% 
CI 44-97) and specificity 99% (95% CI 98-100), Sahli’s method had a sensitivity of 
75% (95% CI 35-97) and specificity 93% (95% CI 86-98), Copper sulphate had a 
sensitivity 83% (95% CI 24-91%) and specificity 99% (95% CI 86-98%), HCS with 
sensitivity 50% (95% CI 15-85%) and specificity 98% (95% CI 97-99%), and clinical 
assessment with sensitivity 50% (95% CI 15-85%) and specificity 75% (95% CI 71-
78%) (Table 12). 
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Table 12: Accuracy of on-site tests used to diagnose anaemia in pregnancy 
 
       Likelihood ratio    (95% CI) *Post test probability % 










+ve  test result 
 
-ve test result +ve  test 
result 
 








1853 56 (19-92) 62 (30-93) 1·7 (1·0-2·9) 0·57 (0·33-1·03) 55 29 
*HCS 
 
4 42 (17-67) 1051 67 (56-76) 67 (48-82) 2·0 (1·3-3·1) 0·50 (0·40- 0·62) 59 27 
*CUSO4 
 
1 58 (48-67) 100 97 (88-100) 71 (55-85) 3·4 (2·1-5·5) 0.05 (0·01-0·19) 71 3.5 
SAHLI method 
 
1 58 (48-67) 100 86 (75-94) 83 (68-93) 5·2 (2·6-10·3) 0·17 (0·09-0·32) 79 11 
NBM 2000 1 
 
77 (72-82) 269 34 (27-41) 92 (82-97) 4·1 (1·7-9·7) 0·72 (0·64- 0·82) 75 34 
HemoCue 1 
 






52 (49-55) 644 73 (70-78) 80 (77-84) 3·8 (3·1-4·6) 0·33 (0·28-0·39) 73 19 









9·3 (2·1-40·4) 0·06 (0·02-0·17) 87 4.2 
HemoCue  
 




Clinical 1 5 (3-6) 644 62 (44-77) 76 (72-78) 2·5 (1·9-3·5) 
 
0·50 (0·31- 0·80) 22 5.3 
HCS 1 3 (2-5) 641 82 (61-93) 76 (73- 79) 3·4 (2·7- 4·4) 
 
0·24 (0·10-0·58) 27 2.6 
HemoCue 1 
 
5 (4-7) 671 97 (85-99) 94 (92-96) 16·7 (12·2-23·0) 0·03 (0·01- 0·22) 65 0.33 
CuSO4 
*(Threshold 88) 
1 28 (20-37) 100 75 (55-89) 94 (86-98) 13·5 (5·1-35·8) 0·26 (0·14-0·50) 60 2.8 
Sahli 
*(Threshold 8.8) 
1 28 (20-37) 100 83 (63-94) 93 (85-98) 11·8 (5·0-28·0) 0·10(0·09-0·43) 57 1.1 
Severe 
Hb <70g/l 
Clinical 2 7 (0-3) 1806 72 (47-97) 71 (34-97) 2·9 (1·1-8·2) 0.4(0·37-0·52) 20 3.4 











1 1 (0-2) 644 50% (15-85) 75 (71-78) 2·0 (0·74-5·3) 0·67(0·25-1·78) 2.0 0.7 
HCS 
 
1 1 (0-2) 641 50 %(15-85) 98 (97-99) 31·9 (10·0-101·4) 0·51 (0·19-1·35) 24 0.5 
HemoCue 1 
 
1 (0-2) 671 83(44-97) 99 (98-100) 138·5 (48·9-392·1) 0·17(0·03-1·00) 58 0.2 
 
*HCS=Heamoglobin Colour scale, CUSO4= copper sulphate method 





Copper sulphate, Sahli’s method and HemoCue have the highest sensitivities (>85%) in 
detecting anaemia. 
 
The review was conducted in a systematic manner, covered a wide range of tests and 
included women with a range of anaemia severity making the findings more generalizable 
across the spectrum of the disease. Included papers were predominantly of a high quality. 
The Cyanmethaemoglobin spectrophotometry method is the global reference standard for 
detecting haemoglobin concentration.   One of the limitations of the review is that it 
included studies that used any laboratory tests as a reference standard, this included 
automated cell counters.  Although these are calibrated against the reference standard this 
may have affected the accuracy of the test, however, this is unlikely to be significant. 
 
In order to compare the accuracy of all identified tests, we used the univariate model to 
pool sensitivity and specificity estimates when fewer than four studies were available. This 
approach does not account for the correlation between both parameters as in bivariate 
model; however, the estimates obtained using both models are fairly similar.(121) There were 
not enough women in the studies with severe anaemia (Hb <60 g/l) therefore the accuracy 
of the data at this level may not be reliable. 
 
Assuming a prevalence estimate for anaemia (Hb <110g/l) of 42%,(89) we calculated post-
test probabilities for all evaluated tests. After the test, amongst test-negative women, using 
the Copper sulphate method the prevalence of women who do not have anaemia was 
reduced to 4%. Using Sahli’s method this probability was reduced to 11% and for 
HemoCue, there was a reduction to 12%. The HCS performed only marginally better 
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(reduction to 27%), than clinical examination alone (reduction to 29%).  Several reviews 
and studies have recommended the use of the HCS,(96) however, in our review this test had 
a high likelihood ratio for a negative test result suggesting it is not as clinically useful as 
advocated.  More training would increase its accuracy as shown in studies, as it performs 
well under lab conditions.(122) NMB2000 the non-invasive haemoglobin probe had very 
poor sensitivity but high specificity, making this test better for ruling in the disease in the 
context of screening.  
 
In LMIC where resources are limited, high cost, inadequate training and lack of facilities 
generally prevent the use of technologically advanced equipment, especially at a primary 
health care level.(123) Health workers, therefore, need a simple, cheap and robust device for 
measuring haemoglobin concentration(123), but this should not be at the expense of 
compromising accuracy. Deciding which is the ‘best’ test depends on many factors, such 
as cost, resources required, the setting in which it will be used, and the skills of the health 
care workers; therefore this may be better evaluated at the local level.  
 
If screening for anaemia is used to decide who should be referred for further investigation 
and treatment than it is important that the screening test has a high sensitivity. This is 
imperative in the case of severe anaemia as it is important not to miss women with this 
condition, as this can have significant clinical implications to both mother and child.   
 
Increasing a test’s sensitivity usually results in a reduction in specificity.(124) Using tests 
with a high sensitivity but not very specific leads to unnecessary referrals for further 
investigation what adds to the cost of the health service and wastes valuable resources.(111)  
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However, cClinical implications of the test results also plays a big role, for anaemia the 
consequence of missing truly anaemic pregnant woman has more severe clinical 
implications than overtreatment. The majority of anaemia in these settings especially in 
pregnancy tends to be secondary to iron deficiency and therefore mild to moderate cases 
can be treated with iron tablets,(125) which tends to be well tolerated. For severe anaemia, 
the risk of treatment is greater as it may involve complex interventions including blood 
transfusions, the side effects of which can be serious including the spread of blood-borne 
disease.(126) Testing is also important to monitor the effects of any intervention or treatment 
given once the diagnosis is established. 
  
More research needs to be done on this topic, as there were very few studies available.  It 
will also be interesting to see how newer non-invasive tests, especially those using readily 
available technology such as mobile phones, will perform in the future.(127, 128) There are 
many studies assessing devices for the detection of anaemia, however these reported 
correlation coefficients which can be misleading and are less clinically useful as compared 
to sensitivity and specificity, studies reporting different parameters also limits the ability to 
perform meta-analysis of these studies, future studies should be encouraged to report these 
more useful accuracy parameters.   
 
6.6: Conclusion 
 Tests found to be accurate in this review should be made more widely available, in order 





Chapter 7: Maternal and fetal outcomes of tuberculosis during pregnancy and the 
postpartum period: A systematic review and Meta-analysis 
 
7.1: Abstract  
Background: There is dearth of data on the epidemiology, clinical features, and outcomes 
of active tuberculosis (TB) in pregnancy.  
 
Methods: We conducted a systematic review and meta-analysis assessing maternal and 
perinatal outcomes in pregnant women with and without active TB, searching Medline, 
Embase, Web of science and Scopus from inception to October 2015. Two independent 
reviewers selected studies, undertook quality assessment and data extraction.  Information 
on study design, setting, population characteristics, TB diagnosis and treatment as well as 
obstetric outcomes were obtained.  Risk of bias was assessed using the Newcastle-Ottawa 
scale.   Data were pooled and Odds ratios using random effects modelling was calculated 
for maternal and perinatal outcomes.  Standard Weighted mean differences were calculated 
for gestational age and birth weight.   
 
 Findings: We included 13 studies (3384 pregnancies associated with active TB, 112530 
pregnant women without TB). Using Newcastle Ottawa scale, 7 studies had a low risk or 
medium risk of bias and 6 had a high risk of bias.  There was a significantly increased risk 
of poor fetal outcomes; perinatal death  (OR 4.2 95% CI 1.5-11.8 I2 57.2%) preterm birth 
(OR 1.7, 95% CI 1.2-2.4, I266..5%), low birth rate weight (OR1.7 95% CI 1.2 -2.4, I2 
53.7%) and birth asphyxia (OR 4.6 95%CI 2.4-8.6, I I2 46.3), Maternal outcomes were also 
significantly worse; maternal morbidity (OR 2.8, 95%CI 1.7-4.6, I2 60.3%), anaemia  (OR 
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3.9, 95%CI 2.2-6.7, I2 29.8%) and Caesarean delivery (OR 2.1, 95%CI 1.2-3.8, I2 61.1%), 
compared to pregnant women without active TB.     
 
Conclusion: TB in pregnancy results in poor maternal and fetal outcomes.   Early diagnosis 
and treatment is important to help prevent poor outcomes.   
 
Publication arising from this Chapter: 
Sobhy S, Babiker ZOE, Zamora J, Khan KS, Kunst H. Maternal and perinatal mortality and 
morbidity associated with tuberculosis during pregnancy and the postpartum period: a 
systematic review and meta-analysis. BJOG 2016; DOI: 10.1111/1471-0528.14408. 
 
Poster presentation at British maternal and fetal medicine society (BMFMS) conference 
2016 and associated abstract publication: 
Sobhy S, Babiker ZOE, Zamora J, Khan KS, Kunst H Maternal and fetal outcomes of 
tuberculosis during pregnancy and the postpartum period: a systematic review and meta-






7.2: Introduction  
 
Tuberculosis (TB) is still one of the world’s deadliest communicable diseases.  Although 
the greatest burden of TB infection is in resource-limited countries, resource-rich countries 
have seen a resurgence of TB, largely as a result of an increase in migrant populations in 
these countries.(129) In 2013, an estimated 9.0 million people developed TB and 1.5 million 
died from the disease.(130) Interestingly, South-east Asia, Western pacific and African 
regions, which have the highest TB disease burden, also have the highest maternal mortality 
rates.  In women, TB is now among the three leading causes of death in reproductive age 
(15–45 years).(131) In 2013, an estimated 510 000 women died as a result of TB, more than 
one third of whom were HIV-positive.(130) It is, expected that the incidence of TB among 
pregnant women would be as high as, if not higher than in the general population.(132, 133) It 
is estimated that as many as 216500 (95% CI 192100-247000) pregnant women have active 
TB globally.(134)Indirect maternal deaths now account for 28% of total maternal deaths; 
these include TB infections.(34) 
 
Studies of active TB in pregnancy have shown varied results and the relationship between 
TB and adverse pregnancy outcomes remains unclear.   Quantitative data synthesis can 
overcome this deficiency and imprecision. Reviews exist on this topic, but none have been 
conducted in a systematic manner or included meta-analysis.  To collate the evidence on 
maternal and perinatal outcomes of pregnancies associated with active TB we conducted a 







Major databases; Medline, Embase, Web of science and Scopus databases were searched 
using the subject keywords and MeSH terms for TB, pregnancy, maternal morbidity, 
mortality and perinatal morbidity, mortality.   We also searched all references of review 
papers and relevant articles.  The search was not restricted by language or date, and is up 
to date till October 2015 (Appendix 15).  Additionally, we searched the reference lists of 
the included studies, and relevant reviews and articles for eligible papers.  Two independent 
reviewers (S.S, H.K) identified all relevant abstracts using a pre-specified inclusion and 
exclusion criteria in a two- stage process.  In the first stage, we screened the titles and 
abstracts of all citations for potentially relevant papers.  In the second stage, we examined 
in detail the full texts of the retrieved papers. Any discrepancies were resolved after 
discussion with a third reviewer (KK). Studies were included if they had a cohort of 
pregnant women with TB and pregnant women without TB as a control group that had 
pregnancy outcome data included.  
 
Quality assessment of the included studies 
Quality assessment of included studies was carried out using the Newcastle-Ottawa scale 
to evaluate the risk of bias in the selection, and comparability of subjects and cohorts and 
of the outcome.(46) Two independent reviewers (SS and HK) allocated stars for adherence 
to a pre-specified criterion. Studies that scored four stars for selection, two stars for 
comparability and three stars for ascertainment of the outcome were regarded to have a low 
risk of bias. Studies with two or three stars for selection, one for comparability and two for 
outcome ascertainment were considered to have a medium risk of bias. Any study with a 
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score of one for selection or outcome ascertainment, or zero for any of the three domains 
was deemed to have a high risk of bias. 
 
Data extraction and analysis 
Using a Piloted data extraction form, information on study design, setting, population 
characteristics, TB diagnosis and treatment as well as obstetric outcomes were obtained.   
Two independent reviewers (SS and HK) extracted data in 2x2 tables for comparative 
dichotomous outcomes.  
 
The outcomes assessed were maternal mortality defined as the death of a woman while 
pregnant or within 42 days of termination of pregnancy, irrespective of the duration and 
site of the pregnancy, from any cause related to or aggravated by the pregnancy or its 
management, but not from accidental or incidental causes.(1) Deaths from active TB are 
classified as an indirect maternal death.  Maternal morbidity was defined as any health 
condition attributed to and/or aggravated by pregnancy and childbirth that had a negative 
impact on the woman’s wellbeing.  
 
Perinatal death included intrauterine fetal deaths after 28 completed weeks of gestation, 
stillbirth and early neonatal death until one week after birth.(135) Apgar scores were classed 
as low if they were less than or equal to 7.  Preterm birth was defined as babies born alive 
between 28- 37 weeks of completed pregnancy. We accepted the authors’ definitions of 
other fetal complications such as small for gestational age.   
 
We calculated the odds ratios of adverse pregnancy outcomes in women with TB for 
individual studies and pooled the numbers for an overall estimate, using a random effects 
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model.  For continuous data, after pooling the standard mean difference was calculated.   
We assessed for heterogeneity using the I2 tests. All analyses were undertaken using Stata 
SE.12 statistical software.(48)  
 
7.4: Results  
Thirteen studies out of 7521 studies met the inclusion criteria (Figure 21).  
 
Figure 21: Study selection process for the systematic review on pregnancy outcomes in 
women with Tuberculosis.   
The studies included 3384 pregnant women with active TB and 119448 pregnant women 




















Citations identified from electronic databases  
(n = 7521) 
 
Articles excluded (n=7468) 
- 2763 duplicates  
- 4705 with exclusion criteria 
 
53 citations included for full text review 
Total no. of studies included (n=13) 
Studies reporting multi-site TB infection (n= 7) 
Studies reporting extra-pulmonary TB (n=2) 
Studies reporting pulmonary TB (n=4) 
 
 
40 studies excluded: 
- Wrong or no control group (n=18) 
- Wrong population (n=7) 
- No outcome data (n=6) 




reported on low birth weight, seven on perinatal death, four on congenital anomalies, three 
on asphyxia and two reported on small for gestational age and acute fetal distress.  Low 
Apgar score at one minute was reported on by one study.  For maternal outcomes, five 
studies reported maternal death as an outcome, five on maternal morbidity, five reported 
on delivery by caesarean section, three reported on anaemia. Miscarriage and antenatal 
admission were reported on by one study each.  Half the studies (6/13) were from low 
income and middle-income countries and 61% (8/13) studies were published after year 
2000.  Study characteristics are shown in appendix 16.  
 
The quality of the studies is shown in figure 22. 100% of included studies had low or 
medium risk of bias for study selection, 53% had low risk of bias for comparability of 
cohorts.  The risk of bias for outcome assessment was low or medium in 100%.  Overall 
53% of studies had low or medium risk of bias.   
 
Figure 22: Quality assessment using the Newcastle-Ottawa Scale of studies included in a 
review on pregnancy outcomes in women with Tuberculosis  
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7.41: Maternal outcomes in women with TB 
Maternal outcomes were poorer in pregnant women with TB compared to those without.  
Although not significant the trend towards more maternal deaths in women with TB was 
present (OR 4.1 95%CI 0.65-25.2, I2 0%).  Of the women who died 50% had HIV co-
infection.  Maternal morbidity was almost 3 times greater  (OR 2.8, 95%CI 1.7-4.6, I2 
60.3%) compared to the control group.   The odds of antenatal admission was 9 times 
greater (OR 9.6 95% CI 2.3-40.6).  Anaemia was increased 4 times in the TB group (OR 
3.85 95% CI 2.21-6.71 I229.8%). Caesarean section was performed twice as often in women 
with TB (OR 2.10 95% CI 1.17-3.79 I2 61%).  The odds of miscarriage were 9 times greater 
in women with TB (OR 9.06 95% CI 4.93-3.16.67).  (Figure 23) 
 
Figure 23: Maternal outcomes in women with Tuberculosis 
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7.42: Perinatal outcomes in women with TB 
Of the perinatal outcomes, perinatal death was 4 times greater in patients with active TB 
(OR 4.2 95% CI 1.49 -11.83, I257.2%), preterm birth was 1. 6 times greater,  (OR 1.7, 95% 
CI 1.2-2.4, I266.5%), low birth weight was 1.7 times greater (OR 1.7 95% CI 1.2 -2.4, I2 
83.1%). low Apgar score was 5 times greater (OR 5.71, 95% CI 1.4 -22.6) and acute fetal 
distress was 2.3 times greater (OR2.34, 95% CI 1.2 -4.5 I2- 0%) compared to babies born 
in the control group.  There was a non-significant difference for outcomes small for 
gestational age and congenital anomalies (Figure 24).  
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Figure 24: Perinatal outcomes in women with Tuberculosis
 
Babies born to mothers with TB had a lower mean birth weight (Standard Weighted mean 
difference -0.54. (95% CI -0.71- -0.38), I2 0%) and were born at an earlier gestation 
(Standard mean difference -0.43. (95% CI -0.61- -0.25), I2 43.8%) compared to those 
without TB.  (Figure 25)  
 







7.43: Breakdown by disease location 
 
Location of TB; pulmonary and extra-pulmonary were reported on by 4 and 2 studies. There 
was not a significant difference in the maternal and perinatal outcomes by location of 
disease. However in one study(136) among those with extrapulmonary TB those that had 
lymph node TB had no  adverse outcomes, but TB at other extra-pulmonary sites did 
adversely affect pregnancy outcomes.  (Table 13) 
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Table 13: Outcomes of pregnancy in women with Tuberculosis by site of disease. 
 
Outcome No. of 
studies 
Extra-pulmonary 




OR (95% CI)  
P value 
Maternal morbidity 2 2∙9 (95% CI 1∙8–4∙6) 1 1∙7 (95% CI 1∙3–2∙3) 0∙057 
Caesarean delivery 2 4∙2 (95% CI 2∙1–8∙6) 2 1∙5 (95% CI 0∙6–4∙0)  0∙087 
Perinatal death 1 4∙2 (95% CI 0∙57–31∙2)  1 2∙4 (95% CI 0∙53–11∙2)  0∙663 
Low birth weight 1 2∙7 (95% CI 1∙02–7∙1)  3 2.2 (95% CI 0∙91–5∙1)  0∙757 
Pre-term birth 2 1∙3 (95% CI 0∙56–2∙8)  2 1∙5 (95% CI 0∙68–3∙4)  0∙867 
Acute fetal distress 1 1∙7 (95% CI 0∙5–5∙8) 1 2∙7 (95% CI 1∙3–5∙7)  0∙526 
Asphyxia 1 3∙1 (95% CI 1∙4–6∙8) 1 7∙7 (95% CI 4∙0–14∙8) 0∙082 
Congenital anomaly 1 0∙78 (95%CI 0∙04–16∙6) 1 3∙3 (95% CI 0∙41–26∙6)  0∙441 
 
7.44: Breakdown of outcomes by timing of diagnosis and treatment 
 
Breakdown of outcomes by timing of diagnosis and treatment showed significantly better 
outcomes when treatment was initiated in first trimester in comparison to second and third 
trimester.  In one study of women who were treated in the first trimester none had preterm 
birth compared to 33% who initiated treatment in second and third trimester.(137)  For those 
who were treated in first trimester there were no cases of perinatal death compared to 23% 
in those treated in second and third trimester.  In mothers who were treated in the first 
trimester 28% developed complications compared to 60% in those who were treated in 
second and third trimester. Another study (138) also found that no woman who were treated 
in first trimester had a baby with low birth weight compared to 60% in those treated in 




Our systematic review highlights that maternal and fetal outcomes were consistently poorer 
in pregnant women with active TB compared to those without. There is a high-risk of 
maternal morbidity, anaemia, perinatal death, preterm birth, low birth weight and fetal 
distress in pregnant women with active TB and this risk was higher when anti tuberculous 
treatment (ATT) was started late or not received at all.  
 
The systematic review was carried out with an exhaustive literature search. It is the first 
review that systematically evaluates the risk of active TB in pregnancy. The review was 
carried out in a stringent manner to reduce bias.  Although the studies included a significant 
number of patients with active TB, not all studies had data available for all maternal and 
fetal outcomes. Not all studies included information on disease location, type, length or 
complications of ATT, limiting sub- group analysis.  Some maternal and fetal outcomes 
had moderate to high heterogeneity but there was insufficient data to do a subgroup analysis 
to explore this further. The strength of this review is that it provides the current best 
evidence summary exploring studies’ characteristics quality and results, which leads to a 
deeper insight into the topic than that afforded by individual studies. 
 
The effects of active TB on pregnancy may be influenced by many factors, including the 
extent of the disease, the presence of pulmonary TB vs extra-pulmonary, other 
comorbidities and the timing of diagnosis and initiation of treatment.  Over 50% of maternal 
mortality occurring in mothers with TB in pregnancy is thought to be due to co-infection 
with HIV.(139) Unfortunately there were not many women with HIV co-infection included 
in our review but it is likely that the outcomes would be even worse in this group. 
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Clinical diagnosis of active TB in pregnant women can be difficult and there is often a delay 
in diagnosis due to the non-specific symptoms related to the physiological response to 
pregnancy(140).   Women who are pregnant are more likely to access healthcare, making 
pregnancy an important screening opportunity for TB especially in developing countries. 
Different screening tests for active TB have been used in antenatal care such as symptom 
check, routine sputum examination by smear (141, 142), and the Xpert® MTB/RIF assay(143), 
however there are no guidelines for routine screening for active TB in pregnancy.  The 
tuberculin skin test and the interferon gamma release assays have been used to screen for 
latent TB infection (LTBI) in pregnancy.(144) The WHO recommends LTBI treatment for 
all HIV-positive pregnant women, however there are no WHO guidelines for LTBI 
screening and management of latent disease in HIV-negative pregnant women.   In order to 
reduce poor maternal and fetal outcomes routine screening for active and latent TB needs 
to be part of standard antenatal screening (ANC) in order to identify active TB early and 
reduce the risk of progression in those who are latently infected.  Early treatment especially 
in low-income countries, which have the greatest burden of disease, will decrease maternal 
and fetal morbidity and mortality. 
Future large prospective studies are needed to examine the effect of active TB on maternal 
and fetal outcomes in pregnancy.  Risk factors affecting outcomes such as HIV co-infection, 
site of disease, pulmonary or extra-pulmonary involvement, timing, type and length of ATT 
need to be further studied.  
 
7.5: Conclusion  
Active TB in pregnancy leads to poor maternal and fetal outcomes.  There is an urgent need 
for active case finding and screening for LTBI in antenatal care in high incidence TB 




















Chapter 8: Conclusion 
 
8.1:Summary of findings 
This chapter provides an overview of the results of the individual chapters.  Detailed results 
are included in the individual chapters.  I have addressed the objectives pre-specified in my 
thesis by quantifying the rates of maternal death associated with pregnant women requiring 
anaesthesia in LMIC and associated risk factors including type of anaesthesia and type of 
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practitioner.  I also quantified risk associated with type of anaesthesia in women with pre-
eclampsia who are particularly high risk. I quantified the rates of maternal death and 
perinatal death associated with caesarean sections and associated risk factors including type 
of caesarean section, and type of surgeon. I explored causes of maternal death from both 
anaesthesia and caesarean sections.    I explored the diagnostic accuracy of point of care 
tests used to diagnose anaemia and I investigated pregnancy outcomes in pregnant women 
with Tuberculosis.   
 
The table below summarises the objectives of my thesis and a column of findings from the 
chapters of this thesis. 
 
Table 14: summary of thesis  
Chapter 
Number 
Population Intervention  Outcome(s) Research 
Design 
Results 


























al studies  
Anaesthesia was the primary 
cause of death in 1.2 per 1000 
(95% CI 0.8 to 1.7, I2 =83%) 
pregnancies exposed to surgery 
(44 studies; 632,556 
pregnancies).   
 
Anaesthesia accounted for 2.8% 
(95% CI 2.4 to 3.4, I2=75%) of 
all maternal deaths (95 studies; 
32,149,636 pregnancies, 36,144 
maternal deaths), 3.5% (95% CI 
2.9 to 4.3, I2=79%) of direct 
maternal deaths, and 13.8% 
(95% CI 9.0 to 20.7, I2=84%) of 




















anaesthesia    
(general/ 
regional) 
Odds of Maternal 
death, admission 
to ITU and PPH. 
Fetal: Perinatal 
death, low Apgar 
scores.   
 
 












Exposure to general anaesthesia 
increased the odds of maternal 
(OR 3.3, 95% CI 1.2 to 9.0, 
I2=58%), and perinatal deaths 
(OR 2.3, 95% CI 1.2 to 4.1, 
I2=73%) compared with 
regional anaesthesia (25 studies; 





to ITU and PPH. 
Fetal: Perinatal 
death, low Apgar 
scores 
The rates of any maternal death 
were higher when anaesthesia 
was administered by non-
physician (9.8/1000, 95% CI 
5.2 to 15.7, I2 =92%) than 
physician anaesthetists 


















Odds of Maternal: 
Death, admission 
to ITU and PPH. 
Fetal: Perinatal 






Included 14 studies (10411 
pregnant women with varying 
severity of pre-eclampsia) 
There was a seven-fold increase 
(OR 7.70, 95% CI 1.9- 31.0, 
I2=58%)in maternal death in 
pre-eclamptic women 
undergoing caesarean section 
with general anaesthesia 
compared to regional 
anaesthesia, there was also an 
increase in pulmonary oedema 
(OR 5.16, 95% CI 2.5-10.4, 
I2=0%) and Intensive care unit 
admissions ((OR 16.25, 95% CI 
9.0- 29.5, I2=65%).   
 
Administration of general 
compared with regional 
anaesthesia also increased the 
odds of perinatal death by two 
fold (OR 3.01, 95% CI 1.4-6.5, 
I2=56%). and the odds of low 
Apgar score at 1 minute (OR 
2.50, 95% CI 1.3-4.6, I2=50%) 




















Of all maternal deaths 24% 
(95% CI 21.7 to 27, I2=93.7%) 
had undergone a caesarean 
section with the highest rates in 
Latin America and the 
Caribbean and the lowest in 
East Asia and Pacific  
 
The overall rate of death in 
women undergoing a caesarean 
section was 4.8 per 1000 (95% 
CI 4.23 to 5.6, I2 = 97%)  
procedures, with the highest 
rates in sub-Saharan Africa.   
 
The overall rate of stillbirth in 
women undergoing a caesarean 
section was 44 per 1000 
procedures  (95% CI 35.0 to 
54.9, I2 = 99%), and perinatal 
death was 73 per 1000 
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caesarean sections  (95% CI 























Odds of Maternal 
death, admission 





death, low Apgar 










The odds of maternal death was 
doubled (95% CI 1.20 to 3.82, 
I2=62%), and perinatal death 
was quadrupled (OR 4.24, 95% 
CI 2.56 to 7.10, I2=83%) with 
emergency compared to elective 
caesarean section.  
 
Caesarean section that was 
performed in the second stage 
of labour increased the odds of 
maternal death by 12 fold (OR 
12.27, 95% CI 2.87 to 52.49, 
I2=0%), and perinatal death 
(OR 9.23, 95% CI 4.24 to 20.10 
compared to those performed 
before full dilatation.  
 
There was an increase in wound 
dehiscence by non-physicians 
clinicians, and there was an 
increase in hysterectomy by 
physicians performing 
caesarean sections.   
 



















specificity of tests 
to diagnose 







Ten studies (4023 pregnant 
women) were included.  
Of the tests identified to detect 
anaemia at a haemoglobin 
concentration of <110 g/l,  
Copper sulphate had a 
sensitivity 97%  (95% CI 88-
100) and specificity 71% (95% 
CI 55-85), Sahli’s method had a 
sensitivity 86% (95% CI 75-94) 
and a specificity 83.3% (95% 
CI 68-93) and HemoCue had 
sensitivity of 85% (95% CI 79-
90) and a specificity 80% (95% 
CI 76-83). 
 









delivery.   
Perinatal 
mortality, low 
Apgar score, low 
birth weight and 









We included 13 studies (3384 
pregnancies associated with 
active TB, 112530 pregnant 
women without TB).  
There was a significantly 
increased risk of poor fetal 
outcomes; perinatal death  (OR 
4.2 95% CI 1.5-11.8 I2 57.2%) 
preterm birth (OR 1.7, 95% CI 
1.2-2.4, I266..5%), low birth 
rate (OR1.7 95% CI 1.2 -2.4, I2 
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53.7%) and birth asphyxia (OR 
4.6 95%CI 2.4-8.6, I I2 46.3). 
Maternal outcomes were also 
significantly worse; maternal 
morbidity (OR 2.8, 95%CI 1.7-
4.6, I2 60.3%), anaemia  (OR 
3.9, 95%CI 2.2-6.7, I2 29.8%) 
and Caesarean delivery (OR 
2.1, 95%CI 1.2-3.8, I2 61.1%), 
compared to pregnant women 





Anaesthesia and caesarean section-attributed maternal and perinatal mortality, and risk 
factors for complications in LMIC 
 
I undertook the largest systematic reviews to-date on maternal and fetal outcomes 
associated with anaesthesia and caesarean section.    Anaesthesia and caesarean sections 
are major contributors to maternal and perinatal deaths in LMIC. General anaesthesia is 
associated with worse outcomes for the mother and fetus and should be avoided unless 
clinically necessary.  The main cause of death from general anaesthesia was airway 
complications.  I found worse outcomes when non- physician anaesthetists administered 
anaesthesia, this cadre of health workers need better training and support to ensure safe 
care.  Second stage caesarean section was a particular risk factor for caesarean section 
outcomes, with high rates of mortality and morbidity. I found the main causes of death 
following caesarean section so that these can be prevented. I identified regions and 
countries where outcomes were poor so interventions can be targeted.   
 
Anaesthesia-attributed maternal and perinatal mortality in women with pre-eclampsia in 
LMIC 
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I found that in women with pre-eclampsia the risk of maternal mortality following general 
anaesthesia was almost double that of the general obstetric population.  I also found a 
significant risk of intensive care admission, pulmonary oedema, postpartum haemorrhage 
and hypertension intra- and postoperatively following general anaesthesia.  Training is 
needed in general anaesthesia to reduce risk when this method is required and regional 
anaesthesia should be otherwise recommended.   
 
Anaemia in pregnancy: testing in antenatal care 
Anaemia is associated with maternal mortality and morbidity; furthermore anaemia is very 
prevalent in pregnancy although the severity of disease varies.  In settings where full blood 
count testing is not available, we found on-site haemoglobin testing with a 
haemoglobinometer should be recommended over the use of the haemoglobin colour scale 
which was previously recommended or clinical tests as the method for diagnosing anaemia 
in pregnancy.  Older tests were also found to be accurate like the copper sulphate and Sahlis 
method, however more research is needed into why the use of these methods are no longer 





TB In pregnancy: maternal and perinatal outcomes   
I found that pregnant women with TB suffered worse outcomes compared to those without 
the disease; women with an early diagnosis and appropriate treatment for the disease had 
better outcomes than those who were diagnosed late.  
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8.2: Strengths and limitations 
The reviews were prospectively registered and followed appropriate protocols.  Extensive 
literature searches using major databases were done without language restrictions to avoid 
missing studies.  Study selection, data extraction and quality assessments were done in 
duplicate to minimise bias and ensure accuracy of data.  Sensitivity analyses were planned 
a priori and Meta-analyses was performed where appropriate; We also assessed for 
heterogeneity and carried out meta-regression where possible to explore potential sources.   
 
The main limitation throughout the reviews was heterogeneity of data. There was 
significant heterogeneity in our findings despite adjusting for various factors, reflecting the 
variation in population, risk factors, setting and outcome.  Due to the non-randomised 
nature of the studies used, there were confounding factors, which could not always be 
controlled for. For the reviews on rates of anaesthesia and caesarean section mortality, the 
majority of studies used were observational, which has limitations.   We were limited by 
the differences in reporting of outcomes, and accepted the author’s definitions, which may 
have created heterogeneity. There were paucity of data from some regions and countries so 
comprehensive global analysis could not be achieved.   
 
 
8.3: Implications for clinical practice, research and policy 
Efforts are needed to provide safe obstetric surgery by improving training, infrastructure 
and resources. Training is needed in general anaesthesia administration including the 
management of airway complications, to be able to deal with problems swiftly.  Training is 
also needed in anaesthetic management of high risk women such as those with pre-
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eclampsia where the potential for complications is much greater, regional anaesthesia in 
this subgroup should be recommended unless otherwise contraindicated.    
 
More needs to be done to ensure that caesarean section is performed for clinical indication, 
and alternate options such as instrumental delivery should be considered prior to embarking 
on second stage caesarean section. Strategies to reduce maternal mortality should include 
increasing the number of anaesthetists and obstetricians, resources including the availability 
of blood, and the level of training in LMIC. Implementation of simple measures, such as 
the WHO ‘Safer Surgery’ checklist before and during surgery would minimise the adverse 
outcomes.(58)  
 
Further prospective research is needed to help address the gap in data regarding rates of 
maternal morbidity related to caesarean section.  Large studies are required to compare the 
outcomes of physician and non-physician anaesthetists to ensure the safety of non-
physician anaesthetists before task shifting can be recommended.  No doubt they are a very 
valuable group of anaesthetic workers however further training, continuing professional 
development and supervision is required at present.   
 
Diagnosing anaemia in pregnancy is important. Increasing access of accurate point of care 
tests should improve the diagnosis of anaemia in LMIC, firstly so treatment can be initiated, 
but also especially in severe cases the appropriate place of delivery can be advised. 
Preventative measure and maternal education of the importance of a good diet and 
engagement with antenatal care providers is required. Large-scale tests are needed into the 
testing of anaemia and to also investigate if the trimester tested or type of blood sample 
affects the results.   
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Women make up a large proportion of the TB burden and pregnancy is a good time to 
capture women who would otherwise not interact with healthcare workers.  Concerted 
effort is needed to integrate tuberculosis prevention, diagnosis, and treatment into maternity 
health services with active screening especially in TB endemic areas and high HIV regions, 
this will not only lead to better maternal and perinatal outcomes but also help with the 
overall WHO END TB agenda.(145) Treatment for latent tuberculosis infection can also be 
initiated for pregnant women who are at high risk of disease progression.(146)  Women with 
TB should also be better monitored throughout pregnancy in order to detect any potential 
complications and act on these early.   More research is needed into the screening methods 
used in pregnancy for active and latent disease.  Studies are also needed to investigate if 
latent TB also carries high maternal and perinatal morbidity and if prophylaxis should be 
given in endemic areas.  Large prospective studies are needed to examine the effect of active 
TB on maternal and fetal outcomes in pregnancy.  Risk factors affecting outcomes such as 




























APPENDIX 1: My role in the thesis 
 
Chapter 3:  
I was involved in the conception of the research question, and designed the protocol. Along with 
Dr. Kuhan D, I undertook literature search, study selection and data extraction.  I carried out the 
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data analysis with help from Javier Zamora and David.  I designed the tables, figures and appendices 
and wrote the first draft of the manuscript. 
 
Chapter 4 
I was involved in the conception of the research question, and designed the protocol. Along with 
Dr. Kuhan D, I undertook literature search, study selection and data extraction, I also carried out 




I was involved in the conception of the research question, and designed the protocol. Along with 
Nilaani Murugesi.  Joshua Vogel from WHO provided access to WHO multi country and global 
survey data.   I undertook literature search, study selection and data extraction.  Javier Zamora and 




I was involved in the conception of the research question, and designed the protocol. Along with 
Ewelina Rogozinska ,  I undertook literature search, study selection and data extraction.  Ewelina 
helped with statistical analysis. I designed the tables, figures and appendices and wrote the first 
draft of the manuscript. 
 
Chapter 7 
I was involved in the conception of the research question, and designed the protocol. Along with 
Dr Heinke Kunst,  I undertook literature search, study selection and data extraction.  I carried out 
the statistical analysis with advice from Javier Zamora. I designed the tables, figures and appendices 
and wrote the first draft of the manuscript, with input from Prof Khalid khan, and Dr. Heinke Kunst   
APPENDIX 2. Search strategy for systematic review on anaesthesia-related maternal 
mortality in low- and middle-income countries 
 
Search History 
1. EMBASE; exp PREGNANCY/; 568978 results. 
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2. EMBASE; pregnant.ti,ab; 154162 results. 
3. EMBASE; (pregnant AND woman).ti,ab; 13995 results. 
4. EMBASE; maternal.ti,ab; 205956 results. 
5. EMBASE; gravid.ti,ab; 4241 results. 
6. EMBASE; parturient.ti,ab; 3490 results. 
7. EMBASE; exp PREGNANT WOMAN/ OR exp PREGNANCY COMPLICATION/; 140046 results. 
8. EMBASE; pregnan*.ti,ab; 446261 results. 
9. EMBASE; mother.ti,ab; 94305 results. 
10. EMBASE; 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9; 872145 results. 
11. EMBASE; exp DEVELOPING COUNTRY/; 77721 results. 
12. EMBASE; (developing AND countr*).ti,ab; 61196 results. 
13. EMBASE; (low AND income AND countr*).ti,ab; 10718 results. 
14. EMBASE; (low-income AND countr*).ti,ab; 5313 results. 
15. EMBASE; (middle- AND income AND countr*).ti,ab; 6413 results. 
16. EMBASE; (middle AND income AND countr*).ti,ab; 6413 results. 
17. EMBASE; (low AND resource AND country).ti,ab; 657 results. 
18. EMBASE; (low-resource AND country).ti,ab; 211 results. 
19. EMBASE; poverty.ti,ab; 17059 results. 
20. EMBASE; africa.ti,ab; 76548 results. 
21. EMBASE; asia.ti,ab; 52712 results. 
22. EMBASE; (south AND america).ti,ab; 13075 results. 
23. EMBASE; 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 OR 20 OR 21 OR 22; 253960 
results. 
24. EMBASE; exp ANAESTHESIA/ OR exp ANESTHESIA COMPLICATION/ OR exp ANESTHESIA 
NURSING/ 
OR exp EPIDURAL ANESTHESIA/ OR exp GENERAL ANESTHESIA/ OR exp NURSE ANESTHESIA 
EDUCATION/ OR exp OBSTETRIC ANESTHESIA/ OR exp REGIONAL ANESTHESIA/; 263973 results. 
25. EMBASE; exp ANESTHESIST/; 17645 results. 
26. EMBASE; anesthetist.ti,ab; 1633 results. 
27. EMBASE; anaesthetist.ti,ab; 3663 results. 
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28. EMBASE; anesthesiologist.ti,ab; 5812 results. 
29. EMBASE; (nurse AND anesthetist).ti,ab; 394 results. 
30. EMBASE; anesthesia.ti,ab; 145229 results. 
31. EMBASE; exp ANESTHESIST/ OR exp ANESTHETIC/; 235989 results. 
32. EMBASE; c-section.ti,ab; 1482 results. 
33. EMBASE; exp CESAREAN SECTION/; 64117 results. 
34. EMBASE; c-section.ti,ab; 1482 results. 
35. EMBASE; exp INSTRUMENTAL DELIVERY/; 68177 results. 
36. EMBASE; (caesarian AND delivery).ti,ab; 638 results. 
37. EMBASE; (caesarian AND section).ti,ab; 1361 results. 
38. EMBASE; (clinical AND officer).ti,ab; 894 results. 
39. EMBASE; (physician AND assistant).ti,ab; 1590 results. 
40. EMBASE; (medical AND assistant).ti,ab; 2602 results. 
41. EMBASE; CRNA.ti,ab; 3351 results. 
42. EMBASE; (operative AND obstetrics).ti,ab; 1277 results. 
43. EMBASE; 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 
37 OR 38 
OR 39 OR 40 OR 41 OR 42; 522070 results. 
44. EMBASE; 10 AND 23 AND 43; 1116 results
 130 
APPENDIX 3: Characteristics of studies evaluating rates of anaesthesia attributed maternal mortality in low- and middle-income countries 
 
a. Studies reporting rates of anaesthesia-attributed maternal deaths  
Ref No.  
* 
Author, Yr Country Setting Method used to 








No. of maternal 
Deaths (direct 
and indirect) 
(147) E. Abdel-Hady, 2007  Egypt Multicentre Prospective 
confidential enquiry 
251016 7 164 
(148) J. Larsen, 1996 South Africa Multicentre Prospective study 41779 9 45 
(149) Z. Amarin, 2010 Jordan Multicentre RAMOS/ 
Confidential enquiry 
397588 3 76 
(150) S. Ara, 2012 Pakistan Urban Retrospective hospital 
based audit 
24667 1 168 
(151) M. Akar, 2004 Turkey Urban Retrospective 430559 9 174 
(152) N. Bano, 2011 Pakistan Multicentre Prospective 47209 2 108 
(153) S. Begum, 2003 Pakistan Urban Retrospective 2040 3 26 
(154) C. Hoestermann, 1996 Gambia, Urban Retrospective hospital 
based audit 
10590 1 75 
(155) A. Bashir, 1995 Pakistan Urban Retrospective hospital 
based audit 
276717 8 215 
(156) N.Vink, 2013 Malawi Rural Retrospective hospital 
based audit 
9800 2 61 
(157) X De Muylder, 1990 Zimbabwe Multicentre Retrospective 51058 3 70 
(158) J. Bolngaa, 2014 Madang Urban Retrospective hospital 
based audit 
10891 1 64 
(159) S. Ngwan, 2011 Nigeria Urban Prospective hospital 
based audit 
4443 2 56 
(160) A. Sule-Odu, 1999 Nigeria Urban Retrospective 5320 3 103 
(161) O. Oladapo, 2006 Nigeria Urban Retrospective hospital 
based audit 
2709 1 75 
(162) N. Obiechina, 2013 Nigeria Urban Retrospective hospital 
based audit 
8022 5 103 
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(163) S. Mahbouli, 2003 Tunisia Urban Retrospective hospital 
based audit 
29845 1 10 
(164) A. El Daba, 2010 Egypt Urban Retrospective hospital 
based audit 
19619 15 187 
(165) R. Rahim, 2006 Pakistan Urban Retrospective hospital 
based audit 
23720 5 311 
(166) S. Yang, 2014 China Urban Retrospective 629544 2 91 
(167) V. Soare, 2012 Brazil Multicentre Retrospective 461999 10 270 
 V. Soare, 2012 Brazil Multicentre Retrospective 452444 11 252 
(168) U. Okfar, 2008 Nigeria Urban Retrospective hospital 
based audit 
6798 6 160 
(169) E. Kongnyuy, 2009 Malawi Multicentre Retrospective 5080 1 43 
 (170) I. Ujah, 2005 Nigeria Urban Retrospective hospital 
based audit 
38768 11 267 
(171) S. Hodorogea, 2014 Moldova Multicentre Retrospective, 
National enquiry 
114625 2 29 
(172) V. Paily, 2014 India Multicentre Prospective 
confidential enquiry 
3307553 12 501 
(173) I. Ujah, 1999 Nigeria Urban Retrospective hospital 
based audit 
12047 8 89 
(174) D. Goswami, 2013 India Urban Prospective study 42355 2 296 
(175) T. Kane, 1992 Egypt Multicentre Retrospective audit 
and Verbal autopsy 
123810 31 156 
(176) G. Ganyaglo, 2012 Ghana Urban Retrospective hospital 
based audit 
19965 3 191 
(177) 
 
A. Granja, 2001 Mozambiqu
e 
Urban Retrospective hospital 
based audit 
74637 4 239 
(178) F. Font, 2000 Tanzania Rural Retrospective audit 
and sisterhood 
method 
8929 2 40 
(179) K. Akpanza, 1994 Togo Urban Retrospective hospital 
based audit 
21603 4 190 
(180) J. Okaro, 2001 Nigeria Urban Retrospective hospital 
based audit 
12949 3 182 
(181) P. Onwuhafua, 2000 Nigeria Urban Retrospective hospital 
based audit 
10572 6 69 
(182) J. Mukherji, 1995 India Urban Retrospective hospital 
based audit 
38870 10 429 
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(183) E. Abe, 2008 Nigeria Urban Retrospective hospital 
based audit 
28186 1 135 
(184) M.Kassas, 1995 Egypt Multicentre Population-based 
retrospective review 
443248 19 718 
(185) Egypt MOH, 2000 Egypt Multicentre Retrospective 
National survey 
1752562 30 580 
(186) NCCEMD, 2007 South Africa Multicentre Confidential enquiry 2598357 107 3959 
(187) A. Aboyeji, 2007 Nigeria Urban Retrospective hospital 
based audit 
13093 3 108 
(188) M. Bukar, 2013 Nigeria Urban Retrospective hospital 
based audit 
8497 2 28 
(189) A. Mungra, 1999 Surinam Multicentre Prospective, 
confidential enquiry 
28337 1 64 
(190) NCCEMD, 2012 South Africa Multicentre Confidential enquiry 1939673 70 2966 
(191) S. Munjanja 2007 Zimbabwe Multicentre Retrospective 
confidential enquiry 
45240 3 316 
(192) Jayashree, 2014 India Urban Prospective hospital 
based audit 
43799 1 34 
(193) P.N. Makinga, 2012 South Africa Multicentre Retrospective 29883 3 61 
(194) Botswana MOH, 2012 Botswana Multicentre Confidential enquiry 50048 2 74 
(190). NCCEMD, 2010 South Africa Multicentre Confidential enquiry 2761888 121 4867 
(195) S. Fawcus, 2005 Cape town Urban Prospective 176822 1 52 
(196) M. Kharouf, 1992 Tunisia Urban Retrospective hospital 
based audit 
42028 5 29 
(197) F. Madzimbamuto 
2014 
Botswana Multicentre Retrospective 50328 2 55 
(198). U. Okeh, 2009 Nigeria Urban Retrospective 1645 4 45 
(199) H. Bashour, 2009 Syria Multicentre RAMOS Design Unknown 10 129 
(200) S. Rutgers, 2001 Zimbabwe Multicentre Retrospective 35050 2 92 
(201) A. Kampikaho, 1991 Uganda Multicentre Retrospective 174915 30 580 
(202). B. Khan, 2012 Pakistan Urban Retrospective hospital 
based audit 
21120 14 163 
(203) S. Kauser, 2006 Pakistan Urban Retrospective hospital 
based audit 
15885 3 46 
(204) A. Fawad, 2011 Pakistan Urban Retrospective hospital 
based audit 
7380 4 767 
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(205) A.G. Mairiga, 2009 Nigeria Urban Prospective hospital 
based audit 
44281 6 767 
(57) A. Dalina, 1996 Malaysia Multicentre Confidential enquiry 1033099 10 475 
(206) Malaysia MOH, 1993 Malaysia Multicentre Confidential enquiry 536883 6 246 
(207) Malaysia MOH, 1994 Malaysia Multicentre Confidential enquiry 533333 6 208 
(208) Malaysia MOH, 
1995-1996 
Malaysia Multicentre Confidential enquiry 1075721 11 471 
(209) Malaysia MOH, 
1997-2000 
Malaysia Multicentre Confidential enquiry 2101361 9 654 
(210) Malaysia MOH, 
2001-2005 
Malaysia Multicentre Confidential enquiry 2434604 2 671 
(211) Malaysia MOH, 
2006-2008 
Malaysia Multicentre Confidential enquiry 1424602 2 396 
(212). P. Wagaarachchi, 
2002 
Sri-Lanka Urban Retrospective hospital 
based audit 
135320 10 133 
(213) E. Nelissen, 2013 Tanzania Rural Prospective cross 
sectional study 
9136 1 32 










Multicentre Prospective study and 
questionnaires of 
pregnant population 
and Verbal autopsy 
for maternal deaths. 
 
17694 1 52 
(215) A. L. Montgomery, 
2007 
India Multicentre Maternal death 
survey/ verbal 
autopsy 
431496 4 1096 
(216) A. Pal, 2005 West Bengal Rural Retrospective hospital 
based audit 
83244 4 519 
(217) V. Ashok, 2008 India Urban Retrospective hospital 
based audit 
18793 1 65 
(218) K. Khatum, 2015 Bangladesh Urban Retrospective hospital 
based audit 
5246 2 96 
(219) M. Cetin, 2002 Turkey Urban Retrospective hospital 
based audit 
7424 1 34 
(220) Swaziland MOH, 
2001 
Swaziland Multicentre Maternal death review 
audit 
16898 2 43 
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(221) Kavoo-Linge, 1992 Kenya Rural Prospective hospital 
based audit 
2171 1 6 
(222) M. Rakotoarimanana, 
2000 
Madagascar Urban Retrospective hospital 
based audit 
91032 23 997 
(223) J. Oyieke  2006 Kenya Urban Retrospective hospital 
based audit 
27455 4 203 
(224). R. Ali, 2012 Pakistan Urban Retrospective hospital 
based audit 
7529 3 31 
(225) G. Igberase, 2007 Nigeria Rural Retrospective hospital 
based audit 
5153 1 115 
(226) B. Asamoah, 2011 Ghana Multicentre Maternal health 
survey and verbal 
autopsy 
Unknown 4 605 
(227) Botswana MOH, 2010 Botswana Multicentre Confidential enquiry 50328 1 82 
(228) Botswana MOH, 2011 Botswana Multicentre Confidential enquiry 45008 2 85 
(229) Botswana MOH, 2013 Botswana Multicentre Confidential enquiry 49839 1 91 
(230) Turkey MOH, 2005 Turkey Multicentre Confidential enquiry 763585 2 218 
(231) Salvador MOH, 2006 El-Salvador Multicentre Confidential enquiry/ 
RAMOS 
Unknown 2 82 
(232) E. Farhat, 2012 Tunisia Multicentre Confidential enquiry 1194329 15 506 
(233) K. Issah, 2011 Ghana Multicentre Maternal death 
notifications and 
audits 
Unknown 2 47 
(234) M. Glenshaw,2005 Zimbabwe Rural Retrospective 18718 5 77 
 
Ramos- Reproductive Age Mortality Studies (RAMOS) use varied sources, depending on the context, to identify all deaths of women of reproductive age and ascertain which of these are maternal or 
pregnancy-related; http://www.maternal-mortality-measurement.org.uk 
Verbal Autopsy- a research method that helps determine probable causes of death in cases where there was no medical record or formal medical attention given.  In the case of the maternal deaths, 
full-time, non-medical field workers are trained to record written narratives from families or other reliable informants in the local language describing the events that preceded the death.  In addition, 
answers to standard questions about key symptoms were also recorded.  These records were then scanned and sent to trained physicians, who independently assigned a probable underlying cause of 
death to each case. In cases where the physicians did not agree on the cause of death, the conflicting physicians were given the other physician’s notes, and cases were anonymously reviewed again. 
Further disagreements were resolved by the opinion of a third, senior physician. http://www.cghr.org/projects/million-death-study-project/what-is-verbal-autopsy/ 
Sisterhood method- the sisterhood method is an indirect measurement technique, which has been adapted to maternal mortality. It reduces sample size requirements because it obtains information by 
interviewing respondents about the survival of all their adult sisters. (The sisterhood method for estimating maternal mortality, WHO 
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b. Studies reporting anaesthesia-attributed deaths in pregnant women undergoing surgical procedures, risk factors for complications in low 
and middle-income countries  
 
Ref Author, Yr. Setting  Study design Population Procedures Anaesthetic 
provider 












Unselected 9833 operative 
obstetric 
procedures 
Physician and non 
physician  
General 8965,  
Spinal 868 
Anaesthetic associated 
deaths- death within 
24hrs of anaesthesia 




























Birth outcomes by C-
sections under general 
and spinal anaesthesia, 
Apgar score and 
perinatal death 

















morbidity and mortality- 
24 hrs. 














in all deaths.  
Not specified C- Section related 















and who were 
induced 






















Unselected 2323 CS,  
390 Cerclage 
Physician  General 2339, 
Regional 332 
To determine the 
incidence of maternal 
mortality related to 
anaesthesia and analyse 
the causes. 











Unselected 729 CS Not specified General 347, 
Regional 374 
The trends of different 
forms of anaesthesia for 
caesarean section in 














Unselected 8070 caesarean 
sectionsCS 





maternal or perinatal 
deaths in the first 72 
hours and various 
quantifiable risk factors 











Unselected 740 CS Not specified Not specified To analyse subjects 
delivered by    
CS, determine the CS 
rate, indication, 

















and outcome of cardiac 
arrest associated during 













Unselected 1579 CS Physicians- Senior 
trainees (more than 
24 months training)  
General & 




To determine the causes 
and risk factors of 

















498 elective CS Not specified General 253, 
spinal 219 
To determine the CS 
rate and trend, 
indication and maternal 
mortality associated  








Retrospective Unselected 2686 CS; 
78% emergency 
Not specified General 2597, 
Regional- 89 
To determine the 
anaesthesia related 
complication after Lscs, 
especially ICU 
admissions and maternal 

















To compare the effects 
of general v spinal 
Anaesthesia on APGAR 
score in term neonates 
born by elective CS,  







Prospective 2% ASA 3 318 CS; 
89% emergency 
Non physician (74 
in Togo)  
or Physician 
anaesthetist 
(1 in Togo) 
General 299, 
Spinal- 13 
Deaths within 24hrs 
after anaesthesia 






Unselected 16697 CS; 
35% emergency 
Physicians or 
surgeons for spinal,  
Nurse in 34% of 
general 
General 4,677  
Spinal 
11,310 
To determine the 
incidence of maternal 
mortality related to 











17,382 CS Unspecified.   All spinal  Incidence of cardiac 
arrest with spinals for 
CS 







Retrospective Unselected 3389 CS Not specified General 469, 
Regional 2920 
To investigate potential 
trends and the rate of 
maternal complications 
associated with general 


















overseeing at the 
referral hospital 
Not specified Review of the 
development of 
anaesthesia and role of 
nurse anaesthetists- 
maternal death post 
procedures 















growth and liquor, 
no congenital 
anomalies or foetal 
distress.  
No maternal co-







To compare the effects 
of general v spinal 
anaesthesia on APGAR 
scar in neonates born to 
full term elective C/S 








Retrospective Unselected 1777 CS,  
63% emergency 











anaesthesia group:  
ASA2 (49.7%), 
ASA3 (21%),  









complications within 24 
hrs. 






Retrospective Emergency CS 
only 











complications within 24 
hrs. 
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Unselected 304  
C-sectionCS 










Prospective Unselected 370 emergency 
CS 
Nurse anaesthetist 















Retrospective Those with 
placenta praevia 
81 CS Not specified General 52, 
Spinal 29 
To determine the 
anaesthetic management 
and outcome in placenta 
praevia.   




















Retrospective Women with 
preterm deliveries. 




Perinatal outcome in 
preterm caesarean 
sections, Apgar score, 
perinatal deaths 













CS related maternal 




Urban Retrospective  C-section for foetal 
distress 





General 172,  
Spinal 66 
Apgar scores with 
general and spinal for 










Retrospective Parturient with 
severe co-
morbidity- ASA 3 
270 CS Physician 
anaesthetists  
General 202,  
Regional 68 









Retrospective Unspecified 2054 obstetric 
procedures 
The surgeon would 
give the anaesthetic 
before operating 






All patients who died 
within 24hrs of an 
anaesthestic 






Retrospective CS with and 
without pre-
eclampsia 




Risk of Stroke, ITU 

















324 CS Not specified General-117 
Spinal- 207 
Apgar scores with 













161 CS Not specified GA- 104 
Spinal- 42 
Epidural 15 
Apgar scores with 
general and spinal in 
elective C-section  








Retrospective Unselected 980 CS; 
94% emergency 
Not specified Not specified To determine the rate, 
pregnancy outcomes, 
indication and 
complications of CS. 







Retrospective Unselected 647 CS;  
90% emergency 
Not specified Not specified Fetal outcomes and 
maternal mortality and 
morbidity post CS. 
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Retrospective Unselected 219 CS; 
58% emergency 
Not specified Not specified Comparison of maternal 
outcomes following 
elective and emergency 
CS 










































Retrospective Unselected-  1254 CS Nurse anaesthetist Mainly 
General 
CS related mortality 







Retrospective Unselected  363 CS; 
53.6% emergency 








Retrospective Exclusions: those 
with obstetric 
complications 
13627 CS Not specified Not specified CS related mortality 












Retrospective Unselected- all 
undergoing C-
section 
3231 CS Physicians  Not specified Outcomes of CS 








Not specified Surgical morbidity 
(280). Malaysia 
MOH, 1992 
Malaysia Retrospective Unselected 37 CS deaths Not specified Not specified Anaesthesia related CS 
deaths 
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Retrospective Unselected 2114 CS Physicians 100% GA To report rates of 
regurgitation and failed 
intubations with GA 
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APPENDIX 4: Quality assessment of studies included in the systematic review of 







a. Studies on anaesthesia-attributed maternal mortality rates  
	
b: Risk of bias assessment by Newcastle Ottawa Scale in studies evaluating 



















































APPENDIX 5: Anaesthesia attributed maternal deaths in pregnant women undergoing 
surgical procedures in individual low- and middle-income countries- country specific 
prevalence’s.  
 
A) Anaesthesia-attributed maternal death as a proportion of all obstetric surgical procedures  
























East Africa; 1.9% 
Burkina Faso 1.9% 





























APPENDIX 6: Study characteristics of included studies for systematic review of maternal and fetal outcomes related to type of anaesthesia in women 
with pre-eclampsia in low- and middle-income countries. 
 
Author, yr Year  Setting  Study design Population Procedures and 
anaesthesia 








Hospital in south 
Africa 
Retrospective All women with Stable 
Eclampsia  
ªStable” eclampsia was 
defined as:  
1. Glasgow coma score >14; 2. 
Rapidly acting anti-
hypertensive agent not 
required; 3. Platelet 
count>100,000/mm3; 4. 
Cooperative; 5. Central 
venous pressure >5 cm H2O; 
6. Normal fetal heart rate 
pattern on electronic 
monitoring. 7. No additional 





Spinal- 2 (not 
analysed) 
Maternal, neonatal and 
anaesthetic complications 
 
Maternal and neonatal 
outcomes are not affected 
adversely by the use of 
epidural anaesthesia in 







Medical college & 
Hospital Kolkata 
Prospective Women with Severe pre-
eclampsia undergoing 
emergency caesarean section.  
Exclusions: < 34 weeks,  
eclamptic patients; history of 
medical disorders, severe 
allergic reaction;  abruption or 
placenta previa; coagulopathy, 
thrombocytopenia with 
platelet count less than 80, 
sepsis, neurological problems, 
hypovolemia, or pulmonary 
edema; multiple gestations or 
173 C-sections,  
27 GA  
146 spinal  
 
Maternal, neonatal and 
anaesthetic complications 
 
Mothers with Severe Pre-
eclampsia receiving general 
anaesthesia and their babies 
required more critical care 
support. Maternal as well as 
neonatal mortality was 
significantly higher with 
general anaesthesia. 
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Retrospective Women with severe pre-
eclampsia 
60 C-sections 
GA  -30     Spinal - 
30 
Perioperative morbidity 
and mortality in severe pre 
eclampsia, 
Spinal anaesthesia should be 
used as first choice for 
severe pre eclamptic 
patients, which is safer than 
general anaesthesia, with 
less postoperative morbidity 
and mortality. 










Registry data Women with pre-eclampsia. 
Mild PET- 3751                    
Severe PET-4816            
Exclusions: those younger 
than 16 or older than 49, hx of 
stroke, those with missing data 
8567 C-sections,  
GA- 1027  
Regional- 7540 
 
Mode of anaesthesia on 
outcomes especially 
stroke, other morbidities 
and mortality 
general anaesthesia for CS 
delivery was associated with 
increased risk of stroke 
when compared with 









Retrospective Women with pre-eclampsia/ 
eclampsia 
Mild PET- 34                    Severe 
PET-76             Eclampsia- 15 
125 C-sections,  
GA- 116   Spinal- 
9           
Perioperative morbidity 
and mortality in pre 
eclampsia/ eclampsia 
Maternal and fetal mortality 
were high.  Use of spinal 









Retrospective Women with pre-eclampsia/ 
eclampsia 




GA- 157   Spinal- 
34 Epidural- 5 




continues to be a cause of 
foetal loss. Early onset 
management of severe pre-
eclampsia with maintenance 
of adequate placental 
perfusion during anaesthesia 









Retrospective Women with pre-eclampsia/ 
eclampsia,  
Mild pre-eclampsia- 25,   
Severe pre-eclampsia-31, 
Eclampsia-15 
71 C-sections,  
GA- 41    Spinal- 
25 Epidural- 5 
Perioperative morbidity 
and mortality in pre 
eclampsia/ eclampsia 
Maternal outcomes 
improved from previous 










Retrospective Women with severe pre-
eclampsia defined as:  Systolic 
blood pressure ≥ 160 mmHg 
and/or diastolic blood pressure 
≥ 110 mmHg with ≥ 2+ of 
Proteinuria on dipstix 
urinalysis. 
96 C-sections  
GA- 59     Spinal-
37 
 
To compare the outcome 
of spinal and general 
anaesthesia in Cesarean 
delivery for women with 
severe pre-eclampsia. 
 
There was no significant 
difference in the maternal 
and perinatal mortality 
outcome of cesarean 
delivery by type of 




eclampsia, other medical 
disorders, multiple 
pregnancies, gestational age 
less than 32 weeks, cases of 
eclampsia.   
 
proportion of birth asphyxia 











Retrospective 82 women with eclampsia  






methods, maternal and 
perinatal outcome 
measures  
Maternal and perinatal 
survival and well being are 
better in eclamptics who had 
spinal anaesthesia for 
caesarean section compared 
to those who had general 
anaesthesia. 
 







Retrospective Women with severe pre-
eclampsia presenting for 
emergency caesarean section 
Exclusions: antepartum 
haemorrhage, cardiac disease, 






(not analysed)  
Postoperative maternal 
outcomes, maternal 
mortality or morbidity, as 
well as any neonatal 
mortality or morbidity. 
Maternal morbidity and 
mortality were not 
significantly different 
between the two groups. 
Neonatal outcomes were 
poorer in the GA group. This 
study supports spinal 
anaesthesia as an 
appropriate anaesthetic 






Retrospective Women with severe pre-
eclampsia, managed according 
to homogenous guidelines.   
Exclusions: epidurals and 
combined spinal-epidural, 
incomplete data 




methods, maternal and 
perinatal outcome 
measures 
Spinal anaesthesia  
Can be safely administered 
in women with severe 
preeclampsia patients 
 





Women with pre-eclampsia 
and a non-reassuring fetal 
heart rate.  
 Mild PET- 30                   Severe 
PET-40        
Exclusions: BMI>35, 
mallampati score>2, clinical 
70 Patients 
GA- 35  
Spinal- 35 
To assess maternal 
heamodynamics and 
markers of neonatal 
hypoxia in women with 
pre-eclampsia.  
Maternal heamodynamics 
were similar with either 
anaesthetic technique.   
Spinal was associated with a 
lower mean umbilical 
arterial pH, the clinical 
significance remains to be 
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signs of hypovolemia, 
abruption, placenta previa, 
platelets<70, cord prolapse,       
< 30 weeks, twins.      
established. 






Women with severe Pre-
eclampsia as per ACOG 
diagnostic criteria 
Exclusions: Cardio vascular 
and pulmonary disease, 
Diabetes, HELLP syndrome, 
Gestational age <34 weeks , 
Fetal bradycardia and any 
contraindications of regional 
anaesthesia including patients 
refusal, severe haemorrhage, 
coagulopathy and sepsis. 




methods, maternal and 
perinatal outcome 
measures 
Spinal anaesthesia  
is a safe alternative to 
general  









Women with severe pre-
eclampsia: BP> 160/90, 
proteinuria > 5g/24h with at 
least one associated symptom.   
Exclusion criteria:  
Cardiovascular/ pulmonary 
disease, HELLP, < 34 weeks, 
fetal bradycardia and any 
contraindication to regional 
anaesthesia.   
60 patients  
GA- 30 
Spinal- 30 
Hemodynamic status of 
severe pre-eclamptic 
women and neonatal 
outcomes 
No difference In BP or 
neonatal outcomes in the 
two groups.   
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APPENDIX 7: Study characteristics of studies included in in caesarean section related maternal and perinatal mortality and morbidity review. 
Author, yr Country Type of hospital , 
setting 












Retrospective All Caesarean sections 371981 To evaluate c/s in both public and private sectors; 
maternal mortality associated with mode of delivery 
in the public sector in Sao Paulo, Brazil 
J.M.Afolayan, 2014(294) Nigeria Teaching hospital Retrospective Inclusion criteria: eclamptic women who had 
c/s 
Exclusion criteria: patients with previous 




To evaluate the comparative advantage of general and 
spinal anaesthesia on maternal and perinatal outcomes 
in eclamptics, after c/s 
L.Cebekulu, 2006(295) 
 
South Africa Referral hospital Cohort Inclusion criteria: singleton live pregnancies 
at 36 weeks or more of gestation with 
cephalic presentations. Exclusion: women 
with previous c/s 
5765  
 
To determine maternal and neonatal complications 
associated with c/s done in the second stage of labour. 
(primary outcome: intraoperative difficulties, blood 
loss, operating time and neonatal morbidity) 
A.Ghazi, 2012 
(296) 
Pakistan Tertiary hospital Prospective  All mothers admitted through OPD or 
emergency recruited. Patients having 
previous myomectomy, hysterectomy or 
classical c/s were excluded) 
100 To compare maternal morbidity and determine its 
cause in elective and emergency c/s 
L.A.O.Ujah, 1999  (173) 
 
Nigeria Teaching hospital Retrospective All women dying in pregnancy, labour and 
puerperium 
 Maternal mortality ratio, trend of maternal mortality, 
age, antenatal booking status, educational status, main 
causes of maternal death, factors contributing to 
maternal deaths 
J.Mukherji, 1995 (182) India Teaching hospital Retrospective MD following CaesareaCaesarea  sections 8017 To evaluate the associated factors resulting in MD 
following c/s 
I.K.Sorbye, 2011 (297) Tanzania Zonal referral 
hospital 
Retrospective all deliveries including Caesarea sections 6765 
 
To compare c/s rates among women formally referred 
to a tertiary care centre vs self-referred women, and to 
assess the effect of referral status on adverse outcomes 
after CS 
I.K.Sorbye, 2011 Nairobi Tertiary/teaching 
hospital 
Retrospective All CaesareaCaesareann sections 1229 To compare total c/s rates, their indication and 
perinatal outcome in 2001 and 2004 
V.Ashok, 2008(298) India Government 
medical college 
hospital 
Retrospective All maternal deaths  To study maternal mortality and common 
complications leading to MD 
B.Onankpa, 2009(299) Nigeria Teaching hospital Prospective All CaesareaCaesareann sections 216 To evaluate fetal outcome for the various indications 
for c/s 
S.J.Etuk, 2001(300) Nigeria Teaching hospital Retrospective All c/s deaths, excluding those who had 
uterine rupture 




kenya District hospital Prospective All CaesareaCaesareann sections 153 To determine the incidence of post-caesarean wound 
infection 
N.P.Khawaja, 2004(302) Pakistan Tertiary hospital Prospective? All Caesarean sections 300 To determine the rate of c/s, indications and outcome 
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S.Pothinam, 1992(303) Thailand Teaching hospital Prospective Patients delivered by Caesarean sections. 
Exclusion criteria: intrapartum fever 
developed before c/s, gestational age of less 
than 28 weeks and loss of medical records 
548  Post-c/s puerperal morbidity, incidence and risk 
factors 
E.A.Wright, 1991(304) Nigeria Teaching hospital Prospective Perinatal deaths on patients delivered by c/s 757 To determine the perinatal mortality rate based upon 
c/s deliveries 





Retrospective MD associated with CaesareaCaesarean 
sections 
2704 To compare frequencies of MD and perinatal 
mortality, and severe morbidity among cases of c/s 
O.T.Oladapo, 2007(161) Nigeria Teaching hospital Retrospective All elective Caesarean Caesarea sections 164  To estimate the maternal morbidity and mortality 
associated with elective c/s at a Nigerian university 
hospital  
E.Gomathy, 2013(307) India Referral hospital; 
rural 
Retrospective Maternal deaths over a 6 year period  To find the frequency and the causes of MD in a rural 
medical college hospital 
C.Pereira, 1996 (308) Mozambique Central/university 
hospital 
Prospective CaesareaCaesarean sections delivered by 
AsistantAssistant medical officer vs 
obstetricians 
2071 Post-operative complications and duration of post-
operative hospital stay of women delivered by c/s 
performed by AMO and obstetricians 
E.Tadesse, 1996 (309) Ethiopia Teaching hospital Prospective  All Caesareanrea sections 318 To obtain base-line data on the rates of c/s, pregnancy 




Nigeria Private hospital descriptive All Caesarean sections 1140 Perinatal asphyxia rate, stillbirth rate, END rate, 
maternal mortality rate 





Retrospective All Caesarean sections 264 ( To determine the indications and outcome of c/s 
S.Kumari, 1990 (311) India District; urban Prospective Neonates delivered by Caesarea sections 
xcept those with prom>24hrs and major 
malformations 
573  Neonatal outcome following c/s 
A.O.Longombe, 1990 
(312) 
Zaire Medical referral 
center; rural 
Retrospective All Caesarean sections 1014 Indications and risks of c/s in rural Zaire 
A.Picaud, 1990 (313) Gabon Centre hospital Prospective All Caesarean sections 1213 Indications of c/s and their evolution in the Centre 
Hospitalier of Libreville 
N.Dey, 1991 (314) India Referral hospital Prospective Unselected cases of Caesarea sections 200 To make an overall assessment of the complications 
of mother and the neonate following c/s under 
improved state of anaesthesia, skilled operative 
technique, antibiotics and neonatal services 
S.P. Munjanja, 2007 (191) Zimbabwe Mixed Retrospective All maternal deaths in the population-based 
birth survey 
 To establish precisely the national estimates for 
indicators relating to mortality of mothers and 
newborns. 
P. Yaïch, 2012 (315) Ivory Coast University hospital Retrospective All emergency Caesarean sections 618  To determine the rate of emergency c/s and the factors 
influencing the maternal/foetal prognosis. 
N.M.Burshan, 2015 (316) Libya Al-khaddar hospital Cross-
sectional 
All Caesarean sections 511 To review the complications of emergency c/s during 
and post-operative period and epidemiological and 
 152 
obstetric factors which could be associated with such 
morbidity. 
A.Gessessew, 2011(317) Ethiopia 11 hospitals and 2 
health centers 
Retrospective All deliveries  2835 To assess the contribution of non-physician clinicians 
to comprehensive emergency obstetric care in Tigray, 
Ethiopia. 
N.G. Omamalin, (318) Philippines University hospital Retrospective All emergency Caesarean sections 
 
703 To determine the leading indications for emergency 
c/s and the clinical maternal and neonatal outcomes 
following emergency c/s in the hospital from 2005 to 
2007 
C.McCord, 2009(319) Tanzania District hospitals Prospective All emergency obstetrical operations, plus 
all cases of eclampsia, postpartum 
haemorrhage or puerperal sepsis 
1087 To address the question the quality of care delivered 
by various non-physician clinicians.  
S.Basak, 2011(320) India Teaching hospital prospective Inclusion: obstructed labour due to CPD 
with: fetus alive, vertex presentation, 
advanced cervical dilatation, well engaged 
fetal head; obstructed labour after failed 
ventouse/forceps; trapped after coming head 
in vaginal breech delivery; shoulder dystocia 
Exclusion: Dead baby, musculoskeletal 
disorders, severe obesity of mother, major 
degree of CPD, previous CS, baby weight > 
4kg 
50 To compare the maternal and neonatal outcomes of 
symphysiotomy and c/s when they were performed in 
women presenting with obstructed labour. 
KS Begum, 2014(321) Bangladesh Tertiary hospital prospective Mothers with previous one lower segment  
Caesarean sections who presented at term 
 
115 To determine the factors affecting the pregnancy 
outcome in patients with previous one c/s 




All women with single pregnancy, living in 
Senegal or mali who delivered in the selected 
health facilities a newborn weighing more 
than 500g were included. 
excluded women with  
immediate life threatening maternal or fetal 
complication (placenta praevia, severe pre-
eclampsia, prerupture or rupture of the 
uterus, transverse lie, brow presentation, or 
major cephalo-pelvic disproportion 
 
11255 To assess maternal and perinatal adverse outcomes 
associated with mode of delivery in 41 referral 
hospitals of Mali and Senegal 
CN Daniel, 2016 (323) Nigeria Tertiary hospital Cross-
sectional 
Women who had a c/s hysterectomy 
following uterine rupture were excluded 
504 To assess the overall c/s rate, indications and 
outcomes 
F.E.Abebe, 2016 (324) Ethiopia Referral hospital Retrospective All Caesarean sections 
Exclusions:  uterine rupture 
723 To assess the rate and factors associated with c/s 
M.Jabir, 2013 (325) Iraq 6 public hospitals Cross-
sectional 
All maternal deaths and near misses in 6 
hospitals 
 To study the characteristics and quality of care 
provided to women with severe complications  
Y.kim, 2012 (326) Afghanistan Referral facilities Cross-
sectional 
All Caesarean sections 173  To gain a greater understanding of the clinical 
indications, timeliness and outcomes of CS deliveries 
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All maternal deaths and near misses 
All women with complications during 
pregnancy, childbirth or within 42 days after 
termination of pregnancy 
 To describe the occurrence and panorama of maternal 
near-miss and death and explore their association with 
CS complications 
N.Maaloe, 2012 (328) Tanzania rural hospitals Retrospective All emergency Caesarean sections 400  To investigate in depth to what extent indications for 
emergency c/s followed evidence-based audit criteria 
for realistic best practice. 
G.B.Madoue, 2015 (329) Chad Tertiary hospital Prospective All Caesarean sections 170 To determine the frequency and main indications of 
c/s 
P.I.Okonta, 2003 (330) Nigeria Teaching hospital Retrospective All Caesarean sections 1031  To audit c/s done over a 5 year period and to compare 
such with those from the same hospital 20 years ago 
S.Rahlenbeck, 2001 (331) Rwanda District hospital Retrospective All deliveries 896 To obtain data on pregnancy outcomes and maternal 
mortality at a district hospital in Rwanda 
B.Sebhatu  (332) Eritrea Maternity hospital Retrospective All Caesarean sections 931  1.To describe the practice of caesarian section in 
Orotta Hospital in terms of the rate of caesarian 
section, the indication of the caesarian section, the 
type of caesarian section, the mode of anaesthesia 
used, the rate of post operative infection, the neonatal 
outcome and the maternal morbidity and mortality 
attributed to the procedure  
 
W.K.Sekirime, 2009 (333) Uganda Tertiary referral Prospective All Caesarean sections 478 To assess whether asymptomatic HIV infection could 
be contributing to the increased morbidity following 
emergency c/s in the form of wound and GTI with 
consequent prolonged stay in the hospital 
B.Utoo, 2013 (334) Nigeria Health facility Retrospective All nulliparaous Caesarean sections 109 To assess the primary c/s rate, indications and fetal 
outcome amongst nulliparous women at a health 
facility in southern Nigeria 
Y.Berhan, 2004 (335) Ethiopia Teaching hospital Retrospective Major emergency obstetric performances 
included 
961  To analyse the rates of variables-specific perinatal 
deaths, maternal and perinatal case fatality rates and 
to determine common indications of operative 
deliveries with their outcome indicators. 
S.H.Hounton, 2009 (336) Burkina Faso National/regional 
and district hospitals 
Rural and urban 
Retrospective All Caesarean sections 2305 To evaluate the effectiveness and cost-effectiveness 
of alternative training strategies for increasing access 
to emergency obstetric care in Burkina Faso. 
E.landry, 2014 (337) 9 facilities in 
Bangladesh 






public, faith based 
Retrospective All Caesarean sections 2941 To review 350 c/s from 2008 from each hospital in 
study, randomly selected from operating room 
register, if less than 350 at site all reviewed.  To assess 
the quality of record keeping for c/s 
O.Asicioglu, 2014 (338) Turkey Tertiary/teaching 
hospital 
Prospective Inclusion: singleton live pregnancies at term 8072 To investigate the maternal and perinatal 
complications of c/s performed in the 2nd stage 
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Exclusion: multiple pregnancies, 
pregnancies with major fetal abnormalities, 
significant maternal disease or pregnancy 
complications  






Tertiary Prospective All women admitted for delivery and if they 
resided within 5km radius of the hospital 
403 To compare the various complications found in 
vaginal and c/s deliveries based on the original elected 
intended mode of delivery. 
S.L.Seal, 2010 (340) Eastern India Teaching  Prospective inclusion: singleton live pregnancies at term 
in nulliparous women with vertex 
presentation 
exclusion criteria: pregnancies with major 
fetal abnormalities, mal-presentations, 
significant maternal disease or pregnancy 
complications  
4185  To evaluate the maternal and perinatal complications 
of c/s deliveries performed in the 2nd stage compared 
with the first stage of labour in nulliparous women. 
I.Teguete, 2012 (341) Mali Tertiary care referral 
center/hospital 
Retrospective All deliveries 4517 To assess the trends of c/s delivery at the Point G 
national hospital in Bamako, Mali over a period of 2 
decades.  
A.Diawara, 2014 (342) Mali Mixed Retrospective All Caesarean sections 262 To assess the impact of free c/s on emergency 
obstetric care 
J. Ngowa, 2015 (343) Cameroon 2 University 
hospitals 
Prospective All Caesarean sections 460 To determine the incidence of maternal complications 
related to c/s in two university hospitals in Yaoundé. 
F.B.Diallo, 1998 (344) guinea University hospital Prospective All elective Caesarean sections,  
Uterine rupture excluded 
434 To determine the frequency of c/s, the problems 
linked to c/s and to determine in which cases c/s can 
be a factor in reducing morbidity and foetal and 
maternal mortality. 
A.Sucak, 2011 (345) Turkey Teaching hospital; 
rural 
Prospective Inclusion: Nulliparous women undergoing 
c/s, fetuses with vertex presentation and 
gestational age older than 36 weeks of 
gestation, and having no maternal comorbid 
disease or not associated obstetric problems  
1389 To compare neonatal and maternal outcomes of the 
primary c/s performed in first stage versus second 
stage of labour. 
D.Geelhoed, 2003 (346) Ghana District hospital, 
rural 
Retrospective All maternal deaths  To measure the impact of the Safe Motherhood 
Initiative on hospital-based maternal mortality since 
its start in 1987. 
G.F.Gonzales, 2013(347) Peru 43 public health 
facilities (40 
hospitals and 3 
health centers); rural 
and urban 
Retrospective All Caesarean sections 
Exclusions: domiciliary deliveries, if no data 
for newborn, incoherent birth weight data in 
relation to gestational age, congenital 
malformation.  
152110 To estimate c/s rates over time during the period 
between 2000 and 2010 in Peru and to present 
outcomes for each mode of delivery. 




Retrospective All Caesarean sections 576 To identify the indications for c/s deliveries. To help 
identify factors associated with variations in CSR and 
help assess the quality of clinical care. 
E. Nelissen, 2013 (349) Tanzania Referral hospital; 
rural 
prospective Inclusion: all maternal near misses and 
maternal deaths 
74 The aim of this study is to assess the occurrence of 
severe maternal morbidity and mortality in a rural 
referral hospital in Tanzania as proposed by the WHO 
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near miss approach and to assess implementation 
levels of key evidence-based interventions in women 
experiencing severe maternal morbidity and 
mortality. 
K.Nahar, 2009 (350) Bangladesh Medical college 
hospital 
Prospective 100 c/s patients randomly selected 225  To determine incidence and indications of LSCS, to 
find out unnecessary indications which may in future 
reduce the incidence rate in the country. 
A.P. Aboyeji, 2007 (187) Nigeria teaching Retrospective All MD between 1997-2002 2016 
 
To determine the maternal mortality ratio in a 
Nigerian tertiary health institution. 
B.C.Ozumba, 2008 (351) Nigeria teaching Retrospective MD  The aim of this study was to identify avoidable factors 
in maternal mortality in Enugu, Nigeria. 
A. I. Eshiet, 2003 (255) Nigeria Teaching  Retrospective All emergency Caesarean sections 1533 To evaluate the morbidity and mortality from 
anaesthesia during the period under review. 
B.C. Ozumba, 2002 (238) Nigeria teaching Retrospective All MD associated with c/s 1684 MD associated with c/s 
E. Ojiyi  2012 (275) Nigeria Teaching  Retrospective All Caesarean sections 363 To determine the rate and the complications 
associated with Caesarean section at the Imo State 
University Teaching Hospital, Orlu 
 
E. Ugwu, 2011 (268) Nigeria Teaching Retrospective All Caesarean sections 980 To determine the rate of caesarean section, pregnancy 
outcome, major indications and complications of  
caesarean section. 
 
E.Y. Kwawukume, 2001 
(352) 
Ghana Teaching; urban Retrospective All Caesarean sections 23171 c/s in developing countries 
G. Chilopora, 2007 (353) Malawi District hospital Prospective All Caesarean sections 2131 To validate the advantages and disadvantages of 
delegation of major obstetric surgery to non-doctors. 
 
G.O. Igberase, 2009 (254) Nigeria; rural tertiary Retrospective All Caesarean sections 1777 To determine the trend in caesarean section rate, 
pattern of presentation and associated maternal 
morbidity and mortality in a tertiary centre in the 
Niger Delta. 
 
I. Kambo, 2002  (277) India Teaching  Prospective 7017 consecutive caesareans 7017 To obtain an estimate of caesarean section rates and 
examine the indications and consequences at teaching 
hospitals in India 
 
A.G. McKenzie, 1998 
(235) 
Zimbabwe Central hospital Prospective major obs procedures 8502 To review anaesthetic-associated deaths (AAD) and 
their avoidable factors. 
N.A. Garba, 2011 (354) Nigeria Teaching Retrospective All Caesarean sections 1005 To determine the cs rate, its morbidity and mortality 
in Aminu Kano teaching hospital, Kano. 
E. Nwobodo, 2011 (245) Nigeria Tertiary Retrospective All Caesarean sections 2284 to determine the caesarean section rate together with 
the trend, indications, and maternal mortality 
associated with elective caesarean operation. 
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U.V. Okafor, 2009 (168) Nigeria teaching Retrospective All Caesarean sections 729 To present the trends of different forms of anaesthesia 
for caesarean section in Eastern Nigeria 
A.O. Okezie, 2007 (242) Nigeria Teaching Retrospective All Caesarean sections 740 To analyse subjects delivered by caesarean sections in 
the University of Nigeria Teaching Hospital (UNTH) 
to determine the caesarean section rate, indications 
and fetal outcome and possible ways of reducing the 
caesarean section rate. 
S.A. Okogbenin, 2004  
(243) 
Nigeria Teaching Retrospective c/s women with cardiac arrest 2218 To review the incidence, associations, and outcome of 
cardiac arrest associated with caesarean section. 
 
T. Kandasamy, 2009 (260) Afghanistan Public maternity 
hospital; urban 
Retrospective All Caesarean sections 392 To use an active facility-based maternal and new-born 
surveillance system to describe caesarean delivery 
practices and outcomes in a resource-poor setting. 
K. Tomta, 2003 (248) Togo Teaching  Prospective All Caesarean sections 306 The objective of this study is to know the results of 
anaesthesia practices, and allow for observation in a 
particularly deprived area. 
W. Wu, 2000 (355) China Teaching hospital  Retrospective All Caesarean sections 1922 This study examined the frequency and indications of 
caesarean birth in Shantou, a southern city in China 
 
N.Fesseha, 2011(356) Ethiopia Mixed Retrospective All caesarean sections 17145 To describe Ethiopian national population-based and 
institutional caesarean delivery rates by sector, and to 
describe indications for caesarean delivery, fetal and 
maternal outcomes, and aspects of quality of care. 
D.A.Adekanle, 2013 (357) Nigeria Teaching; semi-
urban 
Retrospective All caesarean sections 1004 To look at the trends over six years and the 
corresponding perinatal outcome in our health 
facility. 
C.Nwosu, 2004 (274) Nigeria General hospital; 
sub-urban town 
Retrospective  All Caesarean sections 1254 To review the incidence, indications and outcomes of 
Caesarean 
K.Chu, 2012 (358) Sub-Saharan 
Africa 
District hospital Prospective All Caesarean sections 1276 This study reports Caesarean sections rates and 
indications in Democratic Republic of Congo, 
Burundi, and Sierra Leone, and describe the main 
parameters associated with maternal and early 
neonatal mortality. 







Mixed Prospective All Caesarean sections  3233 To determine operative mortality in surgical programs 
from resource-limited settings. 
 
J.Davies 2016 (359) DRC, CAR, 
South sudan 
District Prospective All Caesarean sections 4646 To investigate the POMR of surgical procedure 
including caesarean sections 
M.R. Festin, 2009 (360) Indonesia, 
Malaysia, 
Tertiary and district 
hospitals 
Prospective All Caesarean sections 2592 This audit aimed to report rates and reasons for 




amongst nine hospitals in the four South East Asian 
countries participating in the South East Asia-
Optimising Reproductive and Child Health in 
Developing countries (SEA-ORCHID) project. 
H.F.Akasheh, 2000 (361) Jordan Military Retrospective All Caesarean sections 1339 To review the cs performed at QAMH over a 6 year 
period 
F.Richard, 2008 (362) Burkina Faso District; urban Before and 
after 
All Caesarean sections 1371 To assess the effects of a comprehensive intervention 
(staff training, equipment, internal clinical audits, cost 
sharing system, patients–providers meetings) in 
improving caesarean delivery access and quality in an 
urban district of Burkina Faso. 
 
P.M.Fenton, 2003 (241) Malawi 23 district and 2 
central hospitals; 
rural and urban 
Prospective All Caesarean sections 8070 To examine potentially modifiable factors that may 
influence the high maternal and perinatal mortality 
associated with caesarean section in Malawi. 
G.Kamilya, 2010 (276) India Teaching Retrospective All deliveries after exclusion of medical or 
obstetric comorbidities 
13628  to evaluate the intrinsic risk of maternal death, 
directly attributed to caesarean delivery (CD) 
compared to 
vaginal delivery (VD), and to evaluate further the 
differential risk associated with antepartum and 
intrapartum 
CD. 
P.N.Nana, 2011(363) Cameroon Referral ; semi-
urban 
Faith based ; rural 
Prospective All C-sections (those without a clear 
indication were excluded from the analysis) 
61 The aim of the study was 
to determine maternal, foetal outcomes and cost 
 
A.Moges, 2015 (364) Ethiopia Faith based hospital Retrospective All Caesarean sections after 28 weeks 1547 To determine the prevalence, common indications, 
outcomes and complications of c/s in Attat Hospital, 
Ethiopia. 
O.Akinola, 2010 (365) Nigeria University hospital; 
urban 
Retrospective All Caesarean sections 327 an audit of blood reservation and transfusion practices 
for caesarean section at this centre with a view to 
recommending modifications wherever it is found to 
be suboptimal. 
 
H.Abbassi, 2001(366) Morocco Teaching; urban Retrospective All Caesarean sections 3231 To assess the maternal mortality and morbidity 
associated with c/s 
O.M. Abiodun, 2009 (367) Nigeria Teaching; suburban Retrospective All Caesarean sections- 
 
923 To determine the perinatal mortality rate among 
women who delivered through caesarean section in a 
tertiary health institution in Nigeria and evaluate how 
various social and obstetric factors influence the 
perinatal deaths. 
R.C.Onoh, 2015(368) Nigeria Teaching Retrospective All Caesarean sections 2323 To appraise the cesarean deliveries and the associated 
fetal and maternal outcomes. 
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Y. ali, 1995 (369) Ethiopia Teaching  Prospective All Caesarean sections 100 To provide base line information about the incidence, 
indications and complications of c/s, and suggest 
possible ways of reducing avoidable complications 
S.A.Feresu, 2005 (370) Zimbabwe Central hospital; 
urban 
Retrospective All births 2990 To assess demographic and obstetric risk factors for 
stillbirth and early neonatal death 
 
Swende, 2008(371) Nigeria tertiary Retrospective All Caesarean sections 
 
420 To determine the c/s rate, ascertain the trend of 
emergency c/s, indications for c/s and emergency c/s 
morbidity and mortality at the Federal Medical Centre 
Makurdi. 
S.Wanyonyi, 2006 (372) Kenya University hospital Retrospective All deliveries at the hospital in 2001 and 
2004 
1229  To compare the c/s rate, their indications and the 
perinatal outcome at the Aga Khan University 
hospital for the years 2001 and 2004. 
O.C.Ezechi, 2009 (373) Nigeria Tertiary hospital Retrospective All Caesarean sections 
 
5195 To review the perinatal mortality associated with c/s 
in 4 hospitals in the south western Nigeria 
M.I.Nwafor, 2014 (261) Nigeria University hospital Retrospective Pre-term Caesarean sections excluding those 
for ruptured uterus and multiple pregnancy 
1961 To evaluate perinatal outcome in preterm caesarean 
sections conducted under general anaesthesia (GA) 
and subarachnoid block (SAB) with the aim to 
ascertain any difference in outcome between the two 
methods. 
 
S.Moodliar, 2007 (374) South Africa Tertiary; urban Retrospective All Caesarean sections  744 This study was designed to determine the prevalence 
of complications associated with abdominal delivery 




(Evaluation of Risk 
Factors Associated with 
Recurrent Cesarean 
Section Morbidity) 
Egypt University Prospective 1000 women undergoing Caesarean sections 
under general anaesthesia  
1000 To determine the risk factors related to recurrent c/s 
morbidity and to suggest a morbidity scoring system 
based on these risk factors which can help in the 
prediction of c/s morbidity. 
U. Okafor, 2008 (244) Nigeria Teaching hospital Retrospective Deaths during c/s 1579 To examine the changing trend in maternal deaths 
during caesarean delivery in a tertiary care hospital in 
Nigeria over an 8 year period 





Retrospective Admitted to ICU following c/s due to 
anaesthesia-related complications 
2686 To determine the anaesthesia-related complications 
after c/s in a tertiary hospital 
J.R. Ekoundzola, 2001 
(376) 
DRC University hospital Retrospective All Caesarean sections 745 Babies born by c/s 
P.Foumane, 2014 (270) Cameroon Women and 
children’s hospital 
Retrospective All Caesarean sections 219 To identify the risk factors for 
emergency caesarean deliveries and assess the effects 
of the emergency situation on maternal and fetal 
prognosis. 
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L. Foumsou, 2014 (377) Chad Maternity hospital Prospective All Emergency Caesarean sections 370 The aim of this study was to determine the incidence 
of emergency caesarean in Mother and Child Hospital 
of N’Djamena (Chad).  
 
M.G.Diarra, 2006 Mali Mixed Prospective All Caesarean sections 200 To determine the frequency, indications, prognosis, 
temporary characteristics and cost of c/s. To 
investigate the sociodemographic and psychologic 
profile of women having c/s and to formulate 
recommentions. 
S.Adisso, 2006 (257) Benin University Retrospective All Caesarean sections but focus on 
anaesthetic mortality 
1745 Maternal prognosis following c/s with regards to type 
of anaesthesia used 
P.Imbert, 2003 (258) Senegal Principal hospital Prospective All Emergency Caesarean sections 402 Maternal and paediatric prognosis following 
emergency c/s 
C.T.Cisse, 1998 (271) Senegal Surgical maternity 
hospitals 
Prospective All Caesarean sections 2436 The epidemiology and quality of c/s were investigated 
A.Khan, 2014 (378) Bangladesh Teaching hospital Prospective  130  Caesarean sections randomly selected 130  TO identify the different types & rate of caesarean 
section indications, the outcome of different 
indications, estimate the rate of caesarean section 
proportion of the elective & emergency indications 
and evaluate the complications of caesarean sections. 
A.Rasoarimahandry 
2001 (379) 
Madagascar Central university 
hospital 
Retrospective  529 To evaluate the indications and prognosis of c/s, in 
order to improve caesarean’s management and 
consequently to reduce maternal death. 
D.Goswami, 2013 (174) India Tertiary hospital Prospective All Maternal deaths 8451 The aim of this study was to identify causes of 
maternal mortality at the facility and to assess the 
standard of care, deficiencies in health services and 
preventability of these deaths using facility-based 
maternal death reviews. 
M.E. Akar, 2004 (380) Turkey Research hospital Retrospective All maternal deaths 126779 To determine the incidence and causes of maternal 
deaths in a 20-year period at the Women's Health 
Hospital, Ankara, Turkey 
 
A.N.Johnson, 2012 (381) South Africa Academic hospital Prospective Exclusions: Women who were less than 18 
years of age, had unknown HIV status or 
refused to participate 
272  To determine the incidence of puerperal sepsis after 
c/s at the hospital 
J. Beltman, 2011 (382) Malawi District hospital; 
rural 
Retrospective all cases of obstetric haemorrhage 375 To identify substandard care factors in the 
management of obstetric haemorrhage at district level 
in rural Malawi 
C.Chang, 2011 (239) Taiwan Rural and urban Retrospective All c/s, excluded those with antepartum 
haemorrhage and haemorrhage from 
placenta preavia.  Outcome focus on 
obstetric haemorrhage 
69533 To compare the risk of PPH for patients who 
underwent c/s with general vs spinal/epidural 
anaesthesia 
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A.Zongo, 2015 (383) Senegal and 
Mali 
46 hospitals (mixed 
types); urban and 
rural 
Prospective All deliveries with analysis don’t by mode of 
delivery 
40975 To explore the differential effect of a multifaceted 
intervention on hospital-based maternal mortality 
between patients with cesarean and vaginal delivery 
in low-resource settings. 
V.Govender 2010 (384) South Africa Tertiary Prospective All Caesarean sections 1091 An audit of second stage caesarean section (C/S) at a 
tertiary hospital to compare the frequency of perinatal 
and maternal complications between first and second 
stage C/S and to evaluate the training level of 
physicians. 
T. Belay, 2014 (385) Ethiopia, Addis 
Ababa 
Teaching hospital Prospective For every second stage C/D, the next three 
consecutive first stage C/D cases were taken 
as controls 
388  To compare maternal and perinatal outcomes of 
caesarean delivery (C/D) performed in the second 
stage of labor compared with the first stage in the 
Ethiopian setting. 
J.Moodly, 2009 (386) South Africa District hospital, 
Durban 
Retrospective All Caesarean sections                                            1257  To investigate risks associated with second stage 
caesarean sections 
Rabiu 2011 (387) Nigeria Teaching; urban Retrospective All intrapartum c/s multiple pregnancy, 
previous scar, congenital anomalies, mal-
presentation, significant maternal disease 
excluded. 
3061 To compare maternal and neonatal outcomes between 
caesarean section performed in the first and second 
stages of labour at the maternity unit of the Lagos 
State University Teaching Hospital, Lagos, Nigeria. 
A.Suwal 2013(388) Nepal Teaching hospital/ 
referral hospital; 
urban 
Prospective All lower segment caesarean sections 
(classical excluded)  
254 To compare the maternal and fetal outcome in elective 
and emergency cesarean section. 
M Bokossa 2008 (389) Ivory coast University hospital; 
urban 
Retrospective 197 elective and 197 randomly selected form 
the emergency patients 
1264 To compare outcomes of elective and emergency 
caesarean sections 
K Kizonde 2006 (390) DRC Tertiary hospital Retrospective All caesarean sections 625 To explore maternal and neonatal outcomes following 
caesarean section 
E Ugwa 2015 (391) Nigeria Tertiary; semi-urban Retrospective All Caesarean sections 590 To review the caesarean section rate and perinatal 
mortality in Federal Medical Centre. 
C Tshissuz 2014 DRC Tertiary; urban Retrospective All Emergency Caesarean sections,  312  Outcome focussed on pph and transfusion rate 
associated with caesarean section 






Urban and rural Retrospective All Emergency Caesarean sections: pre-
labour c/s ,  
31821 Aim was to assess the association between caesarean 
delivery and pregnancy outcome at the institutional 
level 
X.De Muylder, 1990 (157) Zimbabwe All health facilities 
in a province in 
Zimbabwe 
Retrospective All the delivery deaths occurring in all the 
health facilities during the study period. 
Exclusions: deaths due to abortion, ectopic 
pregnancy or choriocarcinoma 
3602 To identify which avoidable factors were involved 
most frequently with maternal deaths. 
W.Chau-in, 2010 (249) Thailand Mixed Prospective  16697 to determine the incidence of maternal mortality 
related to anesthesia, to analyze the causes and to 
suggest measures to improve anesthetic safety for the 
parturients. 
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G.Urbani, 2001(392) South Africa Teaching hospitals Prospective All women undergoing c/s who accepted to 
take part, except for those with diabetes 
mellitus. 
307 To document complications associated with cesarean 
section in HIV-infected women. 




The primary objective was to assess the incidence and 
determinants of neonatal morbidity after elective 
caesarean section deliveries. The secondary objective 
was to describe the maternal morbidity associated 
with elective caesarean section. 
W. van den Boogaard, 
2016 (394) 
Burundi Rural Hospital Prospective All Caesarean sections 228 To determine the maternal status of women 2 years 
following a C-section in a district hospital in rural 
Burundi.  
C.M. Ouedraogo, 2015 
(395) 
Burkina Faso District Retrospective All Caesarean sections 3381 To study the epidemiology, clinical and prognostic 
aspects of c/s 
A.Nyamtema, 2016 (395, 
396) 
Tanzania 10 rural centers< 
Tanzania 
Retrospective All Caesarean sections 5868 To describe the results of increasing availability and 
quality of caesarean deliveries and anaesthesia in rural 
Tanzania. 
A.D.Ekanem, 2008 (256) Nigeria Teaching hospital Retrospective All Caesarean sections 431 To assess the maternal outcome of emergency 
caesarean sections in University of Calabar Teaching 
Hospital in relationship to the seniority and 
experience of medical personnel involved in the 
operation 
S.Benzounia, 2016 (397) Morocco Tertiary maternity 
hospital. 
Prospective All the cases of elective and emergency 
caesarean section   
Mothers who had definite antenatal 
complications that would adversely affect 
fetal outcome were excluded from the study. 
588 The objective of the study was to compare the fetal 
outcome and the indications in elective versus 
emergency caesarean section performed in a tertiary 
maternity hospital. 
 
R.Soren, 2016 (398) India Teaching hospital Prospective All subjects undergoing elective and 
emergency Caesarean were included over the 
study period 
2060 To compare emergency and elective Caesarean 
section with regard to intra operative and post-
operative complications in both mother and child. 
 
A.A. El Daba, 2010 (399) Egypt University hospital Retrospective All maternal deaths. Unknown The aim of the study is to estimate the prevalence, 
causes and risk factors of maternal mortality related 
to anaesthesia. 
E.Abe, 2008 (400) Nigeria Central hospital Retrospective MD but Deaths due to abortion and ectopic 
pregnancy were excluded  
 
Unknown To document the maternal mortality rate and pattern 
of obstetric deaths at the Central Hospital, Benin City, 
Edo State, Nigeria. 
G.S. Gebhardt, 2015 (401) South Africa Mixed Retrospective MD and c/s in South Africa Unknown To scrutinise the contribution or effect of the surgical 
procedure on the ultimate cause of death by a cross-
cutting analysis of the  
2011 - 2013 national data. 
P.N. Makinga, 2012 (193) South Africa District hospital Retrospective All reported MD Unknown To determine the clinical and demographic profile of 
maternal deaths, determine the most common primary 
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causes of maternal deaths at district hospital level, 
compare the causes of deaths at district hospital,  
provincial and national level, and to investigate the 
quality of care that was provided to maternal deaths 




Gambia Referral Retrospective All Maternal deaths Unknown To analyse the maternal mortality in the main referral 
hospital in The Gambia, West Africa. 
A. L. Montgomery, 
2014 (403) 
India Mixed Retrospective All Maternal deaths Unknown To estimate the national and regional distribution of 
maternal death and uptake of obstetric service 
indicators among women who died while pregnant or 
postpartum. 
Jayashree, 2014(192) India Government 
teaching hospital 
Prospective All Maternal deaths Unknown To study the MD and the common causes and 




West Africa Mixed Prospective All Maternal deaths Unknown To describe the maternal mortality, estimation of the 
rates and distribution of obstetric causes, from a 
population based survey of pregnant women carried 
out in West Africa. 
 
P.M.Tebeu, 2007 (405) Cameroon Provincial hospital Retrospective All Maternal deaths Unknown The aim of this study was to establish baseline data on 
maternal mortality for future evaluation of pregnancy-
related mortality trends in this city. 
M.N.El-Gharib, 2010 
(406) 
Egypt University hospital Retrospective All Maternal deaths Unknown To assess the etiology, trends and causes of maternal 
mortality in Tanta University Hospital. 
P.Charoenweerakul, 
2009 (407) 
Thailand University hospital Retrospective All Maternal deaths Unknown To analyse the characteristics, leading causes and 
trend of MD at the hospital between the 20th and 21st 
century 
S.J.Pal, 2014 (408) South India District hospital Retrospective Inclusion: all MD occurring during 
pregnancy and within 42 days of delivery, 
ectopic pregnancies, septic abortions, molar 
pregnancies 
Exclusion: all MD occurring after 42 days of 
termination of pregnancy, and accidents 
Unknown To study the causes behind MD in the 3 yr review 
period, to analyse the trend of MMR over 3 years of 
study and to evaluate preventable causes and use the 
data to take measures to reduce MMR. 
A.C.L Granja, 2001 (177) Mozambique Central hospital retrospective
Retrospective 
All Maternal deaths Unknown To describe adolescent maternal mortality and 
analyse its avoidability. 




All Maternal deaths Unknown To investigate the causes of maternal mortality in the 
Dakahlia Governorate in Egypt. 
A. Bashir, 1995 (410) Pakistan Mixed retrospective
Retrospective 




East Sudan  Mixed Retrospective Maternal deaths in that community Unknown To investigate the causes and contributing factors of 
maternal deaths and to identify any discrepancies in 
rates and causes between different areas 
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N. Bano, 2011 (412) Pakistan Mixed prospectivePr
ospective 
All Maternal deaths Unknown To determine maternal mortality to assess the 
achievement of Millennium Development Goal 5 in 
Pakistan and suggest remedial measures. 




All Maternal deaths Unknown This study presents the magnitude and distribution of 
causes of maternal mortality at the beginning of the 
21st century in a Nigerian referral hospital and derives 
recommendations, to reduce the frequency of 
maternal deaths in this centre and in other centres in 
similar setting. 
L.A.O.Ujah, 2005 (170) Nigeria Teaching hospital Retrospective All Maternal deaths Unknown To determine the magnitude, trends, causes and 
characteristics of maternal deaths before and after the 
launch of the Safe Motherhood Initiative in Nigeria, 
with a view to suggesting strategic interventions to 
reduce these deaths. 
J.W.Bolnga, 2014 (414) Papau New 
Guinea 
General hospital Retrospective All Maternal deaths Unknown To assess the frequency, causes, and reporting of 
maternal deaths at a provincial referral hospital in 
coastal Papua New Guinea (PNG), and to describe 
delays in care. 
S.Ray, 2013 (415) Botswana Mixed Retrospective Reported MD Unknown To investigate the underlying circumstances of MD in 
Botswana 
T.T.Kane, 1992 (416) Egypt Mixed Retrospective All Maternal deaths Unknown To determine the incidence and causes of MD in Giza 
Z.Amarin, 2010  (417) Jordan Mixed Retrospective All Maternal deaths Unknown To estimate the number of maternal among Jordanian 
women; to identify the causes of maternal mortality 
P.T.Wagaarachchi, 
2002 (418) 
Sri Lanka Tertiary care 
hospital 
Retrospective All Maternal deaths Unknown To assess the trends in maternal mortality and factors 
affecting substandard care at a tertiary care hospital in 
a developing country. 
A.Kampikaho, 1991 (201) Uganda Mixed Retrospective All Maternal deaths Unknown To estimate MMR, to identify type and cause of MD 
in 5 Kampala hospitals 
S.Mahbouli, 2003 (419) Tunisia Military hospital Retrospective 10 cases of MD Unknown To determine maternal mortality rate during the last 
decade as revealing the quality of obstetrical follow-
up and the necessary measures to be taken. 
M. Kassas, 1995 (420) Egypt Mixed Retrospective All Maternal deaths Unknown To discover avoidable factors and identify the major 
problems and issues that require action concerning 
maternal mortality in Egypt. 
A.Mungra, 1999 (189) Surinam Nationwide (5 
hospitals) 
Retrospective All Maternal deaths Unknown To assess the magnitude, causes and associated 
factors of maternal mortality in Surinam 
 
S. Mukherjee, 2014 (421) India Tertiary teaching 
institute 
Retrospective All Maternal deaths Unknown To study the incidence of maternal deaths and the 
causes at a tertiary (teaching) institute over 6 years 
from January 2006 – December 2010 
A.O. Sule-Odu, 2000 
(160) 
Nigeria Mixed  Retrospective All Maternal deaths Unknown To investigate factors responsible for the high 
maternal deaths so as to reduce it substantially, if not 
eliminate it completely. 
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M.Ashraf, 2015 (422) India Tertiary care center Retrospective All Maternal deaths Unknown To study the maternal mortality and the causes 
resulting in maternal death over 5 years in a tertiary 
care centre, 
W Saleh 2013 (423) Egypt University hospital, 
Cairo 
Retrospective All Maternal deaths Unknown  The aim was to calculate Maternal Mortality Ratio 
(MMR) as well as identify the causes and 
predisposing factors to maternal deaths. 
Karimi-Zarchi 2016(424) Iran Health centers, yazd Retrospective All Maternal deaths Unknown The aim of this study was to determine the frequency 





Malaysia Mixed Retrospective All Maternal deaths Unknown To identify trends in maternal mortality and to analyse 
maternal deaths. 
MOH confidential 
enquiry Malaysia, 1992 
(280) 
Malaysia Mixed Retrospective All Maternal deaths Unknown To identify trends in maternal mortality, analyse 
maternal deaths and formulate recommendations. 
confidential enquiry 
Malaysia, 1993 
Malaysia Mixed Retrospective All Maternal deaths Unknown To statistically analyse maternal deaths that occurred 
in Malaysia, in 1993. 
confidential enquiry 
Malaysia, 1994 (207) 
Malaysia Mixed Retrospective All Maternal deaths Unknown To investigate factors contributing to maternal death 
Confidential enquiry 
Malaysia 1995-96(209) 
Malaysia Mixed Retrospective All deliveries 95529 To identify the major contributory factors to maternal 
death, to then institute remedial measures to reduce 




Malaysia Mixed Retrospective All Maternal deaths Unknown To study the trend of maternal deaths in Malaysia 
Confidential enquiry 
Malaysia 2006-2008 
Malaysia Mixed Retrospective  Unknown To investigate factors contributing to maternal death 
Confidential Enquiry in 
South Africa 2005-2007 
(186) 
South Africa All hospitals; rural 
and urban 
Retrospective All maternal deaths 477210 To investigate maternal mortality in South African, to 
aid make recommendations. 
Confidential Enquiry in 
South Africa 2006-2008 
(190) 
South Africa All hospitals; rural 
and urban 
Retrospective  564271 To investigate maternal mortality in South African, to 
aid make recommendations. 
Saving maternal lives 
2008-10 (190) 
South Africa Mixed Retrospective All maternal deaths Unknown To summarise the findings on confidential enquiries 
into maternal deaths in South Africa for 2008-2010;  
 
Confidential Enquiry in 
South Africa 2011-
13(425) 
South Africa All hospitals; both 
rural and urban 
Retrospective All Maternal deaths 655686 To investigate maternal mortality in South African, to 
aid make recommendations. 
Ministry of Health and 
Population – Egypt, 
2000 (185) 
Egypt Mixed Retrospective  Unknown To investigate maternal mortality in egypt 
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APPENDIX 8: Rate of caesarean section deaths as a proportion of postpartum maternal 








   
Region 
East Asia and Pacific 17 611 2,049 27.5 (22.6; 32.5) 64.2%  
<0.001 
Europe and Central Asia 1 50 135 37.0 (29.3; 45.4) -  
Latin America and the Carribean 16 239 455 73.5 (56.3; 88.4) 37.8%  
Middle-East and North Africa 8 305 1,434 35.7 (14.8; 59.5) 98.2%  
South Asia 18 371 1,517 30.6 (23.7; 37.9) 82.9%  
Sub-saharan Africa 27 1,981 4,528 36.6 (30.6; 42.8) 90.1%  
Year of 
study 
<2000 21 1,158 3,882 31.0 (24.0; 38.5) 95.7%  
0.025 
>2000 66 2,399 6,236 40.4 (33.9; 47.0) 91.7%  
Study 
design 
Prospective 49 370 1,003 42.8 (35.6; 50.2) 63.5%  
0.009 
Retrospective 38 3,187 9,115 32.6 (26.9; 38.6) 96.9%  
Income 
setting 
Low 14 420 835 42.9 (30.5; 55.7) 89.7%  
0.261 Lower-Middle 41 974 3,874 32.1 (25.3; 39.2) 93.1%  
Upper-Middle 32 2,163 5,409 37.6 (30.8; 44.6) 87.9%  
Quality 
Low 5 141 350 37.0 (26.8; 47.8) 71.4%  
0.840 
High 82 3,416 9,768 36.9 (31.6; 42.2) 93.8%  
Overall 87 3557 10,118 36.7 (31.7; 41.7) 93.5% 



























APPENDIX 9: Individual country rates of caesarean section fatality rates/ 1000 
procedures.   
 





Viet Nam 0.239 
Mexico 0.253 






























Cote d'Ivoire 7.552 
Mozambique 8.209 







Burkina Faso 11.35 

























APPENDIX 10: Rates of deaths in women undergoing caesarean section / 1000 
caesarean sections- a sensitivity analysis excluding studies that included only subsets 
of the population. 
 
Outcome CS deaths of total CS (Sensitivity) 
Analysis 
Studies/








East Asia and Pacific 15 140 150,828 0.6 (0.2; 1.0) 74.1% 
<0.001 
Europe and Central Asia 2 51 130,596 0.3 (0.2; 0.4) 98.2% 
Latin America and the Carribean 17 202 215,982 0.6 (0.4; 0.8) 33.4% 
Middle-East and North Africa 6 13 9,021 0.7 (0.1; 1.8) 28.9% 
South Asia 20 258 75,668 2.1 (1.1; 3.3) 83.4% 
Sub-saharan Africa 88 5,737 1,887,464 9.5 (8.2; 10.9) 97.8% 
Year of 
study 
<2000 28 919 299,499 7.5 (4.7; 11.0) 98.4% 
0.015 
>2000 121 5,522 2,173,001 3.8 (3.2; 4.5) 96.5% 
Study 
design 
Prospective 89 1,585 285,217 3.1 (1.9; 4.5) 96.1% 
<0.001 
Retrospective 60 4,856 2,187,283 7.6 (6.5; 8.7) 97.8% 
Income 
setting 
Low 52 1,759 131,481 10.6 (7.8; 13.9) 95.4% 
<0.001 Lower-Middle 39 525 137,595 1.8 (1.0; 2.9) 89.3% 
Upper-Middle 57 4,117 2,200,483 2.5 (2.0; 3.0) 96.0% 
Quality 
Low 23 1,303 120,363 7.5 (5.0; 10.5) 95.1% 
0.005 




District hospital 19 135 17,308 5.7 (3.3; 8.7) 66.9% 
0.013 
Mixed 18 4,713 2,033,020 5.8 (4.3; 7.5) 99.2% 
Private hospital 2 3 1,470 1.5 (0.0; 4.6) 100.0% 
Teaching hospital 38 1,041 224,118 8.8 (5.3; 13.1) 98.2% 
Tertiary hospital 23 281 40,729 8.3 (5.3; 11.8) 89.5% 
Overall 149 6,441 2,472,500 4.5 (3.9; 5.2) 97.1%   
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APPENDIX 11: Caesarean section risk factors related to maternal and fetal outcomes  
  
a. Emergency vs. Elective CS 
Outcome NO. of 
studies 





Events No events Events No events OR     
Maternal death 21 419 129,035 120 125,534 2.17 1.19 3.95 0.011 64.6% 
ITU Admissions 3 282 19,215 391 133,317 2.18 0.39 12.09 0.372 85.5% 
Hysterectomy 6 219 49,018 120 39,806 1.60 0.89 2.89 0.116 64.5% 
Blood transfusion 9 1,844 49,433 794 39,978 1.74 1.02 2.98 0.044 92.8% 
Postpartum haemorrhage 8 153 1,732 47 983 2.87 1.08 7.68 0.035 82.1% 
Anaemia 5 518 1,581 43 479 2.20 1.10 4.39 0.026 65.3% 
Febrile illness 5 350 2,536 68 1,096 1.57 0.87 2.83 0.136 67.9% 
Postpartum infection 3 59 315 6 333 10.16 4.36 23.69 <0.001 0.0% 
Postpartum endometritis 4 33 1,890 9 638 1.171 0.56 2.47 0.677 0.0% 
Wound infection 8 272 3,064 64 837 1.30 0.59 2.89 0.521 82.7% 
Wound dehiscence 2 22 1,464 4 670 3.87 1.26 11.89 0.018 0.0% 
Urinary tract infection 3 41 495 12 447 5.09 1.93 13.42 0.001 24.0% 
Respiratory complications 2 73 1,413 20 654 2.48 1.13 5.43 0.023 48.5% 
Bladder / bowel injury 4 17 2,286 3 975 2.69 0.87 8.18 0.081 0.0% 
Maternal morbidity 1 48 240 19 197 2.07 1.18 3.64 0.011 - 
Uterine extensions 1 28 22 3 47 19.94 5.47 72.71 <0.001 - 
Perinatal death 11 1,624 31,214 105 16,522 4.35 2.86 7.32 <0.001 83.9% 
Low Apgar score- 5 mins.   4 183 608 55 547 3.89 1.83 8.27 <0.001 71.7% 
Neonatal death 1 359 19,700 140 24,523 3.19 2.62 3.88 <0.001 - 
Stillbirth 1 553 20,106 107 24,682 6.34 5.15 7.81 <0.001 - 
 






                First stage  
                 C/S      











4 6 557 1 5,504 12.27 2.87 52.49 0.001 0.0% 
ITU Admissions 
3 10 255 3 1,983 16.68 4.90 56.77 <0.001 0.0% 
Hysterectomy 
5 20 633 3 5,309 22.08 7.56 64.43 <0.001 0.0% 
Blood transfusion 
7 79 2,402 172 6,001 1.99 1.03 3.84 0.041 71.9% 
Postpartum haemorrhage 4 136 441 212 5,307 5.19 1.83 14.73 0.002 83.0% 
Intraoperative complications 3 103 416 220 5,292 17.84 3.34 95.33 0.001 89.7% 
Bladder injury 5 33 778 42 7,617 5.62 2.99 10.58 <0.001 36.9% 
Lower segment tears 3 25 491 26 4,713 7.81 4.28 14.23 <0.001 0.0% 
Febrile illness 4 87 281 125 1,439 4.07 2.95 5.61 <0.001 0.0% 
Postpartum endometritis 2 27 373 172 3,592 1.71 1.11 2.62 0.015 0.0% 
Wound infection 7 72 757 249 6,575 2.77 1.18 6.49 0.019 80.0% 
Uterine extensions 4 86 554 155 6,286 11.45 4.20 31.23 <0.001 85.3% 
Bladder / Uterine extensions 1 4 93 0 291 28.06 1.50 526.01 0.026 - 
Uterine vessel injury 1 13 285 25 3,494 6.38 3.23 12.60 <0.001 - 
Perinatal death 5 23 606 10 5,551 9.23 4.24 20.10 <0.001 0.0% 
Low Apgar score- 5 mins.   3 14 312 7 2,225 11.89 1.09 130.27 0.043 65.8% 
Low Apgar score- 1 mins.   1 15 24 1 38 23.75 2.94 191.59 0.003  
- 
NICU admission 6 134 697 223 6,791 3.57 2.20 5.79 <0.001 69.4% 
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APPENDIX 12: Search history: Accuracy of on-site tests to detect anaemia in 
antenatal care: a systematic review 
 
1. EMBASE; pregnancy.af; 730804 results  
2. EMBASE; exp PREGNANCY/; 595416 results  
3. EMBASE; pregnan*.af; 790375 results 
 4. EMBASE; antenatal.af; 33986 results  
5. EMBASE; ante-natal.af; 603 results 
 6. EMBASE; gravid*.af; 21782 results  
7. EMBASE; parturient.af; 3942 results  
8. EMBASE; prenatal.af; 205568 results 
 9. EMBASE; gestation*.af; 233292 results  
10. EMBASE; 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9; 963515 results  
11. EMBASE; an$emia.ti,ab; 113762 results  
12. EMBASE; exp HEMOGLOBIN/; 222340 results  
13. EMBASE; H$emoglobin.af; 259243 results  
14. EMBASE; Hb.ti,ab; 42341 results  
15. EMBASE; haemoglobin.ti,ab; 35287 results  
16. EMBASE; 12 OR 13 OR 14 OR 15; 292011 results  
17. EMBASE; anaemia.ti,ab; 113762 results  
18. EMBASE; anaemia.ti,ab; 33352 results  
19. EMBASE; 11 OR 17 OR 18; 145584 results  
20. EMBASE; 10 AND 16 AND 19; 3895 results  
21. EMBASE; f$et*.ti,ab,af; 466110 results  
22. EMBASE; cord.ti,ab,af; 289892 results  
23. EMBASE; neonat*.ti,ab,af; 297624 results  
24. EMBASE; placenta.ti,ab; 51372 results  
25. EMBASE; 21 OR 22 OR 23 OR 24; 986330 results  




APPENDIX 13: Study characteristics of accuracy studies for tests to detect anaemia in 
pregnancy.  
Author, Yr Country and setting No. of women Index test Reference test 
Pistorius 
1996(117) 




Copper sulphate Coulter Counter 
Wilkinson 
1997 (118) 
Kwala Zulu, South Africa. 
One mobile clinic team serving 14 
clinic points across the district. 




















Rural maternity clinic 




Colombo district, Sri Lanka 
Field antenatal clinics in 11out of 13 
ministry of health areas in the 
Colombo district 






Anuradhapura district, Sri Lanka 
Ministry of health field clinics 












Community-based antenatal clinics in 
the towns of Gadap, Bin Qasim, 
Kemari, and New Karachi 










JNMC, Sawangi, Wardha 
ANC clinic, civil hospital 







33 villages in Tuljapur and Lohara 








APPENDIX 14: QUADAS-2 quality assessment tool for risk of bias of test accuracy studies 
for the detection of anaemia in pregnancy. 
 















Pistorius 1996        
Wilkinson 1997        
Van den berk 
1999 
?       
Shulman 2001        
Fourn 2004        
Chathurani 2010        
Prapathan 2011        
Khan 2015        
Agnihotri 2015 ?   ?    
Ahankari 2016 ?       













APPENDIX 15: Search strategy for systematic review on pregnancy outcomes in 
women with Tuberculosis. 
 
1. EMBASE; TB.ti,ab; 42940 results. 
2. EMBASE; exp MYCOBACTERIUM TUBERCULOSIS/ OR exp TUBERCULOSIS/; 223787 
results. 
3. EMBASE; exp LATENT TUBERCULOSIS/; 2831 results. 
4. EMBASE; 1 OR 2 OR 3; 236001 results. 
5. EMBASE; (maternal AND mortality).ti,ab; 24924 results. 
6. EMBASE; MATERNAL MORTALITY/; 17214 results. 
7. EMBASE; (maternal AND morbidity).ti,ab; 15710 results. 
8. EMBASE; exp MATERNAL MORBIDITY/; 5705 results. 
9. EMBASE; exp PERINATAL MORTALITY/; 17980 results. 
10. EMBASE; exp PERINATAL MORBIDITY/; 9648 results. 
11. EMBASE; (still AND birth).ti,ab; 11733 results. 
12. EMBASE; (preterm AND birth).ti,ab; 32257 results. 
13. EMBASE; "low birth weight".ti,ab; 25555 results. 
14. EMBASE; "early neonatal death".ti,ab; 476 results. 
15. EMBASE; (congenital AND TB).ti,ab; 124 results. 
16. EMBASE; exp CONGENITAL TUBERCULOSIS/; 91 results. 
17. EMBASE; exp PREGNANCY/; 598759 results. 
18. EMBASE; exp PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY/ 
OR exp 
PREGNANCY COMPLICATION/ OR exp PREGNANCY DISORDER/ OR exp PREGNANCY 
OUTCOME/; 582087 
results. 
19. EMBASE; 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 16 OR 18; 603296 
results. 
20. EMBASE; 4 AND 17 AND 19; 1035 results
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APPENDIX 16: Characteristics of studies included in a systematic review on TB in pregnancy. 
Author/Year Study dates Setting Study design Study population 





Asuquo B, et al 2012 
(426) 




Retrospective cohort study Cases: 24 pregnant women 
with active TB  
Controls: 72 apparently 
healthy pregnant women 
matched for age and socio-
economic status 





-TB milliary- 2 
- TB arthritis- 1 





Preterm birth, Mean birth 
weight   




Cases: 761 pregnant 
women with active TB 
Controls: 3805 apparently 
healthy pregnant women 
matched for age and year 
of delivery 
N.B. HIV/TB co-infected 
women were excluded 




gestational age, and low 
birth weight 
Tripathy SN et al, 2003 
(138) 
1986–2001 Teaching hospital plus 
a private clinic, 
Calcutta, India 
Prospective cohort study Cases: 111 pregnant 
women with active TB 
Controls: 51 apparently 
healthy pregnant women 
matched for age, parity and 








plus  ethambutol; or 
rifampicin, isoniazid, and 
ethambutol  
 
Maternal death and 
neonatal birth weight 
 
Figueroa- Damian R et 
al, 1998 (137) 
1990–1995 Perinatal Institute, 
Mexico city, Mexico 
Prospective cohort study Cases: 25 pregnant women 
with active TB 
Controls:  75 apparently 
healthy pregnant women 
matched for age, 
gestational age and 




Renal Tb - 7 
Either rifampicin plus 
isoniazid; or rifampicin, 
isoniazid, and ethambutol; 




preterm labour, and 
neonatal mortality 
Figueroa- Damian R et 
al, 2001 (428) 
1990–1998 Perinatal Institute, 
Mexico city,  
Retrospective cohort study Cases: 35 pregnant women 
with active TB 
Controls: 105 apparently 
healthy pregnant women 
matched for age, 




Renal Tb- 11      Lymph node 
Tb- 6           Cutaneous Tb- 1 





preterm birth, and perinatal 
death 
Jana N et al, 1994 (429) 1983–1991 Two clinics, 
Chandigarh, India 
Prospective cohort study Cases: 79 pregnant women 
with active TB 
Controls: 316 apparently 
healthy pregnant women 




48% received isoniazid, 
rifampicin, and 
ethabutol.11% isoniazid 
and rifampicin, 15% 
isoniazid and rifampicin. 2 
patients had quadruple 
therapy.  
Preterm labour, small-for-
gestational age, low birth 
weight, and perinatal death 
.  
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Jana N et al, 1999 (136) 1983–1993 One clinic, 
Chandigarh India 
Prospective cohort study Cases: 33 pregnant women 
with active TB 
Controls: 132 apparently 
healthy pregnant women 
matched for age, parity and 
delivered within 48 hours 
of each other 
Extra-pulmonary (33):  
Lymph node Tb-12 Intestine 
Tb- 9    Skeletal Tb- 7       
Renal Tb-                   Tb 
meningitis- 2  Endometrial 
Tb- 1 
62% received isoniazid, 
rifampicin and ethambutol.  
21% received ethambutal, 
rifampicin and 
pyrazinamide.   
  
Maternal morbidity, 
perinatal mortality, preterm 
birth and low birth weight. 
Ali et al, 2011(430) 2008–2010 Maternity hospital, 
Kassala, Sudan 
Retrospective cohort study Cases: 42 pregnant women 
with active TB 
Controls: 42 apparently 
healthy unmatched 
pregnant women attending 
the same hospital 
N.B. 5 women were 








Maternal anaemia, preterm 
birth, and low birth weight 
Maryonawski A et al, 
1971 (431) 
1963–1970 France Retrospective cohort study Cases: 1188 pregnant 
women with active TB 
Controls: 2007 apparently 
healthy pregnant women 
with past history of active 
TB or exposure to TB   









TB hospital, Moscow, 
Russia 
Retrospective cohort study Cases: 371 pregnant 
women with active TB 
Controls: 121 apparently 
healthy unmatched 
pregnant women 
Pulmonary (371) Not all received treatment 
– regimen unknown 
 
Perinatal death, asphyxia, 
congenital anomaly, and 
low birth weight 





TB hospital, Moscow, 
Russia 
Retrospective cohort study Cases: 96 pregnant women 
with active TB 
Controls: 120 apparently 
healthy unmatched 
pregnant women 
Extra-pulmonary (96) Not documented Maternal morbidity and 
preterm birth 





Norway Retrospective cohort study Cases: 542 pregnant 





Pulmonary (542) Not documented Maternal morbidity, 
perinatal death, low birth 
weight, preterm birth, 
congenital anomaly, and 
miscarriage 
Pranevicius A, et al 
2003 (435) 
1993–1997 Teaching hospital, 
Lithuania 
Retrospective cohort study Cases: 77 pregnant women 
with active TB 
Controls: 72 pregnant 
healthy women  
Pulmonary TB (64) 
Extra-pulmonary (13) 
Only 49.3% of women 
received treatment during 
pregnancy.  
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